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ABSTRACT 
In order to initiate an infection, bacteriophages must deliver their large, hydrophilic 
genomes across their host’s hydrophobic cell wall. Bacteriophage φX174 accomplishes 
this task with a set of identical DNA piloting proteins. The structure of the piloting 
protein’s central domain was solved to 2.4 Å resolution. In it, ten proteins are 
oligomerized into an a-helical barrel, or tube, that is long enough to span the host’s cell 
wall and wide enough for the circular, ssDNA to pass through. This structure was used as 
a guide to explore the mechanics of φX174 genome delivery. In the first study, the H-
tube’s highly repetitive primary and quaternary structure made it amenable to a genetic 
analysis using in-frame insertions and deletions. Length-altered proteins were 
characterized for the ability to perform the protein’s three known functions: participation 
in particle assembly, genome translocation, and stimulation of viral protein synthesis.  
 
The tube’s inner surface was altered in the second study. The surface is primarily lined 
with amide and guanidinium containing amino acid side chains with the exception of four 
sites near the tube’s C-terminal end. The four sites are conserved across microvirus 
clades, suggesting that they may play an important role during genome delivery. To test 
this hypothesis and explore the general role of the amide and guanidinium containing side 
chains, the amino acids at these sites were changed to glutamine. The resulting mutants 
had a cold-sensitive phenotype at 22°C. Viral lifecycle steps were assayed in order to 
determine which step was disrupted by the mutant glutamine residues. The results support 
a model in which a balance of forces governs genome delivery: potential energy provided 
by the densely packaged viral genome and/or an osmotic gradient push the genome into 
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the cell, while the tube’s inward facing residues exert a frictional force on the genome as 
it passes. 
 
Bacteriophage must first identify a susceptible host prior to genome delivery. In the final 
study, biochemical and genetic analyses were conducted with two closely related 
bacteriophages, a3 and ST-1. Despite ~90% amino acid identity, the natural host of a3 is 
Escherichia coli C, whereas ST-1 is a K-12-specific phage. To determine which 
structural proteins conferred host range specificity, chimeric virions were generated by 
individually interchanging the coat, spike, or DNA pilot proteins. Interchanging the coat 
protein switched host range. However, host range expansion could be conferred by single 
point mutations in the coat protein. The expansion phenotype was recessive: mutant 
progeny from co-infected cells did not display the phenotype. Novel virus propagation 
and selection protocols were developed to isolate host range expansion mutants. The 
resulting genetic and structural data were consistent enough that host range expansion 
could be predicted, broadening the classical definition of antireceptors to include 
interfaces between protein complexes within the capsid. 
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INTRODUCTION 
 
1.1 Problem Definition 
 
Viral capsids have been honed by selective pressure into machines with two primary 
functions. They need to protect the viral genome until a suitable host cell has been found, 
and once located, they must efficiently penetrate the host’s protective boundaries to 
initiate an infection. These boundaries define cellular life. Without them, a cell is 
incapable of accumulating biologically relevant molecules and it cannot harness 
electrochemical gradients. At a minimum, they consist of semi-permeable lipid 
membranes that provide protection from toxic molecules and foreign genetic elements, 
such as viruses. However, viruses have been evolving alongside their host’s barriers since 
their inception.  
 
Host penetration may be the most critical, yet least understood, step of the viral life cycle. 
In general, a virion must first locate and attach to a permissive host cell. Once bound, the 
virion undergoes irreversible structural changes to initiate the penetration process. The 
penetration event often occurs rapidly and fluidly. There are few, if any, trappable 
intermediate states, which often makes the process an all or nothing event from an 
experimental standpoint. Many of the viral penetration proteins are dynamic and must 
function in multiple environments, including host membranes, the cytoplasm, and the 
viral capsid’s interior. Thus, they typically contain flexible and poorly soluble domains, 
making purification and/or structural determination difficult. Furthermore, mutations 
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intended to study a single aspect of a protein often disrupt its other functions, 
complicating genetic analyses.  
 
The challenges have not blocked progress. Although questions still remain, several 
penetration mechanisms have been well defined. For example, the basic penetration 
mechanism of myoviruses, bacteriophages utilizing contractile tails, is well understood. 
The tail structure attaches to and penetrates the host’s cell wall. Attachment triggers a 
series of conformational changes that propagate through the tail structure, causing its 
contraction. This drives a rigid tube through the cell wall, creating a conduit to the 
cytoplasm for genome transfer. However, several questions remain unanswered, the most 
enigmatic of which is what energy source drives the phage genome into the host’s 
cytoplasm. A deeper understanding of genome delivery mechanisms may elucidate the 
systems’ underlying biophysics. This may allow for its manipulation, which may be 
useful when managing or protecting prokaryotic populations used in industry or those in 
the environment. A more complete understanding of genome delivery could also assist 
drug delivery efforts, which also involve the transfer of large hydrophilic molecules 
across a cell’s hydrophobic barrier.  
 
The genome delivery mechanism of bacteriophage jX174 has been explored in the 
following manuscript. FX174 has been used to explore DNA replication, 
macromolecular assembly, and protein structural relationships for approximately 50 
years. Thus, it has been developed into a genetically tractable system that is easy to 
propagate and manipulate. The phage delivers its genome into an Escherichia coli host 
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with its DNA piloting protein. The basic delivery mechanism was not understood until a 
high-resolution X-ray structure of the piloting protein’s central domain was solved. The 
proteins oligomerize into a tube structure that connects the infecting phage capsid to the 
host’s cytoplasm. This structure was used to formulate and test several structural-
functional hypotheses in an effort to understand the jX174 delivery process and also the 
forces governing genome delivery.  
 
1.2 Literature Review 
 
Bacteriophages are found nearly everywhere bacteria reside and are likely the most 
abundant biological entities on earth, with some estimates having them outnumber their 
bacterial hosts 10 to 1 (1–5). Phages have been grouped into nine taxonomic families 
based on virion morphology and the nature of their genetic material. Each family has a 
distinct capsid morphology with helical, binary, or icosahedral symmetry constructed 
from multiple copies of one, or a few, distinct proteins. Lipid bilayers are also a 
component of some phage capsids, and can line the inner surface of the capsid’s protein 
shell or envelope the capsid within a vesicle.  
 
In order to replicate, phages must identify a susceptible, permissive host, i.e. one 
containing molecular machinery that is compatible with the phage system. For example, 
some phages rely on host chaperones to properly fold their capsid proteins (6, 7). 
Infecting a host lacking the required proteins would be unproductive, therefore phage 
virions have evolved to bind unique molecular markers that are only present on their 
host’s surface. The molecules recognized by virions, termed receptors, vary widely 
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between phage families and species. Surface receptors can include, but are not limited to, 
lipopolysaccharides, membrane proteins, and superstructures such as bacterial pili or 
flagellum (8–11). Once a host has been located, the virion must then penetrate the host’s 
protective barriers and deliver its genetic material to the cytoplasm.  
 
Viruses have been co-evolving with their hosts for billions of years, thus the 
characteristics of a host cell’s external barrier have shaped viral entry mechanisms. 
Animal viruses, for example, can usually interact directly with a host cell’s cytoplasmic 
membrane. This gives them access to the cell’s receptor proteins, allowing them to hijack 
endocytosis machinery to move across the cytoplasmic membrane (12). Plant viruses, by 
contrast, must infect cells encased within an impermeable cell wall. They overcome this 
with the help of an insect vector, whose mouthparts puncture the cell wall and inject the 
virus (13). Bacteriophages must also contend with cell walls of a different type. Bacterial 
cytoplasmic membranes are protected by a complex cell wall composed of multiple 
peptidoglycan and membrane layers. Cell walls come in one of two flavors, termed gram-
positive or gram-negative. Gram-positive walls typically consist of a thick peptidoglycan 
layer facing the extracellular milieu. This is anchored to the cytoplasmic membrane by 
lipid-linked teichoic acids embedded in the peptidoglycan matrix. Gram-negative walls, 
by contrast, are composed of three layers. The outermost component is a lipid bilayer.  Its 
external leaflet is composed of phospholipids and lipopolysaccharides (LPS), which are 
polysaccharide chains linked to a lipid anchor. Sandwiched between the outer and 
cytoplasmic membranes is the periplasm, which is an aqueous space containing a 
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relatively thin peptidoglycan layer and high concentrations of metabolites and proteins, 
including nonspecific nucleases.  
 
The complexity of bacterial cell walls requires equally complex entry mechanisms. The 
mechanisms may be the most critical, yet least understood, aspect of the phage life cycle. 
It is a difficult process to study due to the event’s short duration, lack of intermediate 
steps, and the involved viral proteins are difficult to experimentally characterize. They 
are often poorly soluble and/or are structurally dynamic. Few high-resolution structures 
have been determined, which impedes genetic structure-function analyses. However, 
studies have elucidated the basic genome delivery mechanisms used by many phage 
families, all of which are unique. However, there appear to be three general entry 
methods. In the first, membrane-containing phage virions fuse with or melt into the host’s 
membranes. Families utilizing this method include the membrane containing 
Corticoviridae and the enveloped Cystoviridae. In the second method, the virion interacts 
closely with host cell proteins to penetrate the host. The filamentous Inoviridae and 
icosahedral Leviviridae appear to use this method, hijacking host pilus machinery and 
inner membrane proteins to gain entry. In the third method, the virion carries machinery 
that creates a cell wall spanning channel. This category includes the tailed myo- sipho- 
and podoviridae, the membrane containing Tectiviridae, and the tail-less Microviridae.  
 
1.2.1 The Cystoviridae 
Although most phage virions are composed solely of protein and nucleic acid, lipid 
membranes are a component of some virions. The membranes play a major role in host 
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penetration, and can line the capsid’s inner surface or envelope the capsid within a 
vesicle. Members of the Cysto-, Cortico-, and Tectiviridae families penetrate their hosts 
in significantly different ways. The Cystoviridae will be described first. Phage in this 
family enclose a segmented, dsRNA genome within an enveloped icosahedral capsid 
(Figure 1.1a). Cystovirus j6 was isolated from bean straw in the early 1970s and until 
recently was the only known cystovirus (14–16). An icosahedral image reconstruction of 
its virion has been determined with cyro-electron microscopy (17–19). It has three 
distinct layers. The genome is enclosed within a T=1 polymerase complex found at the 
virion’s center. This complex is responsible for replication and packaging of the RNA 
genome and, unlike other phages, must be delivered to the host’s cytoplasm intact. The 
polymerase complex is encased within a second, T=13, protein shell which is enveloped 
within a lipid bilayer containing the integral membrane proteins P6, P9, and P10. Only P6 
is surface exposed. The host attachment protein, P3, binds to P6’s exposed surface and 
protrudes away from the virion.  
 
Cystoviruses can productively infect members of the pseudomonads and Salmonella 
typhimurium mutants with truncated LPS chains lacking heptose moieties. The virions 
attach to host LPS or the shafts of type IV pili (14, 15, 20). In the j6 system, protein P3 
initially binds to a host pilus (Figure 1.2a). When the pilus retracts, it pulls the virion 
down through the LPS to make contact with the host’s outer membrane (21). P6 then 
mediates membrane fusion with the outer membrane (Figure 1.2b). Membrane fusion was 
verified in vivo by infecting cells with virions containing a high concentration of pyrene-
labeled lipids (22). At high concentrations, the labeled lipids form fluorescence 
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quenching excimers. The excimers break apart and fluoresce if their intra-membrane 
concentration is reduced, which occurs when a labeled membrane fuses with a larger 
membrane. Fluorescence increased after labeled, quenched, wild-type virus was 
incubated with unlabeled, permissive cells. Membrane fusion was further confirmed after 
isolating the outer membranes of infected cells. The viral integral membrane proteins P6, 
P9, and P10 co-purified with the host’s outer membrane fraction. Lastly, an in vitro 
membrane fusion assay was developed to determine which viral proteins triggered fusion. 
Membranes containing fusion promoting proteins can fuse together when brought into 
contact. In this assay, purified j6 particles were brought into contact via centrifugation. 
Wild-type virions did not fuse together. However, fusion was observed after the viral host 
attachment protein P3 was removed. Its removal exposes the surface of viral membrane 
protein P6. Thus, the results suggest that protein P3 is removed from the virion after pilus 
retraction. The newly exposed portion of P6 can then initiate fusion with the host’s outer 
membrane.  
 
The nucleocapsid must traverse the periplasm after membrane fusion. However, the 
nucleocapsid is approximately 50 nm in diameter (14), which is too large to move 
through the periplasm’s peptidoglycan network. A crosslinking analysis of the 
nucleocapsid showed that a lytic enzyme, protein P5, is associated with the 
nucleocapsid’s surface (23). The enzyme was purified and characterized, and was found 
to have endopeptidase activity (24). However, the enzyme is thermolabile, and loses 
activity if incubated at high temperatures (24, 25). This property was exploited to further 
dissect the penetration process. Heat treated virions were capable of fusing with the outer 
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membrane, but became trapped in the periplasm as they could not cross the peptidoglycan 
network (22). Thus, it appears that P5 must create a local lesion in the peptidoglycan 
through which the nucleocapsid passes (24, 25).  Once through the peptidoglycan, the 
nucleocapsid contacts the cytoplasmic membrane where a final protein, P8, interacts with 
the membrane (Figure 1.2c).  
 
200 copies of protein P8 form a pseudo-T=13 lattice around the polymerase complex 
with P4 occupying the five-fold vertices (18, 23). P8 forms a trimer and, when released 
from virions at low pH, can self-assemble into shell-like structures (26). Cvirkaite-
Krupovic and colleagues investigated the interaction between P8 and the cytoplasmic 
membrane (26). They performed membrane flotation assays to determine if a cytoplasmic 
membrane protein was interacting with P8. In these assays, the nucleocapsid was mixed 
with vesicles derived from the host’s cytoplasmic membrane or mock cytoplasmic 
membrane vesicles produced with commercially sourced lipids. The nucleocapsid co-
migrated with both host derived and mock vesicles. Unlike the host derived vesicles, the 
mock vesicles did not contain protein, suggesting that a nucleocapsid component was 
interacting directly with the lipids. The purified nucleocapsid proteins were tested in a 
similar manner. Proteins P2 and P8 floated with the lipid vesicles. However, P2 is buried 
within the nucleocapsid core, while P8 is exposed, indicating that P8 was facilitating the 
interaction. The protein appears to be mainly a-helical and does not contain any 
transmembrane helices based on sequence analysis. Thus P8 is most likely binding the 
lipid head groups, as it likely cannot insert itself into the cytoplasmic membrane. 
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Once protein P8 interacts with the head groups, the final phase of the viral entry process 
is initiated. The nucleocapsid proceeds into the cytoplasm in an endocytic-like manner 
similar to that utilized by animal viruses (Figure 1.2c and d). In the presence of an active 
proton motive force, nucleocapsid-bound P8 proteins create an invagination in the 
cytoplasmic membrane. This closes around the nucleocapsid and buds into the cytoplasm, 
leaving the nucleocapsid within a vesicle (27). The membrane vesicle then breaks down, 
releasing the polymerase complex into the cytoplasm (Figure 1.2e). This process is not 
fully understood. However, approximately 85% of P8 protein appears to be degraded 
during the entry process (27). This may disrupt the membrane vesicle, allowing viral 
genome replication. 
 
1.2.2 The Corticoviridae 
Members of the Corticoviridae infect species of Pseudoalteromonas, marine, gram-
negative bacteria. Although corticoviral prophages appear to be common in marine 
bacterial genomes (28, 29), phage PM2 is the only characterized member. Corticoviruses 
package a circular, dsDNA genome into a membrane vesicle contained within a pseudo-
T=21 icosahedral capsid (30–33). Thus, the envelope is an internal structure (Figure 
1.1b). The capsid contains receptor binding protein P1 at each 5-fold axis of symmetry; 
however, the host receptor has not been identified. The presence of Ca2+ in the receptor 
binding protein and its similarity to bacterial carbohydrate binding proteins suggests that 
it binds host LPS (30). However, the receptor’s presence on the cell surface is dependent 
on intracellular ATP concentration, suggesting that it may be a cell wall spanning 
complex (34). Utilizing an ATP-dependent receptor may be a particularly clever host 
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recognition mechanism, as the virion limits itself to metabolically healthy hosts that can 
support an infection. 
 
The infection cycle of PM2 has not been thoroughly characterized. However, the virus 
does appear to utilize a unique entry mechanism. The proteinaceous capsid, composed of 
proteins P1 and 2, dissociates after receptor recognition (Figure 1.3b), exposing the 
membrane vesicle (35). Viral integral membrane protein PM10 then facilitates membrane 
fusion with the host’s outer membrane (36). The protein’s structure and mechanism of 
action are unknown. This event transfers the genome into the periplasm, where phage 
protein P7 and/or the cellular lytic factor locally degrade the peptidoglycan (34, 35). The 
genome must be protected from periplasmic nucleases at this time, but the mechanism is 
not known. Once through the peptidoglycan, a genome-associated protein creates or 
induces the opening of a cytoplasmic membrane pore (Figure 1.3c). This event is marked 
by the efflux of intracellular K+ ions, which can only cross the cytoplasmic membrane 
through pores or disruptions. K+ release is tightly correlated with genome entry in many 
other phage systems, particularly those that have been shown to open pores for genome 
delivery (37–39). It is assumed that K+ is escaping through the channels used to transfer 
the phage genomes. Thus, a genome associated PM2 protein may create or induce the 
opening of a pore in the in the cytoplasmic membrane through which the genome moves.  
 
1.2.3 The Leviviridae 
Leviviruses package linear, ssRNA genomes into simple T=3 icosahedral capsids 
composed of two protein types (Figure 1.1d). 178 copies of the coat protein constitute the 
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capsid shell and a single copy of the maturation protein occupies one icosahedral vertex 
(40–42). Unlike most phages, levivirus genomes are not packaged into pre-formed 
procapsids. Instead, the genome is a participant in the capsid assembly reaction (43, 44). 
During assembly, the maturation protein binds specific sequences in the genome’s 5’ and 
3’ untranslated regions (45). Coat protein dimers then interact with nucleotide sequences 
known as packaging signals, and assemble into a capsid around the genome.  
 
All known levivirus hosts express conjugative F pili, which are the viruses’ receptor (10, 
41, 46). The viral maturation protein, which can be seen protruding from the capsid in an 
asymmetric cryo-EM reconstruction, attaches to pili shafts (Figure 1.4a) (41, 42). Once 
attached, the virion undergoes its eclipse reaction: the maturation protein cleaves itself 
and the genome becomes RNase sensitive (47–50). The eclipse reaction may occur before 
the virion reaches the cell surface, as phage RNA can be removed from cells with pili 
after virion eclipse (51). The virion can also distinguish between host-bound and severed 
pili, as eclipse only occurs on the former, thus avoiding genome loss (10, 52). However, 
it is not known how the virion makes this distinction. After eclipse, both halves of the 
maturation protein remain attached to the RNA (48). This complex can be isolated and is 
infectious to the intact host (49, 53). After cleavage, the protein-genome complex become 
associated with the host cell, although the details of this step are not understood (Figure 
1.4b) (47). 
 
How the maturation protein-genome complex enters the cell is not known. There are two 
entry routes, directly through the host membrane or through the pilus/pilus pore complex. 
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The complex may remain attached to the pilus until it retracts, bringing the complex in 
contact with the host membrane. However, the X-ray structure of phage Qb’s maturation 
protein may argue against this (54). The structure is slightly similar to bacterial b-barrel 
containing membrane proteins, which are frequently found in bacterial outer membranes. 
However, it seems unlikely that the Qb maturation protein would become membrane 
associated. Although cleavage would alter its structure, the protein does not appear to 
have any transmembrane domains and hydrophobic, surface exposed residues are scant. 
Alternatively, the protein-genome complex may enter the inner lumen of the host’s pilus. 
Virion attachment to the pilus appears to disrupt its structure, which may indicate that the 
phage is inserting its genome into the pilus’s lumen (50). A cyro-EM structure of the F-
pilus showed that there is a 30 Å wide channel running the length of the pilus, which is 
wide enough to accommodate ssDNA and ssRNA (55). Although controversial, there is 
some evidence suggesting ssDNA is transferred through the pilus during conjugation. 
DNA transfer can occur through filters that permit pili passage but prevent direct cell-cell 
contact. Transfer has also been observed between cells that did not appear to be in 
physical contact (56–58). However, the pilus lumen is not wide enough to accommodate 
passage of the intact Qb maturation protein. Maturation protein auto-cleavage may allow 
passage, but the precise timing of cleavage is not known.  
 
1.2.4 The Inoviridae 
Inoviruses are filamentous (Figure 1.1e) (59, 60). Numerous copies of their coat protein, 
p8, form a linear filament with helical symmetry around the circular, ssDNA genome 
(61). One end of the filament holds protein pIII, which is involved in host attachment. 
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Most inovirus pIII proteins attach to pili tips, although some attach to the pilus shaft (62). 
The most studied inoviruses, M13, f1, and fd, attach to the tips of conjugative F-pili (63, 
64). Others, like CTXf and IKe, attach to cholera toxin regulated pili or E. coli N-pili 
tips, respectively (65, 66). Pilus elongation is not required for infection, only the pilus tip 
needs to be exposed on the cell surface (67). Pilus retraction, however, is necessary to 
pull the virion head through the outer membrane to reach its secondary receptor, TolA, 
part of the TolQRA complex (68–70). This complex appears to play a role in cell 
envelope maintenance and cell division (71). Although phage binding may trigger pilus 
retraction, pili appear to randomly enter cycles of extension and retraction (72). Thus, 
virion bound to extended pili may simply wait until they retract. 
 
Protein p3 plays a major role in host recognition, attachment, genome delivery and viral 
egress. The protein has three domains, N1, N2, and C, that are separated by glycine rich 
linkers (73). N2 and N1 recognize and bind the pilus tip and TolA, respectively, to 
initiate an infection. The x-ray structures of both N domains from phage M13 and fd have 
been solved (74). The two domains appear to be folded into a horseshoe-like 
confirmation in receptor-naive virions. N2 binds a pilus tip to initiate the infection 
process (Figure 1.5a). Pilus binding causes domain N1 to swing out, inducing a 
spontaneous prolyl cis-trans isomerization at a proline within the N1-N2 linker (75). This 
locks the N1 domain in its proper position for binding tolA (Figure 1.5b). 
 
Domain C of p3 plays a role in viral egress and entry. During egress, virions are 
simultaneously assembled and extruded through the host’s membranes without damaging 
 25 
the host. Five copies of protein p3 are incorporated into the trailing end of the assembling 
virion. They terminate the assembly process and their C-termini release the “head” of the 
nascent virion from the host’s inner membrane (76). The process is run in reverse during 
entry. P3 domain N2 of the “head” binds the pilus and is pulled into the periplasm where 
domain N1 binds tolA. The subsequent entry steps were elucidated after a p3 
complementation system was developed that separated the C-domain’s entry and egress 
functions (77). In this system, a null-p3 mutant is simultaneously complemented with two 
p3 constructs. One construct contains the wild-type N domains followed by a C domain 
fragment. The resulting protein cannot release phage from cells, but can be incorporated 
into filaments. The second construct contains only the full-length C domain, which 
allows incorporation and release. When expressed, both proteins become simultaneously 
incorporated into chimeric filaments. However, the filaments were not infectious unless 
they contained the wild-type p3 protein. The defect did not appear to affect pilus binding, 
suggesting that the C domain activated during entry only if it was covalently linked to the 
N domains. Subsequent experiments with p3 constructs containing wild-type N domains 
and various C domain fragments showed that an amphipathic α-helix within the C-
domain is required for entry. The domain likely inserts itself into the cytoplasmic 
membrane during infection (Figure 1.5c) (78). Insertion may expose other hydrophobic 
α-helices within the protein, which also merge into the membrane, starting a chain 
reaction in which the trailing coat proteins also merge into the membrane (Figure 1.5d) 
(79, 80). It is unclear how this process is linked to genome delivery, as coat proteins 
become inner membrane associated in the absence of DNA penetration (79). 
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1.2.5 The Tectiviridae 
The most studied tectivirus is PRD1, which packages a linear, dsDNA genome into a 
membrane vesicle contained within a pseudo-T=25 icosahedral capsid (Figure 1.1c) (81–
84). PRD1 capsid walls are constructed with 240 trimers of protein P3 along with several 
accessory proteins. The vertices are occupied by pentamers of P31. Flexible host 
recognition proteins P2 and P5 attach to the P31 pentamers and extend outward from the 
capsid (85). Approximately half of the P3 proteins’ amino-termini are anchored within 
the lipid membrane, securing the membrane to the capsid. The membrane is in a liquid 
crystalline phase and is approximately 50% protein by mass (86, 87). The genome is 
tightly packed within the membrane vesicle, and is estimated to exert ~50 atm of force on 
the capsid walls (88). The overall structure of tectivirus virions are similar to those of the 
corticoviridae. Both encapsidate genome containing membrane vesicles. However, their 
genome delivery mechanisms are quite divergent. 
 
To initiate an infection, PRD1 protein P2 attaches to its receptor (89). Although the exact 
identity of the receptor is unknown, it is a component of conjugative plasmid type P, W, 
or N machinery (Figure 1.6a) (90). Receptor binding likely disrupts the underlying P31 
pentamer, exposing the viral membrane. An extensive deletion analysis of PRD1 proteins 
elucidated the subsequent entry steps (91). Protein P11, which is loosely associated with 
the viral membrane, appears to puncture the host’s outer membrane. Once a hole is 
opened, the viral membrane does not fuse with the host’s membranes. Instead, it 
protrudes through and contacts the peptidoglycan. A membrane 
associated transglycosylase, P7, locally degrades the peptidoglycan. Virions lacking this 
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protein take significantly longer to enter their hosts, suggesting that the virus is not using 
a pre-existing opening through the peptidoglycan, like a pilus channel (92). After or 
while P7 opens a hole in the murein layer, the PRD1 membrane vesicle reorganizes into a 
tube structure connecting the virion to the cytoplasm (Figure 1.6b). 
 
The tube structure has been visualized in situ (93). It emerges from a vertex at the 5-fold 
axis of symmetry, displacing the host interacting pentamer along with its neighboring P3 
trimers. Viral membrane proteins P7, P14, P18, and P32 have been shown to play a role 
in tube formation (89, 91). However, their precise roles have not been defined. The 
density of the tube varies in the cyro-EM structure, suggesting that some of the 
mentioned proteins are acting as scaffolding during its formation. 
 
Efflux of intracellular potassium is correlated with PRD1 genome delivery. The 
potassium is likely escaping through the same channel used to deliver the genome (94). 
This suggests that the membrane vesicle is ion permeable. Some of the vesicle’s integral 
membrane proteins may be ion or water channels. If water permeability facilitates 
genome delivery, then the virus may harness the osmotic gradient between the cytoplasm 
and extracellular environment to drive the genome into the cell (95).  
 
1.2.6 Order Caudovirales: The Myo-, Podo-, and Siphoviridae 
The order Caudovirales contains the well-known tailed phages: the Myo-, Podo-, and 
Siphoviridae. All Caudovirales virions contain linear, dsDNA genomes of varying 
lengths. The genome is stored in an icosahedral head. A tubular, tail-like appendage is 
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connected to the head by a specialized portal structure occupying one of the icosahedral 
verticies. The distal end of the tail can be a relatively simple structure or a large multi-
subunit baseplate to which multiple host-binding fibers or spikes are attached.  
 
The Caudovirales families follow the same general infection pattern (96–98). The virion 
makes a random collision with its host and attaches via the tail’s tip. The initial 
attachment event is a reversible reaction, as the virion can dissociate from the host 
without losing infectivity. Caudovirales reversible attachment is often mediated by tail 
fibers or spikes connected at or near the tip of their virion tail assemblies. These proteins 
usually bind to polysaccharides or membrane proteins. A series of reversible binding 
events may allow the virion to “walk” across the host surface to find a suitable infection 
site, which is often marked with a secondary receptor molecule. Once located, the virion 
then undergoes eclipse, or irreversible receptor binding. This commits the virion to the 
infection and the viral particle loses infectivity. Eclipse of Caudovirales virions is usually 
accompanied by conformational changes in the phage tail. The changes ultimately 
transform the tail into a cell wall spanning conduit. The genome then exits the eclipsed 
particle’s head, flowing through the tail structure and into the cytoplasm.  
 
1.2.6.1 The Myoviridae 
Myoviruses utilize elaborate contractile tails to breach their host’s cell wall (Figure 1.1f). 
Phage T4 is the most studied member, and a number of T4 tail structures have been 
published, including a high-resolution structure of its baseplate (99–101). The baseplate 
is attached to the distal end of the tail. T4 carries two sets of tail fibers, long and short, 
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which are both connected to the baseplate. The long tail fibers appear to make first 
contact with the host cell (Figure 1.7a) (100). Once attached, these fibers propagate their 
binding signal to the baseplate. The short tail fibers, normally folded on the baseplate’s 
bottom, extend and bind irreversibly to the cell surface. This transition is part of a larger 
conformational change in the baseplate, which creates a star-shaped opening at its center. 
Once open, a second series of conformational changes occurs along the length of the tail. 
 
The tail is composed of two concentric tubes, each composed of a repeating protein 
subunit. The outer tube is the tail sheath, whose subunits follow a six-start helical 
arrangement (102). The inner tube is known as the core, which consists of stacked, 
hexameric rings (99). Once the baseplate undergoes its conformational change, a second 
series of changes propagates up the tail sheath (103). The sheath proteins, originally in an 
imbricate arrangement, move as rigid bodies into a compressed, stacked structure (Figure 
1.7b). The change reduces the length of the sheath by approximately 50%, pulling the 
particle’s head towards the host. The tail’s rigid inner core, which is connected to the 
head, is driven into the host. A spike complex at the tip of the tail tube, stabilized by an 
iron ion, is pushed through the outer membrane (104). The spike has glycosidic activity 
(105), and likely digests a local lesion in the peptidoglycan. Afterwards, the spike either 
interacts with the cytoplasmic membrane and/or dissociates, opening the distal end of the 
tail core. The tail tape measure proteins (TMP), stored within the tail tube, exit through 
this opening. The tape measure proteins run along the length of the tail, and are so named 
because they determine the tail’s length during assembly. The T4 tape measure protein 
contains a predicted transmembrane domain within the middle of its sequence (100). 
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Thus, if the spike does not breach the inner membrane, then the tape measure protein may 
perform this function. The genome must then move through the tail tube and into the 
cytoplasm (Figure 1.7c); however, it is not known what triggers genome release. 
 
1.2.6.2 The Siphoviridae 
Siphoviruses utilize long, flexible tails to penetrate their host’s cell wall. (Figure 1.1g). 
The tails are similar to myovirus tail cores and are constructed with a stack of hexameric 
rings assembled around the phage’s TMPs (106, 107). Siphovirus TMPs also determine 
the tail’s length (108, 109). Each tail appears to be built around a core of six TMPs (97, 
110); however, this has yet to be structurally demonstrated. The distal ends of siphovirus 
tails are capped with a tip complex, the structure of which varies between species. They 
can be relatively simple or can resemble myovirus baseplates, and both types may have 
attached tail fibers. Tail fibers and tip complexes contain host cell recognition proteins, 
which bind to host LPS, teichoic acids, or surface proteins (111–113).  
 
After irreversibly attaching to the host, the phage must breach the outer layer of the host’s 
cell wall. This has only been studied in gram-negative siphoviruses: l, T5, and HK97. In 
each system, the TMPs are ejected from the tail after irreversible attachment (Figure 
1.8b). This appears to be a necessary step in the DNA delivery process, as the TMPs 
prevent genome movement by occupying the tail’s central channel. Some TMPs also 
contain predicted transmembrane domains and domains resembling those that digest 
peptidoglycan, both of which would assist cell wall breaching.  
 
 31 
There is evidence that the TMPs interact with components of the cell wall and form 
channels during infection. A purified segment of the T5 TMP digested peptidoglycan and 
triggered fusion of unilamellar vesicles (114, 115). Phage HK97 has been shown to 
require a host periplasmic protein, FkpA, and an inner membrane protein PtsG, to breach 
the host’s inner membrane. The requirements of both proteins are determined by HK97’s 
TMP, suggesting that the TMP is interacting with the specified host proteins (116). The 
phage l TMP may also be interacting with host envelope proteins (117, 118). Mutations 
in a host inner membrane protein, manY, prevented genome delivery. Phage mutants 
were isolated that could plaque on the unsusceptible cell line, and mutations conferred 
changes in the either the TMP or tail tip proteins. Collectively, this suggests that the 
siphovirus TMPs are ejected from the tail and it creates a genome translocating channel 
across the host’s cell wall (Figure 1.8c).  
 
1.2.6.3 The Podoviridae 
Podoviruses have short, stubby tails. Well studied podoviruses include P22, T7, and f29. 
The tail assembly contains host binding proteins projecting away from the virion’s head, 
referred to as tailspikes, although some species utilize fibers like those seen on sipho- and 
myoviruses (119). Like the other tailed phages, these structures bind host LPS or surface 
proteins (120, 121). In some cases, the tail assembly carries two or more types of 
tailspike, each type capable of binding receptors of different hosts (122). The different 
spikes are arranged symmetrically around the tail’s central axis in an alternating pattern. 
Spikes also can have enzymatic activity, allowing the virion to digest its way through 
bacterial capsules and dense, extended LPS arrays to the host’s surface (123, 124). Once 
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through, the virion can engage the secondary receptor with the tail’s central “knob” (9, 
125). The knob likely undergoes a structural change and becomes membrane associated 
(126). This opens the tail’s central channel and may form a pore through the host’s 
outermost membrane (Figure 1.9a). Proteins stored within the virion, termed ejection 
proteins, are then released into the cell wall (Figure 1.9b) (127–130).  
 
Genetic analyses of virion proteins with dynamic extracellular roles, such as ejection 
proteins, are more complex than analyses of intracellular viral proteins. In order to gain 
detailed functional insights, mutations cannot result in absolute lethal phenotypes, i.e. 
mutations can block incorporation during virion morphogenesis or, if incorporated, the 
mutant protein can be entirely non-functional. By contrast, mutations conferring 
conditional lethal phenotypes, such as temperature sensitivity, can reveal temporal and 
functional details that are obscured in absolute lethal phenotypes. One of the first ejection 
proteins to be analyzed was gp16 of phage P22. Ten to twenty copies of Gp16 are found 
within the virion (131). They become associated with phage proheads during virion 
assembly, yet they do not play a structural or scaffolding role, as null-gp16 infections 
produce normal, packaged phage particles. However, the particles are not infectious. Its 
function was not determined until a temperature sensitive gp16 (gp16-ts) mutant was 
isolated (128).  
 
Gp16-ts was used in temperature shift assays to determine when gp16 was active during 
the infection (127, 128). The infection cycle’s pre- and post-genome penetration phases 
were separated by a rapid temperature shift. For example, virions were added to cells at 
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the permissive temperature. After ten minutes, the cells were then quickly shifted to the 
restrictive temperature. This allows adsorption and genome penetration to occur 
permissively, while genome replication and assembly occur restrictively. Cells were 
monitored for infection products to assess when the temperature sensitive gp16 failed to 
function. Infection products accumulated when gp16-ts infections were initiated at the 
permissive temperature. A subsequent shift to the restrictive temperature did not affect 
intracellular steps of the viral life cycle. By contrast, infections initiated at the restrictive 
temperature were blocked. No phage products were observed, even after shifting to 
permissive conditions, suggesting that gp16 played a role during the early infection steps. 
Further experiments showed that gp16-ts particles could adsorb to cells at the restrictive 
temperature and a portion of the genome was released, however it was degraded by host 
enzymes. 
 
Co-infections were performed with gp16-ts and phage containing wild-type gp16 to 
determine if the protein could be provided in trans. Cells were co-infected at the 
restrictive temperature with gp16-ts and a gp16 donor phage. The gp16 donor was 
incapable of genome synthesis, thus infection products are only produced if gp16-ts 
entered a cell. Infection products were observed when gp16 was provided in trans, 
suggesting it is ejected from the virion and plays a role in genome delivery. Later work 
showed that purified gp16 could become associated with membrane fractions. Purified 
gp16 could also trigger the release of dye from vesicles, suggesting it forms a pore for 
genome transport (130). Gp16 and two other proteins, gp7 and gp20, are also ejected 
prior to genome release (129).  Neither protein becomes membrane associated, 
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suggesting that they may function in the gram-negative host’s periplasm or possibly the 
cytoplasm. A low-resolution structure of phage Sf6’s gp20 homolog showed that it forms 
25 Å wide, 150 Å long, decameric channel (132). This may bridge the gap between the 
host’s membranes, like that seen in the cryo-EM tomography structure of phage T7 
infecting E. coli minicells (119). In this structure, it appears that proteins originally 
within the virions head are ejected and form a tubular structure under the virion spanning 
the minicell’s membranes.  
 
1.2.7 The Microviridae 
The Microviridae family is composed of two subfamilies, the Gokusho- and phixvirinae. 
Both subfamilies package circular, ssDNA genomes within small, T=1 icosahedral 
capsids. Very little is known about Gokushovirinae life cycles, especially their 
mechanism of genome delivery. By contrast, the phixvirinae have been studied 
extensively. The subfamily is composed of three genera, named for their canonical 
members a3, G4, and jX174. They infect rough strains of E. coli and Salmonella 
enterica, strains expressing short LPS molecules consisting only of the lipid A moiety 
with its attached backbone and core saccharides. Host LPS molecules are the viruses’ 
only known receptor (8, 133).  
 
Phixvirinae capsids are composed of four structural proteins. Sixty copies of the coat (F 
protein), major spike (G protein), and DNA binding (J protein) proteins compose the 
capsid (134–136). The fourth protein, the DNA piloting protein (H protein), shares 
features with ejection proteins. Each virion contains ten to twelve copies of H protein and 
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they are ejected from the capsid during the infection event. Their location(s) within the 
virion have not been determined, as they cannot be seen in X-ray or cyro-EM virion 
structures, which were determined using averaging techniques (134, 136, 137). By 
contrast, the other capsid proteins are icosahedrally ordered and their structures have 
been determined. The capsid wall is composed of F protein. The highly basic J protein 
binds to a cleft on the inner surface of capsid wall, and is thought to neutralize the 
negatively charged genome. Five copies of G protein decorate the exterior surface of each 
five-fold axis of symmetry, creating a pentagonal frustum rising 32 Å above the coat 
proteins. The G pentamer makes few direct contacts with the underlying coat F pentamer, 
however several indirect contacts are made through coordinated water molecules.  
 
Both F and G proteins play a role in host attachment. As with other phages, two distinct 
attachment steps are required to initiate the infection process, reversible and irreversible 
attachment. Reversible attachment may be mediated by protein F (Figure 1.10a). The 
exterior surface of F contains a Ca2+ dependent sugar binding site, which may bind to 
host LPS sugar moieties to initiate the infection process (138). Although this site is 
conserved in all Phixvirinae clades, there is no direct evidence this site is involved in host 
attachment. If this binding event is reversible, it may allow the virus to “roll” across the 
cell surface until a suitable infection site has been located or multiple sugar binding sites 
become occupied. Irreversible attachment may then occur after host LPS molecules 
interact with the F-G interface, as host range expanding mutations map to this region 
(Chapter 4) (139). 
 
 36 
Irreversible attachment, also called the eclipse reaction, is the committed infection step. 
Two cyro-EM structures of eclipsing jX174 particles bound to an LPS containing bilayer 
have been determined, one of a still-packaged particle and the other post-genome release 
(140). In the structures, one of the virion’s 5-fold axes of symmetry is attached to the 
LPS-containing bilayer. The G-spike has been displaced from this vertex, thus the virion 
is attached via its coat proteins (Figure 1.10b). The location of the displaced G pentamer 
is unknown. Density from the ssDNA genome can be seen within the interior of the 
capsid, which is not uniformly distributed. There is a void above the attached vertex. This 
region may contain an oligomer of DNA piloting proteins, whose role in the infection 
will be discussed below. In the second structure, which lacks DNA density, the attached 
coat protein’s structure is altered. This alteration opens a gate at the 5-fold axis. The 
DNA piloting proteins and genome presumably exit the capsid through this opening. 
 
The DNA piloting protein (H protein) is responsible for “piloting” the phage genome 
through the host’s treacherous cell wall and into the cytoplasm (141, 142). H 
accomplishes this task by creating a channel through the host’s cell wall (Figure 1.10c). 
The structure of the jX174’s H protein channel has been determined (143). In it, residues 
151 to 272 of 10 H proteins are oligomerized into an a-helical barrel (Figure 1.11, PDB 
ID: 4JPP). The barrel, or tube, is 170 Å long with an internal diameter of 22 Å. This is 
long enough to span the host’s membranes and wide enough for two, intercalated strands 
of ssDNA to pass through (144). The barrel has two domains separated by a kink-like 
structure. In domain A, the a-helices contain an 11 residue semi-repeating unit that is 
three helical turns in length (11/3). This switches to a 7/2 semi-repeating unit in domain 
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B. The inner surface of the tube is lined with asparagine, glutamine, and arginine side 
chains. These side chains contain amide and guanidinium moieties, which are frequently 
seen interacting with nucleic acids in other protein structures (145–148). This 
arrangement may be a common feature of polynucleotide translocating tubes. The 
podovirus P22 portal, which is the opening through which the dsDNA genome enters and 
exits the capsid, also features an a-helical barrel with dimensions similar to the H-tube. 
This region of the protein contains semi-repeating hendecad and heptad motifs, 
demarcated by glutamine, asparagine, and arginine residues (143). However, it is not 
known if these residues line the tube’s inner surface, as the portal structure was 
determined to 7.5 Å resolution. The H-tube arrangement is also seen in the portal 
structure of feline calicivirus, a ssRNA virus (149). In the structure, twelve a-helices 
emerge from the portal and form a tube with a minimum internal diameter of 17 Å. 
Several glutamine, asparagine, and arginine residues as well as acidic residues line the 
tube’s inner surface. The tube is much shorter than that formed by H proteins, however 
the calicivirus only needs to penetrate an endosomal membrane and not a gram-negative 
cell wall. 
 
1.2.8 Summary 
Bacteriophage have been co-evolving with their hosts for billions of years, resulting in 
several unique host penetration mechanisms. The mechanisms can be roughly grouped 
into three categories. In the first, the penetration process is initiated when the virion’s 
lipid membranes fuse with the host’s outer membrane. Cystoviruses use this method to 
pass their entire nucleocapsid through the host’s cell wall, while corticoviruses only 
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transport their genome. In the second category, the virion interacts with several host 
proteins to gain access to the cytoplasm. Although the data is sparse at this time, levivirus 
virions may interact extensively with the host’s pilus machinery, while inoviruses rely on 
the host’s TolQRA system to cross the cytoplasmic membrane. The tailed siphoviruses 
may also fall within this category, as their TMPs interact with both periplasmic and inner 
membrane proteins. Lastly, virions in the final category carry proteins capable of forming 
trans-cell wall channels. The channel construction mechanisms are also diverse. 
Tectiviruses use an unusual mechanism in which their virion’s internal lipid vesicle is 
extruded to form a trans-cell wall channel. Proteins associated with the tectivirus virion 
membrane assist in channel formation and prevent membrane fusion. By contrast, myo-, 
sipho-, and podovirus virions all carry tail structures that breach the host’s membrane. 
The myovirus tail can span multiple membranes, while the podo- and siphovirus tails are 
used to eject channel forming proteins through the host’s outer membrane. Finally, the 
tail-less jX174-like viruses create a channel with their DNA-piloting protein.  
 
Although the order of penetration events has been discerned for most bacteriophage 
families, one question still remains: what force or forces move the phage genomes 
through the cell wall? Several mechanisms have been proposed to explain ejection from 
icosahedral capsids (95). The most popularized mechanism points out that the genome 
strands are placed in close proximity. The strands repel each other, and this repulsive 
force pushes the genome out of the capsid once a channel opens. An alternative model 
downplays the role of repulsive forces. Instead, it proposes that osmotic forces power 
genome movement. The genome becomes partially dehydrated during packaging, which 
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creates an osmotic gradient across the capsid. Once a channel to the cytoplasm opens, 
water will flow down its osmotic gradient, i.e. through the capsid and into the cytoplasm. 
This rehydrates and drags the genome through the channel.  
 
Addressing this final question is difficult, as a well-defined in vivo system has not been 
developed. However, the high-resolution structure of the jX174 H-channel has provided 
new details of a DNA translocating channel. This system has been used to explore a 
possible balance of forces governing genome delivery in the jX174 system.  
 
1.3 Dissertation Format 
 
Chapter 1, the introduction, has described the different host penetration processes used by 
nine phage families. Although the processes are diverse and some families use an entirely 
unique entry mechanism, there are common features, such as the use of peptidoglycan 
degrading enzymes, ejection proteins, and construction of cell-wall spanning channels. 
This information is meant to assist the reader in understanding how the following 
microvirus studies fit within a broader context.  
 
Chapter 2 has been accepted with minor revisions to the Journal of Virology. The length 
of the jX714 DNA piloting protein was altered in the first investigation. The repeating 
nature of the protein’s hendecad and heptad motifs suggested that they could be deleted 
or duplicated without abolishing function. This approach was used to address whether 
there are restrictions on the piloting protein tube’s length. 
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Chapter 3 is yet to be submitted to a journal. However, it is a full body of work that is fit 
for publication. The characteristics of the piloting protein tube’s inner surface are 
conserved across phixvirinae clades. 18 of the 23 inward facing side chains belong to an 
arginine, glutamine, or asparagine residue, all of which contain amide or guanidinium 
groups. These groups can form hydrogen bonds with DNA nucleotides, suggesting that 
they may be regulating genome release. The remaining residues are clustered near the 
tube’s C-terminal opening. These residues were replaced with glutamine and subjected to 
a genetic and biochemical analysis to discern the importance of this region and the 
inward facing side chains in general. 
 
Chapter 4 has been accepted with minor revisions to The Journal of Virology. The viral 
proteins responsible for determining phixvirinae host range were identified. Two 
phixviruses, a3 and St-1, are over 90% identical on the nucleotide level. However, a3 
exclusively infects E. coli C, while St-1 infects E. coli K12. Host range expansion 
mutants were isolated with novel selection protocols. The changes conferred by the 
mutations were analyzed and used to identify the protein regions dictating the viruses’ 
host range. 
 
Chapter 5, future directions, discusses the new questions raised by the current results and 
possible ways to address them. 
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1.5 Figure Legends 
FIGURE LEGENDS 
FIG 1.1 Bacteriophage virion morphotypes. a) Cystovirus, b) Corticovirus, c) Tectivirus, 
d) Levivirus, e) Inovirus, f) Myovirus, g) Siphovirus, h) Podovirus, i) Microvirus. Virions 
are not drawn to scale. Black lines represent or outline structural proteins. Dark red, 
edge-less lines represent lipid bilayers. RNA is depicted as brown and orange lines, while 
DNA is depicted as green and blue lines. Pairs of colored lines represent double-stranded 
nucleic acids. 
 
FIG 1.2 Cystovirus j6 penetration steps. a) Host attachment protein P3 binds to a pilus. 
The pilus retracts and triggers P3 dissociation. b) Viral membrane protein P6 initiates 
fusion with the host’s outer membrane (maroon). Nucleocapsid protein P5 locally 
degrades peptidoglycan (purple). c) Protein P8 creates an invagination in the cytoplasmic 
membrane (green). d) The nucleocapsid buds into the cytoplasm. e) Protein P8 degrades 
and disrupts the vesicle, releasing the polymerase complex into the cytoplasm.  
 
FIG 1.3 Corticovirus PM2 penetration steps. a) Receptor binding protein P1 its host 
receptor. b) The capsid dissociates, and viral membrane protein P10 initiates fusion with 
the host’s outer membrane (maroon). Once through, P7 or the cellular lytic factor locally 
degrade the peptidoglycan (purple). c) The genome traverses the cytoplasmic membrane 
(green), possibly by opening a membrane spanning pore. 
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FIG 1.4 Levivirus penetration steps. Few details are known. a) The maturation protein 
binds the host’s conjugative F pili. The maturation protein cleaves itself and the genome 
becomes sensitive to RNases. b) The genome and maturation proteins enter the 
cytoplasm. 
 
FIG 1.5 Inovirus Ff penetration steps. a) Receptor binding protein PIII domain N2 binds 
to a host’s conjugative F pilus tip. The pilus retracts, pulling the virion into the periplasm. 
b) PIII domain N1 binds tolA. c) PIII domain C1 merges into the cytoplasmic membrane 
(green). d) The genome passes into the cytoplasm while the coat proteins dissociate into 
the cytoplasmic membrane.  
 
FIG 1.6 Tectivirus PRD1 penetration steps. a) Receptor binding protein P2 binds a 
component of the conjugative plasmid type P, W, or N machinery. Viral membrane 
protein P11 creates a hole in the outer membrane. The viral membrane protrudes through 
this opening and viral membrane protein P7 locally degrades the peptidoglycan (purple). 
b) Viral membrane proteins P7, P14, P18, and P32 rearrange the viral membrane into a 
tube spanning the cytoplasmic membrane (green). c) The genome passes into the 
cytoplasm.  
 
FIG 1.7 Myovirus penetration steps. a) Tail fibers attach to the host outer membrane 
(maroon), inducing a conformational change within the baseplate. b) The tail sheath 
contracts, driving the rigid tail core through peptidoglycan (purple) to the cytoplasmic 
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membrane (green). c) The tail tip or tape measure proteins penetrate the membrane and 
allow genome release. 
 
FIG 1.8 Siphovirus HK97 penetration steps. a) Tail fibers contact the outer membrane 
(maroon) and the tail tip contacts a secondary protein receptor. b) The tail tape measure 
proteins enter the periplasm, locally degrade the peptidoglycan (purple), and interacts 
with host periplasmic and cytoplasmic membrane proteins (yellow). c) The tape measure 
proteins breach the cytoplasmic membrane (green) and the genome is transferred. 
 
FIG 1.9 Podovirus penetration steps. a) Tail fibers make contact with receptors and the 
tail knob forms a pore through the host’s outer membrane (maroon). b) The ejection 
proteins exit the virion and form a cell wall spanning channel. c) Genome release. 
 
FIG 1.10 Microvirus φX174 penetration steps. a) The virion attaches to host LPS 
molecules (periwinkle). b) A spike pentamer is displaced and the underlying coat proteins 
bind to the outer membrane (maroon). An oligomer of DNA piloting proteins is above the 
attached vertex (red). c) The vertex opens and the DNA piloting proteins are ejected into 
the cell wall where they form a membrane spanning conduit. A portion of the ssDNA 
genome is exposed to host DNA replication machinery. d) The genome is internalized 
while the complementary strand is synthesized. The DNA piloting proteins become 
associated with the cytoplasmic membrane (green) and the dsDNA genome. 
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FIG 1.11 The φX714 DNA piloting protein x-ray structure. Residues 151 to 272 are 
present. Inward facing residues are modeled as sticks. A) View of the structure’s 
longitudinal axis. Four monomers have been removed to display the inner surface. B) 
View from the carboxy terminal opening. PDB ID: 4JPP 
 
 
 
 
 58 
 
Ba
ct
er
io
ph
ag
e 
vi
rio
n 
m
or
ph
ot
yp
es
. 
 59 
 
Cy
sto
vi
ru
s j
6 
pe
ne
tra
tio
n 
ste
ps
 
 60 
 
Co
rti
co
vi
ru
s P
M
2 
pe
ne
tra
tio
n 
ste
ps
 
 61 
 
 
 
 
 
 
 
 
 
 
 
Levivirus penetration steps 
 62 
 
In
ov
iru
s F
f p
en
et
ra
tio
n 
ste
ps
 
 63 
 
Te
ct
iv
iru
s P
RD
1 
pe
ne
tra
tio
n 
ste
ps
 
 64 
 
M
yo
vi
ru
s p
en
et
ra
tio
n 
ste
ps
 
 65 
 
Si
ph
ov
iru
s p
en
et
ra
tio
n 
ste
ps
 
 66 
 
Po
do
vi
ru
s p
en
et
ra
tio
n 
ste
ps
 
 67 
 
 
M
ic
ro
vi
ru
s j
X
17
4 
pe
ne
tra
tio
n 
ste
ps
 
 68 
 
 
 
 
 
 
 
 
The j X174 DNA piloting protein X-ray structure 
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CHAPTER 2 
STRUCTURE-FUNCTION ANALYSIS OF THE FX174 DNA PILOTING 
PROTEIN USING LENGTH-ALTERING MUTATIONS 
 
2.1 Abstract 
Although the jX174 H protein is monomeric during procapsid morphogenesis, 10 
proteins oligomerize to form a DNA translocating conduit (H-tube) for penetration. 
However, the timing and location of H-tube formation are unknown. The H-tube’s highly 
repetitive primary and quaternary structures made it amenable to a genetic analysis using 
in-frame insertions and deletions. Length-altered proteins were characterized for the 
ability to perform the protein’s three known functions: participation in particle assembly, 
genome translocation, and stimulation of viral protein synthesis. Insertion mutants were 
viable. Theoretically, these proteins would produce an assembled tube exceeding the 
capsid’s internal diameter, suggesting that virions do not contain a fully assembled tube. 
Lengthened proteins were also used to test the biological significance of the crystal 
structure. Particles containing H proteins of two different lengths were significantly less 
infectious than both parents, indicating an inability to pilot DNA. Shortened H proteins 
were not fully functional. Although they could still stimulate viral protein synthesis, they 
either were not incorporated into virions or, if incorporated, failed to pilot the genome. 
Mutant proteins that failed to incorporate contained deletions within an 85-amino-acid 
segment, suggesting the existence of an incorporation domain. The revertants of 
shortened H protein mutants fell into two classes. The first class duplicated sequences 
neighboring the deletion, restoring wild- type length but not wild-type sequence. The 
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second class suppressed an incorporation defect, allowing the use of the shortened 
protein. 
 
2.2 Introduction 
Bacteriophages have evolved several mechanisms to transport hydrophilic genomes 
through cell walls containing hydrophobic membranes and peptidoglycan. Myoviruses 
and podoviruses carry tails that, respectively, utilize contractile sheaths (1) and form 
extensions within the membrane (2). In contrast, siphoviruses, filamentous phage, and 
other tail-less viruses co-opt host cell membrane channels for penetration (3–5). 
However, the tail- less microvirus jX174 does not require a host-provided conduit for 
genome transport. Instead, genome translocation is mediated by 10 to 12 copies of the 
DNA-piloting protein H found inside the virion (6–8).  
 
The X-ray structure of H protein’s coiled-coil domain (8, 9) shows 10 parallel proteins 
oligomerized into a tube (Fig. 2.1) The tube is wide enough for passage of the single-
stranded DNA (ssDNA) genome and has been visualized spanning the cell wall. It 
represents the first high-resolution structure of a virally encoded DNA-translocating 
conduit, sharing structural similarities with other viral proteins involved in DNA 
transport. For example, the H structure is entirely a-helical, similar to the a-helical barrel 
domain seen in the P22 portal protein (10, 11). Furthermore, it shares sequence 
similarities with T7 DNA-piloting proteins that form tail tube extensions during infection 
(2, 8). Thus, H protein serves as a paradigm for the assembly and function of long a-
helical supramolecular structures and nanotubes (12, 13).  
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Protein H likely assumes multiple conformations during the jX174 life cycle. For DNA 
translocation, 10 proteins form a 170- Å-long a-helical tube that is separated into two 
domains. The N-terminal domain is composed of 3 11-amino-acid repeating units 
(hendecads), whereas the C-terminal domain is composed of11 7-amino-acid units 
(heptads). Each repeating unit is directly aligned with the equivalent units of neighboring 
H proteins. Although an oligomer is required for DNA translocation, H proteins are 
monomeric in early assembly intermediates (14, 15). Tubes have not been visualized in 
procapsids or virions, but structure determination assumed icosahedral symmetry. 
Therefore, the timing and location of H-tube assembly have yet to be determined. The H-
tube could exist as a fully assembled tube within the capsid or a partially assembled core, 
or it may only assemble externally at the infection site. Lastly, H protein likely assumes a 
third conformation, one required to stimulate viral protein synthesis (16). 
 
Taking advantage of the tube’s repetitive structure, we conducted a genetic analysis: 
altering the protein’s length by the addition or deletion of heptad and hendecad motifs. 
These mutations were used to determine whether larger H proteins could be 
accommodated within the volumetrically constrained capsid or if smaller H proteins 
could span the cell wall for DNA delivery. Length-altered proteins were also assayed for 
function during the intracellular stages of the jX174 life cycle: incorporation during 
assembly and the ability to stimulate the synthesis of other viral proteins. 
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2.3 Results 
Tube length can be increased beyond the internal diameter of the capsid. Although 
the jX174 H-tube structure is a 170-Å-long decamer, H proteins are incorporated as 
monomers during assembly (14, 15). Thus, it is unknown whether they exist within the 
capsid as a fully formed tube, as a partially constructed core, or as monomers ready to 
complete assembly at the infection site. The related bacteriophage G4 encodes two extra 
heptad motifs within its coiled-coil domain, yet the G4 capsid has the same internal 
capsid diameter as jX174, 172 Å. The additional G4 heptads are predicted to assume a 
helical structure (26) If the prediction is correct, the additional heptads would lengthen 
the tube by ~18 Å. While this suggests that the tube is not fully assembled within the 
mature virion, the internal diameter of the G4 capsid was derived from a degraded 
procapsid, not a mature virion (26). To rigorously test whether a fully assembled tube 
exists in the capsid, DNA encoding the two additional G4 heptads was placed within the 
jX174 H gene (H+14). If a fully assembled tube is not encapsidated, motif insertions 
should not inhibit tube assembly or genome piloting. In the structure, neighboring H 
proteins are bound together via specific interhelical contacts between identical heptad and 
hendecad motifs (Fig. 2.1A). If motif alignment is maintained, additional units should not 
dramatically disrupt contacts or reduce tube integrity. Alternatively, if viability requires 
the internal assembly of a complete tube, lengthened H proteins will result in 
noninfectious particles. 
 
The resulting H+14 mutant was viable but exhibited a cold-sensitive (cs) phenotype at 
24°C. This defect was rescued by a variety of point mutations within the inserted codons 
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(Table 2.1; Fig. 1C). To determine if the mutant virions were as infectious as wild-type 
virions, permissively synthesized H+14 particles as well as a cs revertant (H+14 R12L) 
were purified by rate zonal sedimentation and their specific infectivity (PFU/A280) was 
deter- mined. As can be seen in Fig. 2A, both mutant viruses sediment like the wild type: 
the A280 peak coincides with the specific infectivity peak at 114S. The protein 
composition was analyzed by SDS- PAGE (Fig. 2.2C). Elongated proteins were observed 
in mutant particles at wild-type levels as determined by densitometry (data not shown). 
The specific infectivity of the H+14 mutant was reduced compared to that of the wild 
type (Fig. 2.2B). However, reversion of the cs phenotype (H+14 R12L) restored specific 
infectivity to wild-type levels. The H+14 R12L mutant’s wild-type phenotype suggests 
that elongated proteins can be fully tolerated. Thus, it is unlikely that virions contain a 
fully assembled H-tube. Similar results were obtained with the H+11 mutant, which 
contains a duplication of a jX174 hendecad (Fig. 2.1D; see also below). Unlike the 
aforementioned G4-derived heptads, this hendecad is known to form a straight helix in 
the X-ray structure (8).  
 
The jX174 H+14 cs phenotype reflects a kinetic assembly defect. H protein is 
involved in multiple aspects of the viral life cycle, from host attachment to intracellular 
assembly. Previously characterized mutants exhibited both attachment and assembly 
defects (27, 28). Therefore, all aspects of the jX174 H+14 life cycle were analyzed. In 
both attachment and eclipse assays con- ducted at 24°C, the mutant performed like the 
wild type (data not shown). Thus, the kinetics of attachment and the initiation of DNA 
transport (eclipse) did not appear to be affected.  
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Eclipse assays detect the loss of infectivity, which occurs at the initiation of DNA 
piloting. However, they do not determine whether DNA was transported into the 
cytoplasm. Mutations could prevent tube assembly, stall DNA mid-transit, or lower tube 
integrity but not affect eclipse kinetics. In a wild-type infection, a portion of the (+) 
ssDNA genome enters the cytoplasm. Host polymerases then complete genome 
translocation by synthesizing the complementary (-) strand (29), a prerequisite to viral 
transcription and translation. Thus, the kinetics of coat protein synthesis can serve as a 
surrogate marker for genome piloting. Lysis- resistant cells were infected at 24°C with 
wild-type jX174 or the H+14 or H+14 R12L mutant. At designated time points, aliquots 
were removed and whole-cell lysates analyzed by SDS-PAGE (Fig. 2.3A). Coat protein 
band intensity was quantified relative to a host protein band (Fig. 2.3B). The appearance 
and accumulation of coat protein in H+14 mutant-infected cells closely matched those in 
cells infected with the wild type, suggesting that genome piloting is not dramatically 
affected at the restrictive temperature. 
 
During the same experiment, the kinetics of virion production were also monitored; at 
each time point, samples of infected cells were chemically lysed, and titers of infectious 
particles were determined. The kinetics of H+14 progeny production were significantly 
reduced (Fig. 2.3C). Wild-type titers exceeded the input value at 100 min post-infection, 
whereas H+14 mutant titers did not reach that level until 150 min post-infection. Slow 
assembly likely prevents H⫹ 14 mutant plaque formation on lysis-sensitive cells. Lysis is 
programmed to occur during host division (30). Progeny must be produced prior to this 
 75 
event, which occurred at approximately 110 min during these experiments. TheR12 L 
substitution in the H+14 R12L cs revertant partially alleviated this kinetic defect. 
However, kinetics were not restored to wild-type levels (see Discussion).  
 
The reduced infectivity of virions containing two species of piloting protein further 
validate the X-ray structure. In the H-tube, monomers are bound together through a set 
of specific interhelical contacts. As seen in other coiled-coil structures (31), these 
contacts keep monomers parallel and in register, aligning equivalent heptad and hendecad 
motifs. This arrangement likely confers stability during tube assembly and/or DNA 
piloting. A virion containing H proteins of differing lengths could not achieve this 
arrangement and may not assemble into a functional tube. Since H proteins are 
incorporated as monomers during assembly, it is possible to assemble particles containing 
a heterogeneous complement of H proteins. However, these particles should exhibit 
reduced infectivity. To test this hypothesis, lysis-resistant cells were coinfected with the 
wild type and the equally infectious H+14 R12L mutant at 37°C. Particles were purified 
and assayed for protein content and specific infectivity. As shown in Fig. 2C, the wild-
type and H+14 R12LH proteins were found in particles at approximately equal levels. 
The specific infectivity of the heterogeneous particles was reduced compared to those of 
homogeneous wild-type and H+14 R12L populations (Fig. 2.2B). Similar results were 
obtained for wild-type-infected cells expressing the cloned H+14 R12L gene (data not 
shown).  
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Proteins with deleted hendecad and heptad motifs fail to transport DNA or are not 
incorporated into virions. During genome piloting, the coiled-coil domain spans the 
periplasmic space or a membrane adhesion zone (8, 32). A minimal length is likely 
required to bridge this gap. Although characterizing the phenotypes associated with 
length-shortened tubes could directly ad- dress this question, internal deletions could also 
affect H protein incorporation or oligomerization. To explore these possibilities, nine 
cloned H genes with internal deletions were constructed. The mutant genes lacked DNA 
encoding a single hendecad (D11), a single heptad (D7), or two sequential heptads (D14). 
Cloned-gene expression was assayed for the ability to complement an am(H) mutant or 
inhibit wild-type plaque formation. Unlike the cloned wild-type gene, the mutant genes 
were unable to complement (Table 2.2). Although wild-type plating efficiency was not 
significantly lowered, the expression of the D11-1 and D11-2 genes reduced wild-type 
plaque size. Expression of the remaining genes, the D11-3, D7-3, D7-10, D14-2&3, D14-
3&4, D14-9&10, and D14- 10&11 genes, did not affect wild-type plating efficiency or 
plaque size. 
 
To determine whether the DH proteins failed to function in DNA transport or were not 
incorporated during assembly, lysis-resistant cells expressing the deletion constructs were 
infected with an am(H) mutant. The resulting particles were purified (Fig. 2.4A and B), 
and their protein composition (Fig. 2.4D and E) and specific infectivity (Table 2.3) were 
determined. In this assay, specific infectivity is strictly defined as PFU/A280, regardless of 
the genotype of the plaque-forming particle. For particles generated in cells expressing 
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the mutant H genes, plaques were formed by am+ revertants. Thus, the actual specific 
infectivity of the mutant particles is lower than the assay suggested.  
 
The sedimentation profiles of the am(H) infections are depicted in Fig. 4A and B. 
Particles containing mutant H proteins or lacking H protein are known to sediment at 
110S and/or 70S (33). Therefore, naturally occurring am+ revertants were used to 
estimate particle S values. When the am(H) mutant was complemented by the cloned 
wild-type gene, particle infectivity and absorbance peaks aligned. In contrast, particles 
from infections with uncomplemented mutants or from cells expressing the D7 and D14 H 
genes migrated in two distinct peaks. The material in the faster peak migrated slightly 
slower than 114S. As previously documented for particles that sediment at 110S (33), 
these particles exhibited a reduced specific infectivity (Table 2.3) and lacked scaffolding 
proteins (Fig. 2.4D and E). The A260/A280 ratios, used to estimate DNA content, did not 
significantly differ from that of the wild type (data not shown). The rightmost peak is 
likely composed of 70S particles. Noninfectious, they arise from aborted genome 
packaging attempts or premature eclipse (33). 
 
Although all infections of D7- and D14 gene-expressing cells produced assembled 
particles (Fig. 2.4A and B), H protein content varied depending on which heptad(s) was 
deleted (Fig. 2.4D). Only the proteins lacking just the 10th or both the 10th and 11th hep- 
tads appeared to be incorporated efficiently. However, the expression of these cloned 
genes did not affect wild-type plating efficiency or plaque size, as would be expected if 
virions contained H proteins of two different lengths. This suggests that the shortened 
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proteins cannot compete with the wild-type protein for incorporation. To test this 
hypothesis, cells expressing the clonedD7-10 or D14-10&11 genes were infected with 
either wild-type or am(H) jX174. Cells expressing the cloned D14-9&10 gene were used 
as a control for an unincorporated protein. Expression of the cloned genes did not appear 
to affect wild-type progeny sedimentation (Fig. 2.4D): infectivity and A280 peaks 
coincided, and specific infectivity was not significantly reduced (Table 2.3). Particles 
were analyzed by SDS-PAGE (Fig. 2.4E). For each exogenously expressed DH gene, the 
particles synthesized in cells infected with either the wild type or the am(H) mutant were 
analyzed adjacent to each other. The wild-type H protein migrates more slowly than the 
DH proteins. While the D7-10 or D14-10&11 proteins are present in the particles 
produced in the am(H) mutant infections, only the larger wild-type protein is present in 
the particles isolated from wild- type-infected cells. 
 
A similar analysis was conducted with D11 proteins. am(H) progeny produced in cells 
expressing D11 H genes were characterized as described above. The resulting particles 
were not infectious and migrated slower than 114S (Fig. 2.5A and Table 2.3). H 
protein content varied depending on which hendecad motif was deleted. As can be seen 
in Fig. 5C, D11-1 and D11-2 proteins were incorporated into particles, whereas D11-3 
proteins were not. As previously described, D11-1 and D11-2 gene expression reduced 
wild-type plaque size. To investigate this dominant negative effect, cells expressing D11 
constructs were infected with the wild-type virus (Fig. 2.5B). Particles synthesized in 
D11-1 and D11-2 gene- expressing cells exhibited a reduced infectivity compared to those 
assembled in D11-3 gene-expressing or nonexpressing cells (Table 2.3). The D11-1 and 
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D11-2 proteins were incorporated at approximately equal levels alongside the wild-type 
protein (Fig. 2.5C). Incorporation of the D11-1 and D11-2 proteins likely reduced both 
infectivity and plaque size. 
 
Irrespective of functional piloting and incorporation, all mutant proteins retain 
some level of function. In addition to the aforementioned functions, de novo H protein 
synthesis is required for the efficient production ofother viral proteins (16). To deter- 
mine if the D7, D11, and D14Hproteins retained the last function, lysis-resistant cells 
expressing the DH gene constructs were infected with an am(H) mutant. The resulting 
whole-cell lysates were examined by SDS-PAGE 3 h post infection. Without 
complementation, the amount of viral coat protein seen in lysates of cells infected with 
the am(H) mutant is greatly diminished (Fig. 2.6, top, rightmost lane). Complementation 
with the wild type or any of the DH genes restored coat protein levels to that observed in 
infections with the wild type. This result demonstrates that once in the cell, this additional 
function occurs independently of the protein’s ability to be incorporated into particles. 
 
Reversion analysis of DH mutants. To determine if the virus could adapt and utilize the 
DH proteins, a reversion analysis was conducted. For this analysis, the DH genes were 
constructed directly within the jX174 genome instead of being expressed from a 
plasmid. This allows selective pressure to be applied to all viral genes. The resulting 
strains displayed a complementation-dependent phenotype, growing only in cells 
expressing a cloned wild- type gene (Table 2.4). A cloned H gene from the related a3 
bacteriophage also complemented. Based on sequence similarities, the overall 
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architecture and length of the a3 and jX174 coiled-coil domains are identical. To avoid 
recovering wild-type recombinants when selecting for second-site revertants, DH mutants 
were propagated in cells expressing the a3 H gene before the selection. Although the D7-
10, D11-1, D11-2, and D14-10&11 mutants were recovered, they could not be propagated 
in cells synthesizing the a3 H protein, likely because the proteins could outcompete a3 H 
for incorporation. To alleviate this problem, an amber mutation was placed at a glutamine 
codon immediately upstream of the deleted hendecad or heptad(s), resulting in the D7-
10am, D11- 1am, D11-2am, and D14-10&11am mutants. Although this prevented the 
synthesis of the DH proteins during viral propagation, DH-utilizing mutants could still be 
isolated on supE cells. The supE informational suppressor inserts glutamine at amber 
codons during translation. 
 
Revertants were selected for the loss of the complementation- dependent phenotype. Only 
two types of revertants were isolated, one each from the D11-1am and D7-3 mutants. In 
the D11-1am revertant, the hendecad immediately following the deletion was duplicated. 
Thus, the revertant (D11-1am+11) possessed a wild- type number of hendecads but not a 
wild-type sequence. This mutant was independently isolated from two stocks; in each in- 
stance, it appeared at a frequency of 10-9. Amber reversion resulted in the D11-1+11 
strain (Fig. 2.1E), which displayed a wild-type plating phenotype and specific infectivity 
(data not shown). In addition, a more complex reversion event occurred during strain 
construction. The resulting H+11 mutant contained four hendecads (Fig. 2.1D). Its 
phenotype and specific infectivity were similar to those of the wild type. In coinfections, 
both the wild- type and H+11 proteins were incorporated into particles. These particles 
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also exhibited a reduced specific infectivity, 4.7´1011 PFU/A280, compared to 1.7 ´1012 
PFU/A280 and 9.7´1011 PFU/A280 for the wild-type and H+11 parents, respectively.  
 
The D7-3 revertant contained a true deletion utilizer. It was 
isolated from two independently grown stocks at a frequency of 10-8 (Table 2.4). A single 
point mutation in gene H, causing a G®V substitution at amino acid 80, restored plaque 
formation. Although utilizers of the other DH proteins were not found above a frequency 
of 10-9, recombination rescue experiments were performed to determine if the G80V 
mutation was active in other backgrounds. Two plasmids containing only a portion of the 
H gene were used in these experiments. One plasmid contained the G80V mutation, 
while the other contained only wild-type sequence. As these plasmids contain only the 
first 149 codons of the complete 328 codon gene, DH or am(H) mutant plaque formation 
requires recombination with the plasmid. These results are presented in Table 2.4. A 
mutant with an amber mutation at codon 26, the am(H)Q26 mutant, served as a positive 
control. In the absence of a complementing clone, it exhibited a reversion frequency of 
4´10-6. However, in the presence of the wild-type or G80V H gene fragments, plating 
efficiency rose to 10-3 and 9.0´10-4, respectively. The higher plating efficiency on non-
complementing cells resulted from recombination rescue. The D7-3 revertant produced 
viable recombinants in cells containing the G80V gene H fragment at a frequency of 
3´10-4. No viable recombinants were obtained in cells containing the wild-type gene H 
fragment (frequency < 5.0´10-7). The plating efficiencies of the remaining mutants—the 
D7-10am, D11-1am, D11-2am, D11-3, D14-2&3, D14-3&4, D14-9&10, and D14-
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10&11am mutants—were several orders of magnitude lower than the positive control, 
indicating that the G80V mutation is not active in these backgrounds. 
 
2.4 Discussion 
Fully assembled tubes are unlikely to exist in the capsid. The inner diameter of the 
jX174 capsid is 172 Å, whereas the H-tube is 170 Å in length. The similar dimensions 
suggest that the assembled tube is not stored in the capsid. To test this hypothesis, tubes 
were theoretically lengthened by inserting either one hendecad or two heptad motifs, 
increasing the tube length by 16 or 18 Å, respectively. However, the X-ray structures of 
the length-altered proteins were not determined.  
 
The H+14 mutant displayed a cs phenotype and a reduced specific infectivity, 
approximately one-half the wild-type value. At the restrictive temperature, attachment, 
eclipse, and DNA piloting appeared to be unaffected; however, mutant particles 
assembled more slowly than the wild-type control. The underlying molecular defect 
remains to be determined. The mutant H protein could be incorporated into pentameric 
assembly intermediates more slowly than the wild-type protein, or the resulting 
intermediates may be less efficiently organized into procapsids. Nonetheless, a single 
substitution within the inserted sequence (H+14 R12L) suppressed the assembly defect 
and restored specific infectivity to the wild-type level. The nearly wild-type phenotype of 
the H+14 R12L, as well as the wild-type phenotype of the H+11 mutant, demonstrates 
that the virus can tolerate these insertions. This result, along with the absence of an 
external tail-like structure, strongly suggests that the H-tube is not fully assembled in the 
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capsid. The proteins may remain monomeric or could associate into a semiassembled, 
core-like structure. A core could be located in the virion’s center or situated under a 
single 5-fold axis of symmetry, creating a unique vertex. Further structural studies are 
necessary to investigate these possibilities. Previous X-ray structures or electron 
microscopy (EM) reconstructions could not determine the location of H proteins due to 
the imposition of icosahedral averaging and/or noise created by the packaged DNA (8, 
34, 35).  
 
Defective particles containing functional H proteins of differing lengths support the 
biological significance of the X-ray structure. In the H-tube structure, equivalent 
heptad and hendecad motifs are aligned via specific interhelical contacts. This 
arrangement likely keeps the parallel a-helices in register, possibly guiding tube 
assembly and ensuring stability during genome piloting. If functional H proteins of 
differing lengths were packaged into the same particle, the length mismatch would place 
a-helices out of register and likely prevent proper tube assembly. To test the biological 
significance of this arrangement, cells were coinfected with wild-type and the equally 
infectious H+14 R12L or H+11 mutants. The two H proteins were found at equal levels 
in the resulting 114S particle population, but a significant portion of the population was 
defective. The incorporation of both H protein species likely explains the loss of specific 
infectivity. This reduction was not complete; approximately 10% of particles were still 
infectious. Virions can carry 12 H proteins. However, only 10 compose an H-tube. 
Although some virions may contain 10 identical H proteins, the probability of this 
randomly occurring is far lower than 10% if each species of H protein is incorporated 
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with equal efficiency. Indeed, the elongated and wild-type H proteins appear to be 
present in the progeny population at roughly equal levels. This suggests that a functional 
tube can be constructed with some heterogeneous protein combinations or that there is a 
cis-acting mechanism that partially governs assembly: i.e., virions are preferentially 
assembled from proteins translated from the same message. Similar results were obtained 
with the D11-1 and D11-2 deletion proteins that could effectively compete with the wild-
type protein. 
 
Deletions of hendecad and heptad motifs result in H protein incorporation defects 
and/or infectivity loss. The DH proteins can be divided into two groups: those that were 
incorporated into virions and those that were not. H proteins containing deletions within 
an 85-amino-acid segment, spanning the third hendecad to the ninth heptad, were not 
efficiently incorporated into particles (Fig. 2.4D). This region either contains an 
incorporation domain or is essential for its proper folding. However, a single amino acid 
substitution, G80V, in cis with the D7-3 mutation resulted in viable virions. This 
suppressor is allele specific, rescuing only the D7-3 mutant. This mutation resides 128 
residues away from the deletion, possibly indicating that multiple regions affect 
incorporation. Alternatively, the G80V substitution may suppress com- peting off-
pathway reactions favored by the D7-3 H protein. The other deletions may more 
efficiently promote these competing reactions, requiring multiple or stronger suppressors. 
Alterna- tively, the G80V substitution could rescue the incorporation of these proteins, 
but unlike D7-3 protein, they may be unable to form functional tubes. Our assays were 
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based on the formation of viable progeny; thus, they do not distinguish between these 
models. 
 
Proteins with deletions of the first two hendecads or the last two heptads were 
incorporated. However, these particles were un- infectious, indicating a defect in tube 
formation or genome piloting. These proteins differed in the ability to compete with the 
wild-type H protein. When the wild type was allowed to assemble in the presence of D11-
1 and D11-2 proteins, the two species were incorporated at approximately equal levels. 
As before, the resulting hybrid particles exhibited reduced infectivity. In contrast, 
only the wild-type H protein was found in particles synthesized in the presence of the D7-
10 and D14-10&11 proteins. 
 
Tube length requirements and its evolution. A minimum tube length is likely required 
to span the cell wall. Compared to the wild-type structure, deletions of two heptads, one 
hendecad, or a single heptad would, respectively, shorten the 170-Å tube by 
approximately 18 Å, 16 Å, or 9 Å. The G80V mutation permitted D7-3 mutant protein 
incorporation into viable progeny, which reduces the minimum tube length to 161 Å. The 
assays used in these studies measure viability: DH proteins that fail to properly 
oligomerize cannot be distinguished from those too short to span the cell wall. Thus, the 
minimal tube length imposed by the host has not been precisely determined. The tube 
length required for infectivity could change throughout the course of evolution. If the cell 
wall became thicker, the virus would need to adapt by duplicating DNA encoding 
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repeating motifs. Indeed, duplication events occurred during our studies: the D11-1 
mutant duplicated a neighboring hendecad, restoring the protein to wild-type length. 
 
Multiple functions likely require multiple structures. H protein must adopt at least 
two conformations during the viral life cycle. It is incorporated as a monomer during 
procapsid assembly and then oligomerizes into a tube during infection. As discussed 
above, both conformations can be perturbed by deleting a hendecad or heptad. It was 
previously demonstrated that efficient viral coat protein production requires de novo H 
protein synthesis (16), indicating that H plays another intracellular role in the viral life 
cycle independent of assembly. Thus, it is likely that H has a third conformation. 
Regardless of the incorporation and tube assembly defects, exogenous expression of each 
DH construct restored am(H) coat protein synthesis to wild-type levels, indicating that its 
ability to perform this third function has remained intact. The region(s) of the protein 
associated with this function has yet to be determined. 
 
2.5 Materials, Methods, and Acknowledgements 
Phage plating, media, buffers, and stock preparation. Plating, media, buffers, and 
stock preparation have been previously described (17). 
 
Bacterial strains, phage strains, and plasmids. The Escherichia coli C strains C122 
(Su-), BAF5 (supE), and BAF30 (recA) have been previously described (17, 18). RY7211 
contains a mutation in the mraY gene, conferring resistance to viral E protein-mediated 
lysis (19). 
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The jX174 H gene was cloned by PCR amplification. DNA between nucleotides 2931 
and 3917 in the published sequence (20) was amplified with primers that introduced an 
XbaI site upstream of the gene’s start codon and a downstream XhoI site. The PCR 
product was digested with XbaI and XhoI and ligated into pSE420 DNA (Invitrogen) 
digested with the same enzymes. 
 
Cloned D11 H genes were constructed by first PCR amplifying the gene’s 5’ region up to 
the hendecad to be deleted. The upstream primer introduced an XbaI site as described 
above. The introduced downstream restriction sites were SacII for the D11-1 gene, NaeI 
for the D11-2 gene, and SpeI for the D11-3 gene. The PCR product and pSE420 were 
digested with the desired enzymes and ligated. The remaining 3’ H gene codons were 
then PCR amplified with primers introducing restriction sites at each end of the product. 
The downstream primer introduced an XhoI site, while the upstream primers introduced 
the matching restriction site downstream of the 5’ cloned fragment. The PCR products 
and the respective cloned 5’ genes were digested and ligated. 
 
Clones of all D7 and D14 H genes were constructed by directly mu- 
tagenizing the cloned jX174 H gene. Primers were designed to flank the heptad(s) to be 
deleted. The entire plasmid was then PCR amplified using Q5 DNA polymerase (New 
England BioLabs [NEB]) and the requisite primers. The PCR product’s 5’ hydroxyl 
termini were phosphorylated and ends ligated using T4 polynucleotide kinase and ligase 
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(New England BioLabs), respectively. The nucleotide sequence of all clones was verified 
by a direct DNA sequencing analysis. 
 
The H+14 clone was generated by first PCR amplifying nucleotides 2931 to 3719 of the 
jX174 sequence, which includes the 5’ region of gene H up to the insertion site for the 
additional 14 codons. The upstream primer introduced an XbaI site as described above. 
The downstream primer introduced seven codons of the inserted sequence and a BmgBI 
restriction site. The PCR product was digested with XbaI and BmgBI and ligated into 
pSE420 digested with the same enzymes. jX174 nucleotides 3720 to 3917 were then 
PCR amplified. The upstream primer introduced a BmgBI restriction site along with the 
remaining seven codons of the inserted sequence. The downstream primer introduced an 
XhoI site. The PCR product and the previously constructed clone were digested with 
BmgBI and XhoI. The digestion products were ligated, resulting in the cloned H+14 
gene. 
 
jX174 H+14 was generated via recombination-rescue with a non-expressing H+14 clone. 
A mutant containing an amber mutation at codon E265 in gene H, the am(H)E265 
mutant, was plated on cells containing the plasmid at 37°C. Plaques that developed at a 
frequency higher than the am+ reversion frequency were isolated. The H genes were 
sequenced to confirm the presence of the inserted codons. 
 
To generate the jX174 D11-1am and D11-2am amber mutants, ssDNA 
 89 
was first mutated by site-directed mutagenesis as previously described (21). For the D11-
1am mutant, Eco53KI and EcoRV restriction sites were, respectively, introduced into 
gene H codons 154 and 165 and 166 along with an amber mutation in codon 151. For the 
D11-2am mutant, Eco53KI and EcoRV restriction sites were, respectively, introduced in 
codons 164 and 165 and 175 and 176 with an amber mutation in codon 158. The mutated 
DNA was transfected into cells expressing the wild-type H gene. The resulting amber 
mutants were isolated and their replicative-form (RF) DNA was purified as previously 
described (22), digested with the requisite enzymes, and re-ligated. The ligation product 
was transfected into cells expressing the H gene of phage a3, and the resulting D11-1am 
and D11-2am mutants were isolated and sequenced to verify the genotype. 
 
The jX174 D7-3, D7-10am, D11-3, D14-2&3, D14-3&4, D14-9&10, and D14-10&11am 
mutants were generated using the same method as used to generate D7 and D14 H gene 
clones. Primers flanked the hendecad or heptad(s) to be deleted and, if necessary, 
introduced amber codons. The entire genome was then PCR amplified with Q5 DNA 
polymerase (NEB) and the described primers. The product’s 5’ hydroxyl termini were 
phosphorylated and ends ligated using T4 polynucleotide kinase and ligase (NEB), 
respectively. The resulting viral genomes were transfected into cells expressing the H 
gene of phage a3. Mutants were isolated as described above and sequenced to verify their 
genotypes. 
 
Generation of ssDNAand double-stranded RF DNA, rate zonal sedimentation, and 
protein electrophoresis. The protocols for ssDNA and double-stranded RF DNA 
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isolation and purification, rate zonal sedimentation, and protein electrophoresis protocols 
have been previously described (21–23).  
 
Attachment, eclipse, and coat protein quantification. Attachment and eclipse assays 
have been previously described (24, 25). Coat protein quantification as a surrogate 
marker for genome piloting was performed as follows. Phage were pre-attached to 
RY7211 cells infected at a multiplicity of infection (MOI) of1.0 in HFB buffer (17) at 
15°C and incubated for 30 min. The infected cells were pelleted at 4°C and the 
supernatant was removed. Infected cells were suspended in 1.0 ml of iced TKY medium 
(1.0% tryptone, 0.5% KCl, 0.5% yeast extract) with 10mM MgCl2 and 5.0 mM CaCl2. 
The infected cells were added to 9.0 ml of TKY broth with 10 mM MgCl2 and 5 mM 
CaCl2 warmed to the experimental temperatures. At the desired time points, 1.0-ml 
aliquots were pelleted and resuspended in 0.1 ml of HFB buffer. Ten microliters of the 
concentrated sample was diluted into 90 µl of BE buffer (17) containing 10 mg/ml of 
lysozyme. Infected cells were allowed to lyse overnight at 4°C, and the titers of released 
virions were determined. The remainder of the concentrated sample was placed at -20°C 
immediately after collection. Thirty-microliter volumes of the concentrated samples were 
run on SDS-PAGE gels as previously described (23). SDS-PAGE gels were stained with 
Coomassie brilliant blue and digitized with a LICOR scanner. Relative coat protein levels 
were determined by densitometry analysis using ImageJ software (NIH). Coat protein 
intensity was normalized to the intensity of a host protein band indicated in Fig. 3. 
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2.7 Figures and Tables 
 
 
TABLE 2.1 Plating efficiencya of H+14 and revertant mutants 
––––––––––––––––––––––––––––––––––––––––––––––––– 
           Temperature 
                                    ––––––––––––––––––––––––––––––– 
Mutant   24°C  33°C  42°C 
––––––––––––––––––––––––––––––––––––––––––––––––– 
Wild-Type  0.6  1.0  0.9 
H+14   1×10-4  1.0  0.9 
H+14 T3Ib  4×10-2  1.0  1.5 
H+14 R5H  0.3  1.0  0.6 
H+14 H7Y  0.2  1.0  0.5 
H+14 R12L  0.1  1.0  0.5 
––––––––––––––––––––––––––––––––––––––––––––––––– 
a Plating efficiency is defined as assay titer/titer at 33°C. 
b Revertant names reflect the amino substitution found in within 
the inserted two heptads. Thus, T3I indicates a TàI substitution for  
amino acid 3 in the inserted sequence (Figure 2.1C).  
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TABLE 2.2 Wild-type and am(H) plating efficienciesa on cells expressing   
Δ7, Δ11, or Δ14 H genes at 33°C. 
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
    Virus 
   –––––––––––––––––––– WTc plaque size 
Expressed gene  am(H)b wild-type reduction >50% 
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
None    6.0 × 10-5 1.0  No 
 
Wild-type H   1.0  1.1  No 
 
Δ7-3    1.5×10-4 1.1  No 
 
Δ7-10    1.6×10-4 1.0  No 
 
Δ14-2&3   1.6×10-4 1.1  No 
 
Δ14-3&4   1.8×10-4 1.1  No 
 
Δ14-9&10   1.7×10-4 0.8  No 
 
Δ14-10&11   1.9×10-4 0.9  No 
 
Δ11-1    <4.0×10-6 0.5  No 
 
Δ11-2    2.0 ×10-4 1.2  Yes 
 
Δ11-3    2.0 ×10-4 1.5  Yes 
 
––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
a For am(H), plating efficiency is defined as assay titer/titer on cells expressing 
the wild-type H gene. For wild-type, it is defined as assay titer/titer on cells with 
no cloned gene.  
b am(H)G7 was used in the experiments with Δ7 and Δ14 H genes, whereas 
am(H)Q158 was used in experiments with Δ11 genes. Both amber mutants 
exhibited the same reversion am+ frequency. 
C Plaques were compared to those formed on cells expressing the wild-type H 
gene.  
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TABLE 2.3 Specific Infectivity (pfu/A280) of 110S-114S particles produced in am(H)G7 
and wild-type infections in cells expressing Δ7, Δ11, and Δ14 genes 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
         Specific infectivitya  
  Expressed ––––––––––––––––––––– H Proteins Corresponding 
Virus  Gene  Rawb  Normalizedc Incorporatedd Figure   
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
 
am(H)G7 None  2.0 × 1010 2.0 × 10-2 None  Fig. 4A, B, & D 
  WT H  9.0 × 1011 1.0  Yes  Fig. 4A, B, & D 
  Δ7-3  9.0 × 109 1.0 × 10-2 None   Fig. 4A & D 
  Δ7-10  4.0 × 109 5.0 × 10-3 Yes  Fig. 4B, D & E 
  Δ14-2&3 7.0 × 109 8.0 × 10-3 Trace  Fig. 4A & D 
  Δ14-3&4 2.0 × 1010 2.0 × 10-2 Trace  Fig. 4A & D 
  Δ14-9&10 2.0 × 108 2.0 × 10-4 No  Fig. 4B, D & E 
  Δ14-10&11 2.0 × 108 2.0 × 10-4 Yes  Fig. 4B, D & E 
 
Wild-Type None  2.0 × 1012 1.0  WT  Fig. 4C & E 
  Δ7-3  9.0 × 1011 0.5  only WT Data not shown 
  Δ7-10  2.0 × 1012 0.8  only WT Fig. 4C & E 
  Δ14-2&3 1.0 × 1012 0.6  only WT Data not shown 
  Δ14-3&4 2.0 × 1012 1.1  only WT Data not shown 
  Δ14-9&10 2.0 × 1012 1.2  only WT Fig. 4C & E 
  Δ14-10&11 1.0 × 1012 0.8  only WT Fig. 4C & E 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
 
Continued on following page 
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TABLE 2.3 Continued 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
    Specific infectivitya  
  Expressed ––––––––––––––––––––– H Proteins Corresponding 
Virus  Gene  Rawb  Normalizedc Incorporatedd Figuree  
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
 
am(H)G7 WT H  4.0 × 1011 1.0  Yes  Fig 5A & C 
  Δ11-1  2.0 × 108 5.0 × 10-4 Yes  Fig 5A & C 
  Δ11-2  2.0 × 108 5.0 × 10-4 Yes  Fig 5A & C 
  Δ11-3  4.0 × 107 9.0 ×10-5 No  Fig 5A & C 
 
Wild-type none  4.0 × 1011 1.0  WT  Fig 5B &C 
  Δ11-1  2.0 × 1010 7.0 × 10-2 Both proteins Fig 5B &C 
  Δ11-2  2.0 × 1010 4.0 × 10-2 Both proteins Fig 5B &C 
  Δ11-3  4.0 × 1011 1.1  Only WT Fig 5B &C 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
a In these assays specific infectivity is strictly defined as pfu’s/A280, regardless of the 
genotype of the plaque-forming particle (see text for details).  
b Raw data is pfu’s/A280.  
c For experiments conducted with am(H)G7, data is normalized to the specific infectivity 
of particles generated in cells expressing the wild-type H gene. For experiments 
conducted with wild-type jX174, data is normalized to the specific infectivity of 
particles generated in cells without mutant cloned gene expression.  
d For experiments conducted with am(H)G7, “Yes” indicates that mutant H protein was 
found at levels comparable to the particles generated in cells expressing the wild-type H 
gene; “No:” H protein levels were below the sensitivity required for detection; “Trace:” a 
faint amount of protein could be detected by SDS-PAGE.  
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TABLE 2.4 Plating efficiencya and recombination rescue of Δ7, Δ11, and Δ14 mutant 
phage. 
 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
 
  Expressed cloned gene   Unexpressed clone of codons 1-149 
  –––––––––––––––––––   –––––––––––––––––––––––––––––––––– 
Virus  None Wild-type H   without G80V  with G80V  
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
 
am(H)Q26 4.0 ×10-6 1.0  1.0 × 10-3c  9.0 × 10-4 
 
Δ11-1amb 1.0×10-9 1.0  <3×10-6   <3×10-6  
  
Δ11-2am  <3×10-9 1.0  <5×10-7   <5×10-7  
 
Δ11-3  <2.0 × 10-9 1.0  <1.0 ×10-6  <1.0 × 10-6  
 
Δ7-3  1.0 × 1 0-8 1.0  <5.0 × 10-7  3.0 × 10-4 
 
Δ7-10am <8.0 × 10-9 1.0  <1.0 × 10-6  <1.0 × 10-6 
 
Δ14-2&3 <8.0 × 10-10 1.0  <8.0 × 10-6  <8.0 × 10-6 
 
Δ14-3&4 <3.0 × 10-10 1.0  <2.0 × 10-7  <2.0 × 10-7 
 
Δ14-9&10 <6.0×10-10 1.0  <3.0 × 10-7  <3.0 × 10-7  
 
Δ14-10&11am <1×10-9  1.0  <1×10-6   <1×10-6 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
 
a Plating efficiency is defined as assay titer/titer on cells expressing the wild-type H gene.  
b Plating efficiencies calculated with titers obtained on sup+ cells containing the specified 
clone. 
c bold text indicates recombination rescue.  
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FIGURE LEGENDS 
 
FIG. 2.1 H protein structure and sequence. (A) The crystal structure of the H protein 
coiled-coil domain (PDB ID: 4JPP). A single monomer is shown in cyan. (B) The 
sequence of the H protein’s structured region.  Hendecad and heptad start positions, 
sequences, and numerical designations are listed in the figure. (C) The sequence and 
position of the 14 inserted amino acids found in the H+14 mutant. Mutant residues are 
underlined. Arrows indicate mutated residues found in cs revertants. (D) The sequence 
and position of the inserted hendecad found in the H+11 mutant. (E) The sequence and 
position of the hendecad duplication found in the Δ11-1 revertant. 
 
FIG. 2.2 Assembled particles produced in wild-type (black circles), H+14 (white 
circles), and H+14 R12L (white squares), and wild-type ´ H+14 R12L infected cells 
(black squares). (A) 280nm absorbance profiles of infected cell extracts analyzed by rate 
zonal sedimentation. Fraction 1 represents the gradient bottom. Profiles were aligned by 
the most infectious fraction, marked 114S. (B) Specific infectivity (pfu/A280 ×1012) of 
fractions. (C) SDS-PAGE analysis of 114S peaks.  
 
FIG. 2.3 Characterization of the H+14 mutant. (A) SDS-PAGE analysis of cells infected 
with either wild-type, H+14, or H+14 R12L. (B) Quantification of coat to host protein 
ratios seen in panel A; wild-type (black circles), H+14 (white circles), H+14 R12L (white 
squares). The host protein used in this analysis is indicated in the figure. (C) Titers of 
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progeny produced in wild-type (black circles), H+14 (white circles), or H+14 R12L 
(white squares) infected cells. 
 
FIG 2.4 Characterization of the Δ7 and Δ14 proteins in am(H) or wild-type infected cells. 
280nm absorbance profiles of either am(H) (A and B) or wild-type (C) infected cell 
extracts analyzed by rate zonal sedimentation. Particles were assembled in cells 
expressing cloned wild-type H (black), Δ7-3 (green), Δ7-10 (yellow), Δ14-2&3 (red), 
Δ14-3&4 (blue), Δ14-9&10 (purple), Δ14-10&11 (maroon) genes, and in non-expressing 
cells (white). Fraction 1 represents the gradient bottom. Profiles were aligned by the most 
infectious fraction, marked 114S. (D) SDS-PAGE analysis of particles produced in 
am(H) infected cells expressing cloned wild-type H (WT H), Δ7-3 (Δ3), Δ7-10 (Δ10), 
Δ14-2&3 (Δ2&3), Δ14-3&4 (Δ3&4), Δ14-9&10 (Δ9&10), and Δ14-10&11 (Δ10&11) 
genes, or non-expressing cells (NE). (E) SDS-PAGE analysis comparing wild-type and 
am(H) particles synthesized in cells expressing Δ7-10, Δ14-9&10, or Δ14-10&11 genes. 
 
FIG. 2.5 Characterization of the Δ11 proteins in am(H) or wild-type infected cells. 
280nm absorbance profiles of either am(H) (A) or wild-type (B) infected cell extracts 
analyzed by rate zonal sedimentation. Particles were assembled in cells expressing cloned 
wild-type (black), Δ11-1 (blue), Δ11-2 (green), Δ11-3 (purple) H genes, and in the 
absence of cloned gene expression (white). (C) SDS-PAGE analysis comparing wild-type 
(WT) and am(H) particles synthesized in cells expressing Δ11-1, Δ11-2, or Δ11-3 H 
genes.  
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FIG 2.6 Viral protein levels in am(H) infected cells with and without ΔH gene 
expression. Viral coat protein levels in uninfected (UI), wild-type (WT), and am(H) 
infected cells expressing the ΔH gene constructs. 
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FIG 2.1 H protein structure and sequence 
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FIG 2.2 Assembled particles produced in wild-type, H+14, H+14 R12L, and wild-type ´ 
H+14 R12L infected cells  
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FIG 2.3 Characterization of the H + 14 mutant 
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FIG 2.4 Characterization of the D7 and D14 proteins in am(H) or wild-type infected cells 
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FIG 2.5 Characterization of the D11 proteins in am(H) or wild-type infected cells 
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CHAPTER 3 
MUTAGENIC ANALYSIS OF A DNA TRANSLOCATING TUBE’S INTERIOR 
SURFACE 
 
 
3.1 Abstract 
To initiate an infection, bacteriophage ΦX174 uses a collection of identical DNA piloting 
proteins to move its genome into a host Escherichia coli. To accomplish this, the piloting 
proteins oligomerize into a cell wall spanning, decameric tube that is wide enough for the 
genome to pass through. The inner surface of the tube is primarily lined with amide and 
guanidinium containing amino acid side chains with the exception of four sites near the 
tube’s C-terminal end. The four sites are conserved across microvirus clades, suggesting 
that they may play an important role during genome delivery. To test this hypothesis and 
explore the general role of the amide and guanidinium containing side chains, the amino 
acids at these sites were changed to glutamine. The resulting mutants had a cold-sensitive 
phenotype at 22°C. Viral lifecycle steps were assayed in order to determine which step 
was disrupted by the mutant glutamine residues. Virion assembly, host adsorption, and 
virion eclipse were not affected. Genome delivery, however, appeared to be inhibited. 
The genome delivery event was dissected into two parts: 1) channel formation was 
observed by monitoring cytoplasmic K+ efflux, and 2) the location of the infecting 
genomes within fractionated host membranes was tracked with qPCR. The results support 
a model in which a balance of forces governs genome delivery: potential energy provided 
by the densely packaged viral genome and/or an osmotic gradient push the genome into 
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the cell, while the tube’s inward facing residues exert a frictional force on the genome as 
it passes.  
 
3.2 Introduction 
To establish an infection, bacteriophages (phages) must move their hydrophilic genomes 
through hydrophobic host cell membranes. In general, phage virions undergo irreversible 
conformational changes after binding their requisite host surface receptor. The changes 
allow specialized cell wall breaching proteins to create an opening in the host’s 
cytoplasmic membrane through which the genome passes. Genome transfer is powered 
by potential energy that may be stored within the highly condensed, packaged genome or 
by the osmotic gradient existing across the cytoplasmic membrane (1, 2).  
 
The mechanism by which phage breach the gram-negative cell wall varies between phage 
families.  Myovirus contractile tails push a rigid tube through the outer membrane and 
periplasm, allowing the tail’s tip to puncture the cytoplasmic membrane. The linear, 
dsDNA genome then moves through this tube into the cytoplasm (3–5). Like myoviruses, 
podo- and siphoviruses use tail structures to breach outer membranes. However, their 
tails are not contractile; instead, proteins are ejected from the virion that form an inner 
membrane traversing conduit (6, 7).  By contrast, the tail-less, icosahedral leviviruses use 
an attachment protein that binds to host pili (8). Pilus retraction pulls the virion to the cell 
surface where the attachment protein with its bound RNA genome enter the cell (9, 10). 
Similarly, filamentous inoviruses initially attach to host pili(11). Again, retraction brings 
the virion within reach of cytoplasmic membrane. Interactions between the virion and a 
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host periplasmic protein allow the viral coat proteins to melt into the cytoplasmic 
membrane, simultaneously delivering the ssDNA genome to the cytoplasm (12, 13).  
 
The mechanism employed by the icosahedral, tail-less, ssDNA containing microviruses 
combines many features observed in the aforementioned phages. Microviruses first attach 
to host lipopolysaccharides, triggering the removal of a spike protein G complex at the 
membrane-interacting vertex (14). Whether the spike complex melds into the membrane, 
as is seen with inovirus coat proteins, is not known.  A portion of the newly exposed coat 
protein pentamer interacts with the host’s outer membrane. The coat proteins undergo a 
conformational change to form a pore at the virion’s 5-fold axis of symmetry that is 
reminiscent of myovirus base plates transforming from closed to star configurations. 
Then, like the sipho and podovirus ejection proteins, 10 copies of the DNA pilot protein 
H emerge from the capsid. They form a genome translocating channel which has been 
visualized traversing the cell wall (15). 
 
Protein H is monomeric during early assembly and within the procapsid (16–20); 
however, 10 encapsidated monomers must oligomerize for genome delivery(15). 
Although an H oligomer appears to exist in unopened, membrane-bound virions (14), it is 
unknown whether the monomers oligomerize into a core structure prior to host contact 
like that seen inside the T7 virion (5). After the virion opens, the H proteins form a 
channel to the cytoplasm through which ΦX174’s circular, ssDNA genome moves. 
Afterwards, both H and the genome become associated with the host’s cytoplasmic 
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membrane in a process that appears to be coupled to synthesis of the complementary 
genomic strand (21–23).  
 
An X-ray structure of the φX174 H protein’s central domain was solved to 2.4 Å 
resolution (15). In the structure (Figure 3.1A), H protein residues 151-271 form a 
decameric a-helical tube that is 170 Å long and 22-25 Å wide. Although tube-like 
oligomers are typically associated with phages, a similar structure has recently been 
reported in caliciviruses (24).  H protein likely adopts this structure during genome 
delivery, as the tube is long enough to span the host’s cell wall and wide enough to 
permit passage of the circular genome’s two antiparallel ssDNA strands (25). The tube’s 
inner surface is primarily lined with amino acid side chains containing amide and 
guanidinium moieties. 18 of the 23 inward facing positions are occupied by asparagine, 
glutamine, and arginine side chains, with glutamine being the most abundant (Figure 
3.1C). As these amino acids are frequently observed interacting with DNA nucleotides in 
other protein structures (26–29), they may be facilitating the release and transit of the 
phage genome. 
 
Four of the five inward facing sites lacking amide and guanidinium groups cluster near 
the H-tube’s C-terminus: T244, M251, K254, and E258 (Figure 3.1C and D). The 
location and chemical characteristics of this region are conserved across the three 
microvirus clades, indicating that this region may be important for optimal DNA 
transport. To test this hypothesis and explore the general role of the amide and 
guanidinium groups, the amino acids at these sites were changed to glutamine. The 
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results of the subsequent genetic and biochemical analyses suggest a general model in 
which the H-tube’s inner surface exerts a frictional force on the passing viral genome. 
This may balance the force provided by capsid pressure and/or the osmotic gradient that 
drives the genome into the cytoplasm, thereby regulating genome delivery.  
 
3.3 Results 
Mutating inward facing residues to glutamine results in a cold sensitive phenotype. 
Amino acid side chains with amide and guanidinium groups; like those found in 
asparagine, glutamine, and arginine; can interact with nitrogenous bases (26–29). 
Eighteen of the 23 side chains lining the H tube’s inner surface belongs to N, Q, or R 
residue (15). The remaining inward facing side chains lacking amide or guanidinium 
groups cluster between amino acids 244 and 258 (Figure 3.1B). This arrangement is 
highly conserved. Forty-two H protein sequences from all three microvirus clades (30) 
were aligned using the PRALINE multiple sequence alignment program (31, 32). Of the 
four inward facing residues, T244 and K254 are completely conserved, whereas the 
respective hydrophobic and acidic characteristics of M251 and E258 are maintained. This 
suggests that this region of the H-tube may regulate ssDNA transport. To test this 
hypothesis, codons T244, M251, K254 and E258 were individually mutated to glutamine 
codons in a cloned wild-type H gene, resulting in four mutant genes: T244Q, M251Q, 
K254Q, E258Q. A double mutant gene, T244Q/M251Q, was also constructed. For all 
subsequent biochemical experiments, virions were generated by complementing a null-H 
mutant, am(H)M251, with cloned wild-type or mutant H genes. This complementation-
dependent approach circumvents genetic differences arising from compensatory 
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mutations. Thus, any phenotype or defect can be directly associated with the mutant H 
proteins.  
 
The mutant and wild-type genes were assayed for the ability to complement a null-H 
mutant, am(H)M251, at 22, 37, and 42°C (Table 3.1). The cloned K254Q and E258Q 
genes complemented the null-H mutant at all temperatures. By contrast, the T244Q, 
M251Q, and T244Q/M251Q genes complemented poorly at 22°C. The severity of the 
cold-sensitive (cs) phenotype varied. Plating efficiencies on M251Q and T244Q/M251Q 
expressing cells was several orders of magnitude below those obtained at higher 
temperatures. Only a slight plating efficiency reduction was seen on T244Q expressing 
cells, however plaque size was greatly reduced (Table 3.1).  
 
Infectious particles containing T244Q, M251Q, and T244Q/M251Q H proteins are 
produced at 22°C. Mutations in the H gene can prevent H protein incorporation during 
morphogenesis or result in H-containing, uninfectious particles (33, 34). To determine 
whether the cs H proteins were incorporated at 22°C, lysis resistant cells expressing the 
mutant H genes were infected with am(H)M251. As stated above, this approach 
circumvented the possible effects of fitness-enhancing secondary mutations. Thus, all 
other viral structural protein sequences should be identical. The infected cultures were 
split and concentrated after a 5-minute incubation at 37°C to ensure rapid infection 
initiation. The resulting infected cell pellets were resuspended in media pre-heated to 22 
or 37°C and respectively incubated for 6 or 3 hours. Infected cell extracts were applied to 
linear sucrose gradients and centrifuged. Each infection produced particles that 
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sedimented at 114S, the S value of φX174 virions (Figure 3.2A). The 114S peak fraction 
was run on an SDS-PAGE gel to determine protein content. The mutant H proteins 
appeared to be incorporated at levels comparable to the wild-type H protein (Figure 
3.2B). Particle specific infectivity (Plaque forming units/Abs280) was determined by 
titering the 114S particles at 37°C. Infectious particles were produced at both 
temperatures. However, the specific infectivity of mutant H protein particles was reduced 
compared to those containing the wild-type H protein (Table 3.2).  The reduction was 
independent of synthesis temperature: populations synthesized at 22 and 37°C had nearly 
identical infectivity values. The greatest reduction was seen for the T244Q/M251Q H 
protein particles, which was only 10% the wild-type value. These data suggest that the 
primary defect involved mutant H protein function, and not H protein incorporation.  
 
Mutant H proteins did not alter attachment or eclipse kinetics at the restrictive 
temperature. After virions are assembled, they must attach to and eclipse on host cells. 
Eclipse, also called irreversible attachment, is the committed early infection step during 
which virions undergo conformational changes and lose infectivity (14). Defects 
affecting either event could produce the cs phenotype. Therefore, the kinetics of both 
extracellular steps were determined. For both assays, virions were produced in 
am(H)M251 infected cells expressing the mutant and wild-type H genes. In this, and all 
other experiments, the multiplicity of infection (MOI) was based on plaque forming units 
(PFUs) to control for the observed differences in specific infectivity. 
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To assay attachment kinetics, viruses and cells were mixed in liquid media containing 
Ca2+ (5.0 mM) which is required for efficient attachment (35). At selected times post 
infection, samples were centrifuged to separate attached and unattached particles. The 
latter remain in the supernatant. Thus, supernatant titers reflect the titer of unattached 
virions. No significant differences were observed between mutant and wild-type H-
protein containing particles at 22°C (Figure 3.3A). Eclipse kinetics were measured by 
pre-attaching virions at 4°C, a temperature that inhibits eclipse. Subsequently, cells and 
attached phage were diluted into 22°C media. At selected time points, attached particles 
were removed by diluting samples into an EDTA solution. EDTA chelates the Ca2+ ions 
required for attachment; thus, releasing attached but uneclipsed virions. The proportion of 
uneclipsed, infectious particles was then determined. Mutant eclipse kinetics did not 
significantly differ from those of the wild-type control at 22°C (Figure 3.3B).  
 
Particles containing mutant H proteins did not efficiently infect cells at 22°C. After 
eclipse, H protein delivers the viral genome to the host. This process can be indirectly 
monitored by observing the kinetics of viral coat protein accumulation within infected 
cells. To perform these experiments, am(H)M251 virions carrying mutant H proteins 
were pre-attached to lysis resistant cells containing an inducible wild-type H gene. Thus, 
differences in genome delivery can be attributed to the mutant H proteins. However, after 
genome delivery, only wild-type H protein will be synthesized. This strategy eliminates 
any differences that could arise from de novo H protein synthesis, which is required for 
optimal viral protein synthesis (36). After pre-attachment, the infected cell culture was 
split. Each aliquot was diluted into pre-heated 22 or 37°C media containing IPTG to 
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induce the wild-type H gene. At each time point, a sample was collected, the cells 
pelleted, and the whole cell lysates run on an SDS-PAGE gel. The resulting gels were 
coomassie stained and digitized. The intensity of the viral coat protein band was 
compared to the indicated host protein band to determine the relative amount of coat 
protein in each sample (Figure 3.4A). The results of three biological replicates are plotted 
in Figures 3.4B and C. Virions carrying the wild-type H protein appeared to efficiently 
deliver their genomes at both 37 and 22°C: viral coat protein levels started to respectively 
rise after 50 and 320 minutes (Figures 3.4B and C). At 37°C, no significant differences 
were observed between cells infected with T244Q, M251Q, and wild-type H protein 
containing virions. However, protein levels within the T244Q/M251Q infected cells 
appeared to be mildly reduced (Figure 3.4B). By contrast, viral coat protein accumulation 
at 22°C was greatly reduced or entirely blocked in cells infected with mutant H protein 
containing particles (Figure 3.4C). These data indicate that the cs H proteins cannot 
perform a function occurring between eclipse and viral gene expression at 22°C.  
 
Mutant H proteins opened cytoplasmic channels at 22°C, but viral DNA delivery to 
the cytoplasmic membrane was inhibited. After attachment and eclipse, the virus must 
open a channel to the cytoplasm through which the infecting genome traverses. As with 
other phage systems, cytoplasmic K+ diffuses through the genome delivery channel (6, 
37–39). Thus, channel formation can be assayed by monitoring the release of intracellular 
K+ ions. To this end, am(H)M251 virions containing mutant or wild-type H proteins were 
pre-attached to lysis resistant cells on ice. The infected cultures were split and diluted 
into K+ free starvation media pre-warmed to 22 or 37°C. A K+ selective electrode was 
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used to monitor the extracellular K+ concentration. Representative plots are shown in 
Figure 3.5A and 5B. K+ efflux was observed regardless of assay temperature or H protein 
within the virus. The virions carrying mutant H proteins produced as much or more efflux 
as virions carrying the wild-type protein. This suggests that the mutant H proteins can 
open a channel, but the 10 α-helices that constitute the channel are dysfunctional.   
At 22°C, cells infected with T244Q and M251Q mutant particles consistently exhibited 
more efflux that wild-type. The experiment depicted in Figure 3.5A and B was conducted 
five times and the relative efflux was the same in each iteration. The five biological 
replicates were analyzed with a linear mixed effects model (Material and Methods and 
Supplemental Material). The results of this analysis suggest that the differences were 
statistically significant. Although the amount of input phage was determined by plaque 
forming units, mutant particles exhibit a lower specific infectivity than wild-type 
particles. Thus, elevated efflux may reflect this, at least for the single mutants.  
 
It is possible to follow infecting genomes as they traverse the cell wall from the inner to 
the outer membrane (21, 40). Some of the energy needed to fully transport the genome is 
provided by DNA replication machinery (22, 23). If the mutant H proteins cause a 
significant portion of the infecting genomes to stall mid-transit, then a higher proportion 
of them may remain associated with the outer membrane, which can be detected using 
qPCR after separating the cell wall into inner and outer membrane fractions.  
 
To locate the infecting genomes, cells were infected at 22 or 37°C. Cells were extensively 
washed in a starvation buffer (Materials and Methods) to inhibit post-eclipse viral DNA 
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replication. After eclipse, infected cells were collected, washed twice to remove 
unattached and uneclipsed particles, converted to spheroplasts, and sonicated in the 
presence of EDTA. The resulting cytoplasmic and outer membrane vesicles were 
collected and separated in percoll gradients. Separation efficiency was determined by 
analyzing gradient fractions for succinate dehydrogenase activity and keto-deoxy-d-
manno-8-octanoic acid (KDO) content, respective inner and outer membrane markers 
(41). Fractions with the most KDO had a density of 1.03 g/mL. Those with the highest 
succinate dehydrogenase activity had a density of 1.01 g/mL. Both values are consistent 
with those previously reported when using this membrane separation protocol (41). 
 
The fractions were analyzed by qPCR to produce an inner/outer membrane, genome 
copy-number ratio (I:O ratio). As depicted in Figure 3.5C, there was approximately 22-
fold more wild-type genomic DNA associated with the inner membrane than the outer 
membrane at both temperatures (I:O ratio ≈ 22).  Infecting cells with M251Q H 
containing particles resulted in lower I:O ratios, approximately 68 and 50% of the 
respective wild-type values at 37°C and 22°C. T244Q/M251Q H containing particles 
appeared to be even less efficient, producing ratios approximately 33% and 12% of the 
respective 37°C and 22°C wild-type values. As can be seen in Figure 3.5C, DNA 
transport was not entirely blocked for mutant H-tubes, especially at 22°C. Several 
technical, structural, and biological factors may account for this (See Discussion). 
Nonetheless, these data indicate that DNA is less efficiently transported by the mutant H-
tubes.   
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Second-site genetic analysis of cs H mutants. Second-site suppressing mutations often 
elucidate mechanisms by which the phage can overcome a defective process, providing 
mechanistic insights that are often difficult to obtain solely with biochemical data.  To 
conduct the second-site reversion analysis, the T244Q, M251Q, and T244Q/M251Q 
mutations were moved into the phage genome by recombination rescue. As expected, all 
three resulting mutants exhibited a cold-sensitive phenotype (Table 3.3). The mutants 
were plated at 22°C to select for suppressors of the cs phenotype. To ensure the recovery 
of a broad suppressor array, 26 independent sources of cs(H)T244Q and cs(H)M251Q 
and 19 independent sources of cs(H)T244Q/M251Q were used in the analysis (42). The 
recovered suppressors are listed in Table 3.3. Eight unique suppressing mutations were 
found in the coat protein F gene and five in the piloting protein H gene. The suppressors 
in gene H confer substitutions near the narrowest region of the H-tube X-ray structure 
(Figure 3.1B), and likely suppress by altering H protein structure (see Discussion). 
 
The coat protein substitutions occurred near, adjacent to, or at sites previously isolated 
when selecting for suppressors of cs assembly defects. Two of the identified coat protein 
substitutions, T204I and M330I, were identical to previously isolated suppressors (43–
46). Although particle assembly and DNA transport are seemingly unrelated phenomena, 
second-site suppressor isolation is based on plaque formation, which can be affected by 
modest burst size increases. Thus, broad allele specificity can reflect general suppressing 
mechanisms (47, 48). To test this hypothesis, the F-T204I and F-M330I were moved into 
the wild-type background and the kinetics of phage production was monitored at 22°C 
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(Figure 3.6). The burst size of both su(H) F-T204I and su(H) F-M330I were significantly 
higher than the wild-type control.  
 
The ability to rescue via a general mechanism may be related to the severity of the 
parental defect. The cs phenotype of the double mutant is significantly tighter than both 
single mutants.  Suppressing mutations in gene F were only recovered for the single 
mutants. This could reflect a limited sample pool, as it is unlikely that the selections went 
to saturation, or it could be directly related to the defect severity conferred by the parental 
mutations. To distinguish between these two possibilities, the suppressors in gene F were 
moved into the cs(H)T244Q/M251Q background. As can be seen in Table 3.4, the 
suppressing mutations in gene F were unable to rescue the double mutant. 
 
3.4 Discussion 
Mutant phenotype and H-tube structure: As seen in the X-ray structure, the inner 
surface of the H tube is lined with amide and guanidinium containing glutamine, 
asparagine, and arginine side chains. However, there are four exceptions near the tube’s 
C-terminal end: T244, M251, K254, and E258 (Figure 3.1). This arrangement is 
conserved across the three microvirus clades, which suggests that the residues play an 
important role during DNA transport. The four residues were mutated to glutamine to 
investigate the arrangement and function of the H-tube lumen. The K254Q and E258Q 
mutations did not result in a discernable phenotype, whereas the T244Q and M251Q 
mutants conferred cs phenotypes when expressed from plasmids in complementation 
studies and when place directly within the phage genome. A third mutant, 
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T244Q/M251Q, also conferred a particularly pronounced cs phenotype. The H-tube 
atomic structure may explain the phenotypic differences associated with these four sites. 
Unlike T244 and M251, K254 and E258 form an inter-helical salt bridge (15). Thus, their 
side chains may not be entirely free to interact with the DNA as it passes through the 
tube. Moreover, glutamine can also act as both a hydrogen bond donor and acceptor. 
Replacing K254 or E258 with glutamine may replace the inter-helical salt bridge with an 
inter-helical hydrogen bond. 
 
Mutant phenotype and defective function:  The viral life cycle was investigated to 
determine which step was disrupted by the cs H proteins. At 22°C, the mutant H proteins 
were incorporated into virions as efficiently as wild-type. The resulting particles also 
displayed wild-type attachment and eclipse kinetics at the restrictive temperature. Lastly, 
the results of K+ efflux experiments indicate that they can form channels through host cell 
walls. However, the results of two experiments suggest that the infecting viral DNA was 
not efficiently reaching the cytoplasmic membrane at 22°C, the site of stage I viral DNA 
replication. 1) Viral coat protein did not accumulate within cells infected with mutant H 
containing virions. 2) After cell wall fractionation, less genomic DNA was associated 
with the inner membrane than observed in wild-type samples.   
 
To the best of our knowledge, tracking infecting genomes in separated cell wall 
components via qPCR has not been previously attempted in other phage systems. Thus, 
the extent that results can be directly related to the severity of mutant phenotypes is not 
entirely known. The M251Q and T244Q/M251Q mutants have strong cold-sensitive 
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phenotypes and temperature affected the results of the pPCR assay. Unlike the assay 
conducted with the wild-type H protein, in which the same amount of genomic DNA 
became associated with the cytoplasmic membrane regardless of temperature, samples 
generated with mutant H proteins exhibited a marked decrease of inner membrane 
associated viral DNA at 22°C, which is consistent with a cs phenotype. However, inner 
membrane genome association was not entirely eliminated. Indeed, more DNA was 
consistently detected in the inner membrane fraction. For example, the I:O ratio for the 
T244Q/M251Q mutant at 22°C was approximately 2, indicating that twice as much 
genomic DNA was detected in the inner membrane fraction. By comparison, the I:O ratio 
for wild-type was an order of magnitude higher.  
 
Several factors may affect I:O ratios. Firstly, cell wall fractionation is a messy affair; 
definitely not for the faint hearted or those traumatized by impurities. The molecular 
markers used to distinguish between inner and outer membrane fractions typically differ 
by only 5-10 fold regardless of protocol (41), indicating a significant amount of cross 
contamination.  Secondly, it is unknown into which fraction the genome will segregate if 
it is within the H-tube, which spans the cell wall. Thirdly, the requisite experimental 
conditions under which the assay had to be performed differ from those occurring during 
a typical infection. However, all of these phenomena would equally affect wild-type and 
mutant samples. Thus, the results likely reflect the nature of the defective phenotype.  
 
The function of the amide and guanidium group surface: This data can be interpreted 
within a model in which a balance of opposing forces governs genome movement. One 
 124 
force propels the genome inward. It is likely driven by capsid pressure created by the 
densely packaged viral genome, the osmotic gradient existing between the host’s 
cytoplasm and environment, or a combination of the two (1, 2).  The opposing force may 
be friction created by the H tube’s inward facing, amide and guanidinium groups, which 
form hydrogen bonds with DNA nucleotides (26–29).   
 
While invoking a force that opposes genome delivery may seem counter-intuitive, 
systems more effectively perform work when potential energy is released in small, 
manageable increments. Nuclear power plants, internal combustion engines, and 
oxidative phosphorylation, in which electrons are transferred from NADH to O2 via 
several intermediate reactions, all demonstrate this concept: releasing too much potential 
energy at one time can destructively overwhelm the systems.  Our results are consistent 
with this model and the observed cs phenotypes. The additional amide groups, via 
interactions with DNA, may be increasing the frictional force.  Hydrostatic and osmotic 
pressures are directly proportional to. Thus, the force driving the genome into the cell 
would be decreased at lower temperature.  This, combined with the increased drag 
introduced by the additional amide group, could perturb the optimal balance between the 
two forces, either kinetically trapping the genome or greatly slowing its delivery.  
Alternatively, the added amide groups could have unanticipated effects on the H-tube’s 
structure, which could produce the same phenotype. Regardless of the molecular 
mechanism, the defect occurs after the cell wall is breached.  
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The results of the K+ efflux studies indicate that the cs H proteins breached the inner 
membrane.  The relative magnitude of phage-induced efflux at 22°C was dependent on 
the H protein type. This observation was found to be significant after constructing a 
linear mixed effects model built from five replicate data sets. To the best of our 
knowledge, a similar statistical analysis has not been conducted on K+ efflux data. Thus, 
the biological significance of this statistically significant observation cannot be rigorously 
adjudicated. Nonetheless, some speculation may be warranted. Single mutants effluxed 
more K+ than wild-type at 22°C, whereas double mutant efflux resembled wild-type. For 
the single mutants, this may be due to reduced specific infectivity. MOI was based on 
PFUs.  Thus, if a population of virions had a reduced specific infectivity, as was observed 
for the mutants, more non-plaque forming, virus-like particles were added. These 
particles may still be capable of forming effluxing channels. However, the double mutant, 
which effluxed K+ like wild-type, exhibited the lowest specific infectivity. It also 
exhibited the strongest cs phenotype and accordingly, transported less DNA to the 
cytoplasmic membrane. Thus, an additional variable may be influencing this 
phenomenon, one directly related to the efflux through any one H-tube. The two extra 
glutamine residues within double mutant tubes may grip the DNA so tightly that the tube 
becomes more clogged or obstructed. Alternatively, as mentioned above, the added amide 
groups could have unanticipated effects on the H-tube’s structure, which may cause a 
percentage of double-mutant H-tubes to collapse. 
 
Regardless of the molecular defect, the results of the second-site genetic analysis further 
underscore the synergistic effects conferred by the two mutations. The cs phenotype of 
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the single mutants cs(H)T244Q and cs(H)M251Q could be suppressed by intergenic and 
intragenic mechanisms, i.e. alterations to the viral coat or DNA pilot proteins, 
respectively. By contrast, only the intragenic mechanism appears to operate in the 
cs(H)T244Q/M251Q double mutant background.  The suppressors in gene H confer 
changes at the H-tube’s narrowest point. In general, these mutations decrease side chain 
size but did not radically alter chemical characteristics. The changes could be increasing 
the tube’s diameter or the tube’s elasticity or flexibility. Regardless of the precise 
suppression mechanism, the mutations are likely alleviating inhibited genome delivery by 
directly modifying the H-tube structure. By contrast, the coat protein suppressors appear 
to be compensating for inhibited genome delivery instead of correcting it. These 
suppressors were similar or identical to previously isolated suppressors of cs assembly 
defects. When moved into the wild-type background, they increased the viral burst size at 
22°C. Thus, increasing the burst size may be compensating for inhibited genome 
delivery, which can be explained by the mechanics of plaque formation. As evinced by 
the leaky phenotypes of the single mutants (plating efficiencies ~10-2 at 22°C), DNA 
delivery is not entirely inhibited. However, to form a plaque, enough first-round progeny 
must successfully infect neighboring cells: a situation made more probable by a larger 
burst size.  As can be seen in the piloting assay results, the double mutant phenotype is 
quite tight when compared to the single mutants. Its ability to associate DNA with the 
inner membrane is pronouncedly less efficient.  Thus, its DNA delivery success rate may 
be too low and can only be rescued by an unobtainable burst size. Accordingly, when the 
suppressors found in the coat protein were placed directly within the double mutant 
background, they did not rescue on the level of plaque formation.  
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Relationship to other phage systems: Evoking a force that naturally counters the one 
propelling the genome into the cell may seem counterintuitive. However, slow, regulated 
penetration may be common in other phage systems in which large amounts of potential 
energy, in the form of capsid pressure and/or osmotic imbalance, must be controlled. For 
example, the complete transit of the phage λ genome requires approximately five minutes 
(49). Moreover, in some phage systems, potential energy may not need to drive the entire 
genome into the cell. The efficient transfer of fX174 ssDNA appears to be coupled to 
synthesis of the complementary genomic strand (21–23). Thus, the H-tube may not be 
intended to deliver the entire genome to the host. The friction produced by the amide and 
guanidinium groups may prevent complete transfer, so that only a small portion is 
presented to host DNA synthesis machinery. If hosts are not actively synthesizing DNA, 
penetration is often incomplete. The energy released by the hydrolysis of the dNTP’s 
during DNA synthesis is greater than the potential energy stored within the newly formed 
bonds of DNA’s phosphate background. Thus, microvirus genome penetration may have 
evolved to exploit the unharnessed energy released in nucleic acid biosynthesis. Phages 
T5 and T7 may be other examples of phages that exploit the unharnessed energy released 
in cellular processes to perform work. They release their genomes in discrete steps (50, 
51) and internalization of the entire T7 or T5 genome may be facilitated by host 
transcription or translation machinery, respectively (52, 53). 
 
3.5 Materials, Methods, and Acknowledgements 
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Bacterial strains, phage strains, and plasmids. The Escherichia coli C strains C122 
(Su-), BAF8 (supF), and BAF30 (recA) have been previously described (43, 54). RY7211 
contains a mutation in the mraY gene, which confers resistance to viral E protein 
mediated lysis (55).  
 
The T244Q, M251Q, K254Q, E258Q, and T244Q/M251Q H genes were constructed by 
mutagenizing the previously described cloned φX174 H gene (33). Abutting primers 
introducing the desired mutation were used to PCR amplify the entire plasmid with Q5 
DNA polymerase (New England Biolabs). The PCR product’s 5’ hydroxyl termini were 
phosphorylated with T4 polynucleotide kinase (New England Biolabs) and the resulting 
product was circularized with T4 DNA ligase (New England Biolabs). Cloned nucleotide 
sequences were verified with direct DNA sequencing.  
 
Mutant phage strains cs(H)T244Q, cs(H)M251Q, and cs(H)T244Q/M251Q were 
generated via recombination-rescue with the T244Q, M251Q, and T244Q/M251Q H 
clones using am(H)M251, a mutant containing an amber mutation at codon M251 in gene 
H. Cells carrying mutant H constructs were infected with am(H)M251. Recombinants 
were then selected by plating the resulting progeny on C122 (Su-) and confirmed by 
sequencing the H genes. Strains su(H)-F T204I, su(H)-F M330I, su(H)-F R386H, su(H)-
F T204I/cs(H)T244Q/M251Q, su(H)-F M330I/cs(H)T244Q/M251Q, and su(H)-F 
R386H/cs(H)T244Q/M251Q were generated via site-directed mutagenesis using purified 
phage ssDNA in the same manner used to create the mutant H constructs.  
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Second-site genetic analysis. Second-site suppressing mutations of the cold-sensitive 
(cs) phenotype were isolated in direct selections. cs(H)T244Q, cs(H)M251Q, and 
cs(H)T244Q/M251Q were plated with C122 at 37°C. Plaques were allowed to develop 
and were collected. cs(H)T244Q plaque samples were suspended in 0.1 mL of water. This 
solution was plated with C122 at 22°C. cs(H)M251Q and cs(H)T244Q/M251Q plaque 
samples were added directly to 2 mL of molten top agar, slewing agar bombs, and plated 
with C122 at 22°C. Plaques that appeared larger or more transparent than background 
plaques, if any, were selected and re-plated at 22°C to confirm the loss of the cs 
phenotype. Cs revertant genomes were sequenced to identify the second-site suppressing 
mutation. 
 
Media, buffers, phage plating assays, and mutant H containing particle preparation. 
Media, buffers, phage plating assays, and phage stock preparation have been previously 
described (43). For the majority of assays, mutant H containing particles were generated 
by infecting RY7211 at OD660=0.08 with am(H)M251 at a MOI of 1. Infections were 
performed at 37°C and the cells were expressing either wild-type or mutant H constructs. 
Expression of the constructs was induced at the time of infection by adding IPTG to a 
final concentration of 40 μM. The cells were pelletized three hours after infection and 
resuspended in BE at 1/100 the original culture volume. Lysozyme was added to a final 
concentration of 1.0 mg/mL and the infections were lysed at 4°C overnight. Afterwards, 
150 μl chloroform was added and the lysates were vigorously vortexed. Cell debris was 
pelletized and the phage containing supernatant was collected. 
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Protein electrophoresis, rate zonal sedimentation, and generation of ssDNA.  The 
protocols for protein electrophoresis, rate zonal sedimentation, and ssDNA purification 
have been previously described (46, 56, 57). 
 
Attachment, eclipse, coat protein quantification, and burst size assays. Attachment 
and eclipse assays have been previously described (58, 59). Coat protein quantification as 
a surrogate for genome DNA delivery was performed as follows. RY7211 cells were 
grown to OD660=0.08, pelletized, and suspended in one tenth the original volume of HFB 
buffer [0.06M NH4Cl / 0.09M NaCl / 0.1M KCl / 0.1M Tris-HCl (pH 7.4) / 1.0 mM 
MgSO4 / 1.0 mM CaCl2] containing 10 mM MgCl2 and 5.0 mM CaCl2 at 4°C. Phages 
were pre-attached to cells for 30 minutes at 4°C. The cells and attached phage were 
pelletized and resuspended in 4°C TKY media [1% tryptone, 0.5% KCl, 0.5% yeast 
extract] containing 10 mM MgCl2 and 5.0 mM CaCl2. The samples were then diluted into 
TKY containing 10 mM MgCl2 and 5.0 mM CaCl2 at 22 or 37°C. At time points, 1.0 mL 
samples were collected, pelletized, and the pellets frozen. After freezing, the pellets were 
suspended in 100 μL HFB. 30 μL of the concentrated samples were run on SDS-PAGE 
gels as previously described (57). SDS-PAGE gels were then stained with Coomassie 
brilliant blue and digitized with a LICOR scanner. Relative coat protein levels were 
determined by densitometry analysis using ImageJ software (NIH). Coat protein intensity 
was normalized to the intensity of the host protein band indicated in Figure 3.4.  
 
Burst size assays followed the same protocol as the coat protein quantification assay with 
the following changes. At time points, 1.0 mL samples were collected, pelletized, and 
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suspended in 100 μL HFB. 10 μL of the concentrated sample was diluted into 1.0 mL of 
BE buffer containing 1.0 mg/ml of lysozyme. The concentrated samples were frozen and 
the diluted samples allowed to lyse overnight at 4°C. Lysates were titered the following 
day and bursts were calculated by dividing the time point’s total phage by the total input 
phage. 
 
Potassium efflux assays. K+ efflux experiments are based on those described by Cumby 
et al. (6) and assays were performed by first producing mutant H containing virions as 
described above. The virions were dialyzed thrice against 1.0 L of SM buffer (100 mM 
NaCl, 10 mM MgSO4, 50 mM Tris pH=7.5) at 4°C to remove potassium. C122 was 
grown to OD660=0.08 in TKY at 37°C. Cells were pelletized and washed in an equal 
volume of SM buffer, washed again in 1/10th the volume SM buffer, and suspended in 
1/100th the volume iced SM+ buffer: SM buffer containing 10 mM MgCl2 and 5 mM 
CaCl2. The cell culture was divided into 1.0 mL aliquots, kept on ice, and chilled virus 
was added to a MOI of 75. Iced SM+ buffer was added to equalize aliquot volumes. 
Infections were incubated for 15 minutes on ice to allow virus pre-attachment. A single 
infection was diluted into 9.0 mL 37°C SM+ buffer every minute. Immediately after the 
first dilution, an Orion Ionplus potassium electrode (Thermo Scientific) connected to a 
Sartorius PB-11 pH meter was inserted into an infection and a reading was taken after 1 
minute. This electrode was then rinsed with DI H2O, blotted dry, and placed into the 
dilution of the subsequent infection. The electrode was rotated between infections at one-
minute intervals once all infections were diluted. 
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Statistical analysis of the K+ efflux data: Raw K+ efflux data was modeled with a linear 
mixed effects model.  Fixed effects were included for virus condition (levels: uninfected, 
wild-type, T244Q, M251Q, K254Q, and T244Q+M251Q), temperature (levels: 22 and 
37°), and time.  Because plots of the data showed a clear non-linear (half-parabolic) 
change in the extracellular K+ level over time, both linear and quadratic effects of time 
were incorporated into the model.  Additionally, because different K+ efflux trajectories 
for each virus/temperature condition were desired, all fixed effect interactions were 
included.  Finally, in order to capture some of the correlation structure likely present in 
the data due to the experimental design, two random intercepts were included: one for 
experiment day and another for the final test tube from which measurements were 
collected.  Planned contrasts of the four mutant virus conditions versus both wild-type 
and uninfected were conducted at 25 and 150 minutes in the 37 and 22° conditions, 
respectively. 
 
It is worth noting that the correlation and variance structure of the data is likely more 
complex than that described above.  Firstly, there are actually four potential sources of 
random variation and consequent correlation in the data:  virus batch, experiment day, 
original test tube (before splitting into separate tubes for the two temperature conditions), 
and final test tube.  Second, sequentially close measurements from the same final test 
tube are likely correlated.  Third, evidence of temporal heteroscedasticity was revealed 
after modeling explorations.  In order to determine whether incorporating this more 
complex variance and correlation structure into the model affected the contrast 
inferences, another model was fit to the K+ efflux data.  It included an exponentially 
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decreasing correlation and variance structures over time and also random intercepts for 
virus batch, experiment day, original test tube, and final test tube.  The fixed effects 
structure was identical to that of the simpler model, and the same planned contrasts were 
conducted.  Because the two models’ inferential results were identical, the simpler model 
conclusions were presented. The complete details of the statistical analysis are posted in 
the supplemental material.  
 
Infected membrane separations and qPCR. The membrane separation protocol was 
based on that described by Morein et al. (41). C122 was grown to OD660=0.1 in TKY at 
37°C. The cells were pelletized and washed in an equal volume of SM buffer, then 
concentrated 10-fold in SM buffer, and again concentrated 10 fold in iced SM+ buffer. 
The concentrated culture was divided into 2.0 mL aliquots and kept on ice. Chilled virus 
was added to a MOI of 1.0 and additional iced SM+ buffer was added to equalize 
infection volumes. The virus was allowed to pre-attach for 30 minutes at 4°C. The 
infections were split and each half was diluted 10-fold in 37 or 22°C SM+ buffer and 
incubated for 10 or 30 minutes, respectively. The infections were then diluted 10-fold in 
iced SM+ buffer, pelletized, and washed in 40 mL iced BE buffer. Pellets were 
suspended in 15 mL iced 10 mM Tris (pH = 7.5) containing 0.5 M sucrose. Lysozyme 
was added to a final concentration of 0.1 mg/mL. The infections were incubated for 30 
minutes at 4°C and were then slowly diluted (~3 mL/minute) with 15 mL iced 10 mM 
Tris (pH = 7.5). EDTA was added to a final concentration of 1.0 mM and samples were 
sonicated in an ice bath with a Branson Sonifier 450. Samples were sonicated 15 seconds 
at a time with a 45 second cool down between pulses. This cycle was repeated until the 
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OD600 of the infection stopped decreasing. This took four to five cycles and an infection’s 
final OD600 was usually between 10 and 30% its original value. Samples were then spun 
at 1500×g for 10 minutes to pelletize any remaining intact cells. The supernatants were 
then centrifuged for 90 minutes at 257,000×g in a Beckman Type 70Ti rotor to pellet 
membrane vesicles. The resulting supernatant was removed and the moist pellets were 
stored at 4°C overnight in sealed containers. Membrane pellets were then suspended in 
15 mL gradient buffer [10 mM Tris, 1 mM EDTA, 16.2% Percoll (v/v), pH = 7.5] with 
an 18-gauge syringe and vigorous vortexing. The mixtures were transferred to 15 mL 
glass corex tubes and spun for 50 minutes at 14,500×g in a Sorvall SA600 rotor. The 
resulting gradients were fractionated into 250 μL fractions from the bottom with the 
peristaltic pump of a BioRad BioLogic LP connected to a model 2110 fraction collector. 
Fraction succinate dehydrogenase activity was tested with a Biovision succinate 
dehydrogenase activity colorimetric assay kit and KDO content was determined by the 
thiobarbituric acid method (60).  
 
qPCR analysis of fractions was performed on an Applied Biosystems 7300 Real-Time 
PCR System using Applied Biosystems SYBR Green PCR Master Mix. The thermal 
cycling program started with 2 minutes at 50°C followed by 3 minutes at 95°C to activate 
the DNA polymerase. This was followed by 40 cycles of 95°C for 15 seconds and 58°C 
for 1 minute. Absolute quantification was performed by generating a standard curve with 
purified φX174 ssDNA. Dissociation curves were performed to confirm primer fidelity. 
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3.7 Figures and Tables 
TABLE 3.1. am(H) plating efficiencies on cells expressing gene H clones 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
E.O.P.a at: 
–––––––––––––––––––––––––––––––––––– 
Expressed H Gene 22°C  37°C  42°C 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
Wild-Type  1.0  1.0  1.0 
None    <1.3×10-4 <9.0×10-5 <4×10-5 
T244Q   0.3b  1.0  0.5 
M251Q  <1.3×10-4 1.9  0.7 
K254Q  0.7  1.0  0.5 
E258Q   0.8  2.8  0.6 
T244Q+M251Q <1.3×10-4 0.7  0.8 
––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
a Efficiency of plating. Values are normalized to those obtained from cells expressing the 
wild-type H gene at the same temperature. 
b Plaque size reduced by >50% of wild type. 
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TABLE 3.2. Specific infectivitya of 114S particles at 37°C 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
Specific Infectivity 
–––––––––––––––––––––––––––––––– 
Synthesis Temperature  Expressed Gene Raw S.I.b Wild-type Normalizedc 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
37°C    Wild-Type  8.0×1011 1.0 
None   3.9×108  3.9×10-4 
T244Q   1.9×1011 0.4±0.1 
M251Q   2.3×1011 0.4±0.1 
T244Q/M251Q  5.4×1010 0.1±0.02 
22°C    Wild-Type  3.3×1012 1.0 
None   4.9×108  1.5×10-4 
T244Q   9.7×1011 0.4±0.2 
M251Q   9.4×1011 0.4±0.1 
T244Q/M251Q  2.3×1011 0.1±0.1 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
a Specific infectivity is defined as pfu’s/A280, regardless of the plaque forming particle’s 
genotype. 
b Raw S.I. reported in units of pfu’s/A280. 
c Data is normalized to the specific infectivity of particles generated in cells at the same 
temperature expressing the wild-type H  gene. ± values represent the standard deviation obtained 
from three biological replicates. 
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TABLE 3.3. Suppressing Mutations of T244Q, M251Q, and T244Q+M251Q 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
       E.O.P.a 
     Independent  –––––––––––––––––––––––––––––– 
Strainb     Isolationsc 22°C  37°C  42°C 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
Wild Type    N/Ad  0.2  1.0  0.7  
 
cs(H)T244Q    N/A  4.8×10-2  1.0  1.0 
su(H)-F H73Y/cs(H)T244Q  Two  0.3  1.0  1.2 
su(H)-F Y158H/cs(H)T244Q  Three  0.2  1.0  0.7 
su(H)-F T204I/cs(H)T244Q  One  0.2  1.0  1.3 
su(H)-F M330I/cs(H)T244Q  One  0.3  1.0  0.9 
su(H)-F R386H/cs(H)T244Q  One  0.3  1.0  0.9 
su(H)-H R185H/cs(H)T244Q  One  1.0  <6.4×10-5 <6.4×10-
5 
su(H)-H A194S/cs(H)T244Q  One  0.2  1.0  1.0  
 
cs(H)M251Q    N/A  2.6×10-2  1.0  1.0 
su(H)-F T100A/cs(H)M251Q  One  0.1  1.0  1.6 
su(H)-F Y158H/cs(H)M251Q  One  0.3  1.0  1.2 
su(H)-F T204I/cs(H)M251Q  One  0.2  1.0  1.1 
su(H)-F L319F/cs(H)M251Q  One  0.1  1.0  0.6 
su(H)-F M330I/cs(H)M251Q  Two  0.3  1.0  0.8 
su(H)-F V333F/cs(H)M251Q  One  0.1  1.0  1.2 
su(H)-F R386H/cs(H)M251Q  One  0.1  1.0  0.7 
su(H)-H E197D/cs(H)M251Q  One  0.4  1.0  1.1 
su(H)-H M198V/cs(H)M251Q  One  0.5  1.0  0.9 
 
cs(H)T244Q/M251Q   N/A  <9.5×10-6 1.0  1.2 
su(H)-H M198I/cs(H)T244Q/M251Q One  0.1  1.0  1.2 
su(H)-H M198V/cs(H)T244Q/M251Q Two  0.2  1.0  0.9 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
a Efficiency of plating. Values are normalized to those obtained from plates incubated at 
37° 
b Strains with mutations suppressing the T244Q, M251Q, or T244Q/M251Q mutations 
are labeled with the gene in which the suppressing mutation was found, the 
corresponding amino acid change, and the genetic background in which it resides. For 
example, su(H)-F H73Y/cs(H)T244Q indicates that the strain has H73Y in gene F within 
the cs(H)T244Q background. 
c Plaques were picked from plates incubated at 22°C 
d Not applicable. Strains were either pre-existing or constructed. 
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TABLE 3.4. Comparison of gene F suppressing mutation activity in T244Q, M251Q, and  
T244Q+M251Q genetic backgrounds 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
E.O.P.a at: 
––––––––––––––––––––––––––––––––––– 
Backgroundb     22°C  37°C  42°C 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
Wild-Type     0.4  1.0  0.8 
su(H)-F T204I     1.2  1.0  0.7 
su(H)-F M330I     0.4  1.0  0.6 
su(H)-F R386H     0.7  1.0  0.8 
 
cs(H)T244Q     2.8×10-2 1.0  0.8 
su(H)-F T204I/cs(H)T244Q   0.4  1.0  0.8 
su(H)-F M330I/cs(H)T244Q   0.5  1.0  1.0 
su(H)-F R386H/cs(H)T244Q   0.2  1.0  1.0 
 
cs(H)M251Q     2.6×10-2 1.0  1.1 
su(H)-F T204I/cs(H)M251Q   0.1  1.0  0.6 
su(H)-F M330I/cs(H)M251Q   0.2  1.0  0.5 
su(H)-F R386H/cs(H)M251Q   0.1  1.0  0.7 
 
cs(H)T244Q/M251Q    <1.1×10-5 1.0  0.7 
su(H)-F T204I/cs(H)T244Q/M251Q  <1.9×10-3 1.0  <1.9×10-3 
su(H)-F M330I/cs(H)T244Q/M251Q  <6.9×10-6 1.0  0.5 
su(H)-F R386H/cs(H)T244Q/M251Q  <6.0×10-6 1.0  1.0 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
a Efficiency of plating. Values are normalized to those obtained from plates incubated at 
37° 
b Strains with mutations suppressing the T244Q, M251Q, or T244Q/M251Q mutations 
are labeled with gene in which the suppressing mutation was found, the corresponding 
amino acid change, and the suppressed mutation, if any. For example, su(H)-F 
T204I/cs(H)T244Q indicates that the strain has T204I in gene F and T244Q in gene H 
while su(H)-F T204I indicates that the strain has T204I in gene F and a wild-type H gene. 
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FIGURE LEGENDS 
 
 
FIG 3.1: Structure of the φX174 H-tube. A) The φX174 H protein’s coiled-coil domain 
when oligomerized as a decameric tube. The amino terminal end is facing up and two 
opposing monomers are colored in cyan (PDB file: 4JPP). B) The H-tube as seen from its 
C-terminal opening.  Inward facing residues are modeled as sticks. C) Primary sequence 
of the coiled-coil domain. Inward facing residues are colored. Blue residues were mutated 
in this study. D) The inner surface of three α-helices between Q241 and Q265. Inward 
facing side chains are modeled as sticks. Inward facing side chain labels appear to the 
right of the helices. 
 
FIG 3.2:  Assembled particles produced in infected cells expressing mutant H constructs. 
(A) 280nm absorbance profiles of infected cell extracts analyzed by rate zonal 
sedimentation. Fraction 1 represents the gradient bottom. The specific infectivity peak is 
indicated with an arrow and a color legend resides in the upper right graph quadrant. (B) 
SDS-PAGE analysis of specific infectivity peaks. The white space between lanes 
indicates the removal of irrelevant lanes from the gel. 
 
FIG 3.3: Attachment (A) and eclipse (B) kinetics of virions containing either the wild-
type or mutant H proteins. A color legend is provided in the lower right quadrant of each 
panel. Error bars represent the standard error of the mean calculated from either six 
biological replicates (attachment) or three biological replicates (eclipse). 
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FIG 3.4: Viral coat protein levels in infected cells expressing the wild-type H protein. 
SDS-PAGE analysis of infected cells incubated at 37 (A left) or 22°C (A right). 
Quantification of coat to host protein ratios of infected cells seen in panel A. The host 
protein band used in this analysis is indicated with an arrow in panel A. 37°C results are 
shown in panel B, 22°C results are in panel C. A color legend in provided in the upper 
left quadrant of panel B. Error bars represent the standard error of the mean calculated 
from three biological replicates. 
 
FIG 3.5: Potassium efflux curves and genome quantification. Efflux values are reported 
as the increase in millivolts after the initial millivolt reading. More positive values 
indicate more extracellular K+ is present. (A) Representative potassium efflux curves in 
φX174 infected cells at 37°C and (B) 22°C. A color legend in provided in the upper left 
quadrant of panel B. (C) Infecting genome copy number ratios. Data is presented as I:O 
ratios, which is the genome copy number of the inner membrane over that of the outer 
membrane. I:O ratios of particles carrying wild-type H (black), M251Q H (blue), and 
T244Q+M251Q H (purple) are shown. Error bars represent the standard deviation 
obtained from three technical replicates. 
 
FIG 3.6: Titers of progeny produced in lysis-resistant cells infected with wild-type 
φX174 (circles), su(H)-F T204I (triangles), or su(H)-F M330I (squares). Data is 
displayed as the viral burst size, which is the calculated by dividing the total progeny by 
the total input phage. Error bars depict the standard deviation obtained from three 
biological replicates. 
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FIG 3.1 Structure of the φX174 H-tube 
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FIG 3.2 Assembled particles produced in infected cells expressing mutant H constructs 
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FIG 3.3 Attachment (A) and eclipse (B) kinetics of virions containing either the wild-
type or mutant H proteins 
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FIG 3.6 Titers of progeny produced in lysis-resistant cells infected with wild-type 
φX174, su(H)-F T204I, or su(H)-F M330I 
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CHAPTER 4 
RECESSIVE HOST RANGE MUTANTS AND UNSUSCEPTIBLE CELLS THAT 
INACTIVATE VIRIONS WITHOUT GENOME PENETRATION: 
ECOLOGICAL AND TECHNICAL IMPLICATIONS 
 
4.1 Abstract 
Although microviruses do not possess a visible tail structure, one vertex rearranges after 
interacting with host lipopolysaccharides. Most examinations of host range, eclipse, and 
penetration were conducted before this “host-induced” unique vertex was discovered and 
before DNA sequencing became routine. Consequently, structure-function relationships 
dictating host range remain undefined. Biochemical and genetic analyses were conducted 
with two closely related microviruses, a3 and ST-1. Despite ~90% amino acid identity, 
the natural host of a3 is E. coli C; whereas ST-1 is a K12-specific phage. Virions 
attached and eclipsed to both native and unsusceptible hosts; however, they breached 
only the native host’s cell wall. This suggests that unsusceptible host-phage interactions 
promote off-pathway reactions that can inactivate viruses without penetration. This 
phenomenon may have broader ecological implications. To determine which structural 
proteins conferred host range specificity, chimeric virions were generated by individually 
interchanging the coat, spike, or DNA pilot proteins. Interchanging the coat protein 
switched host range. However, host range expansion could be conferred by single point 
mutations in the coat protein. The expansion phenotype was recessive: genetically mutant 
progeny from co-infected cells did not display the phenotype.  Thus, mutant isolation 
required populations generated in low MOI environments: a phenomenon that may have 
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impacted past host range studies in both prokaryotic and eukaryotic systems. The 
resulting genetic and structural data were consistent enough that host range expansion 
could be predicted, broadening the classical definition of antireceptors to include 
interfaces between protein complexes within the capsid. 
 
4.2 Introduction 
 
The molecular events mediating early infection have been defined for many bacterial and 
animal viruses (1-6). This process begins with receptor recognition, perhaps the most 
critical extracellular factor governing host range. Accordingly, mutations in viral 
antireceptors are often necessary and sufficient to gain access to new hosts (7-11).  
 
Bacteriophage tail components recognize a diverse range of host cell receptors: 
monomeric proteins, multimeric complexes, lipopolysaccharides (LPS), peptidoglycan, 
and teichoic acids (12). For most non-tailed and filamentous phages, unique vertices, 
spike complexes, or terminal proteins perform this function (13-16). Some phages require 
two receptors: one located on the cell wall’s outermost surface, and a second one 
embedded within a membrane (17-19). In general, interactions with the initial receptor 
govern reversible attachment, whereas interactions with the secondary receptor are 
irreversible, inducing the conformational changes leading to penetration.  
 
Considering the genetic tractability of most model phages, host range mutants have been 
isolated in relatively few systems. When isolated, mutations overwhelmingly alter the 
protein mediating irreversible attachment (8-10, 20). As is typical of most enfants 
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terribles, φX174-like phages behave badly. The φX174-like phages fall into three 
evolutionary clades, each represented by φX174, G4, and α3 (34). To date, all 
characterized microviruses use host LPS as a receptor (35) (21) and, with the exception 
of a few phages within the α3 clade (see below), all known phages share a common host, 
E. coli C. ΦX174 host range mutations alter one of three structural proteins: the capsid, 
the spike, and the DNA pilot proteins (22-27). Indeed, conformational changes involving 
all three structural proteins have been documented during early infection (28-30).  
 
LPS outer core structure is the most critical, and perhaps the only, extracellular host 
range determinant of the φX174-like phages (21). Reversible attachment may be 
mediated by conserved coat protein residues that form a 6-carbon sugar binding site 
(Figure 4.1). Although this has yet to be experimentally addressed, x-ray structures of the 
φX174 capsid contain ordered sugars bound to these residues  (31, 32). Moreover, Ca++ 
ions, which facilitate attachment, structurally change this site from a nonbinding to a 
binding conformation (33).  
 
Two lipid bilayer-attached structures derived from cryo-EM studies, pre- and post-DNA 
release, elucidate the conformational switches associated with irreversible attachment, or 
eclipse. In both structures, the G protein spike at the lipid-interacting vertex has been 
removed (30). An annulus of coat protein residues merges with the lipid bilayer, 
anchoring the infecting virion to the membrane. In the post DNA-release structure, there 
is a pore at the attached vertex, presumably through which the DNA translocating 
conduit, or H-tube, emerges and penetrates the cell wall (28, 29).  
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While the cryo-EM and x-ray structures demonstrate how three proteins can mediate 
attachment and penetration, without supporting genetic and biochemical data, the 
relationship to host range remains obscure. The results of past studies are limited. Firstly, 
most were conducted before DNA sequencing was commonplace. Thus, the identity of 
the host range altering substitution remains unknown. Secondly, host strains were often 
poorly defined, many being E. coli C-K12 hybrids. Thus, selections were unilateral: 
expanding host range to an alternative host. More detailed comparisons would be 
facilitated if a naturally occurring microvirus of the alternate host was concurrently 
examined.   
 
Bacteriophage ST-1 is one of two known E. coli K12 specific microvirus (36). The three 
structural proteins that may govern host range: the viral coat, major spike, and DNA pilot 
proteins; respectively display 91.4, 89.8, and 85.7% identity with those of bacteriophage 
a3, an E. coli C specific phage. The three early infection stages: attachment, eclipse and 
penetration; were biochemically characterized in both native and unsusceptible hosts. To 
compliment these biochemical assays, host range switching and expansion was 
genetically analyzed.  During the course of this study, it became apparent that standard 
laboratory protocols, often deemed trivial, can greatly influence experimental results. 
Due to recessive phenotypes, standard protocols had to be altered. This phenomenon may 
have broader implications, influencing the results of other prokaryotic and eukaryotic 
virus host range research. Moreover, unsusceptible host interactions inactivated viruses; 
in essence culling the population from which an expanded host range mutant could 
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emerge. This may reflect a novel facet of the virus-host arms race. Lastly, the genetic and 
biochemical data were easily interpreted within a structural context, allowing phenotype 
prediction, which may expand the classic antireceptor definition to include interfaces 
between capsid complexes. 
 
4.3 Results 
 
Virions reversibly and irreversibly attach to unsusceptible hosts, but breach only 
native host cell walls: Reversible attachment, eclipse, and K+ efflux assays were used to 
analyze phage-cell interactions with both permissive and unsusceptible hosts. To assay 
attachment, phage and cells were co-incubated in a CaCl2 containing starvation buffer at 
16°C. Calcium ions promote reversible attachment (33), whereas low temperature and 
starvation prevent eclipse (49). Cells and attached phage were removed by centrifugation. 
Thus, supernatant titers directly reflect the unattached phage population. To analyze the 
next entry step, eclipse or irreversible attachment, the pellets were resuspended in a 
CaCl2-containing nutrient broth pre-heated to 37°C. Uneclipsed particles were removed 
by the addition of EDTA, which chelates the Ca++ ions.  For a3, no significant 
differences in attachment or eclipse efficiencies were observed as a function of host range 
(Figure 4.2A). By contrast, some statistical differences were observed for ST-1. 
However, they are likely too small to account for the <10-10 titer on the E. coli C host.  
 
During penetration, many phages create a conduit connecting the phage particle with the 
host’s cytoplasm. Potassium ions, the cells’ primary osmolyte, diffuse through this 
channel (46, 48, 50).  Thus, K+ efflux assays detect viral-mediated cell wall breaches. 
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Phages were pre-attached to cells at 4° to inhibit eclipse. Afterwards, infected cultures 
were diluted into K+-free buffer at 37° and extracellular K+ levels were monitored as 
described in Materials in Methods. In contrast to the previous experiments, biologically 
significant differences were observed.  Efflux only occurred when the phages were 
incubated with their respective permissive hosts (Figure 4.2B and C). Negative DmV 
readings were observed when phages were added to unsusceptible hosts, suggesting K+ 
uptake. However, the initial cell and phage preparations are lacking significant K+ levels. 
This effect may be caused by an influx of trace NH4+ ions present in the phage 
preparations. NH4+, when above 2.7 ppm, can interfere with K+ selective electrodes when 
K+ concentrations are at or below 1 ppm.  All efflux experiments were conducted using 
the same cell and phage preparations. Thus, trace ions effects should be the same in all 
experiments, but are masked when K+ efflux occurs.  
 
Host range correlates with the viral coat protein found in a3 – ST-1 chimeric 
particles:  To determine whether interchanging individual structural proteins altered host 
range, chimeric particles were generated by separately interchanging the viral coat F, 
major spike G, and DNA pilot H proteins. To interchange the G and H proteins, the 
corresponding genes were cloned and used to complement a3 and ST-1 nonsense 
mutants. Chimeric phages were generated in their permissive hosts and subsequently 
assayed for plaque formation on their unsusceptible hosts, both expressing the 
appropriate cloned gene. For example, a3 am(G) phage was initially grown in E. coli C 
expressing the ST-1 G gene, which complemented as well as the a3 gene.  The resulting 
progeny were then plated on E. coli K12 expressing the ST-1 G gene. Plating efficiency 
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was less than 10-6.  Similar results were obtained for the other three chimeric particles. 
Thus, the G and H proteins were interchangeable but did not alter host range.   
 
Cloned coat F gene induction was too toxic to conduct complementation assays as 
described above. Therefore, chimeric particles were generated via recombination as 
described in Material and Methods. Briefly, E. coli C cells harboring the cloned ST-1 F 
gene were infected with wild-type a3. For ST-1, K12 cells contained the cloned a3 gene. 
Putative recombinants were identified by plaque formation on the parental phage’s 
unsusceptible host. They were recovered for both phages (frequency~10-5).  Subsequent 
plating assays were used to determine whether host range had expanded or switched 
entirely. Both phenotypes were observed. Members of each phenotypic class had their 
coat protein genes sequenced (Table 4.1 and Figure 4.3).  
 
Figure 3 contains the amino acid sequences of both phages, which are ~90 % identical. 
Although differences were observed throughout the entire sequence, they tended to 
cluster in small groups. Due to highly similar viral genome sequences, it was not possible 
to determine precise recombination junctions. Therefore, recombinant names reflect the 
position of the first amino acid categorically encoded by the donor gene. Thus, the name 
a3–R184 describes an a3 parent in which all gene F codons after and including 184 were 
donated by the ST-1 gene (Figure 4.3). As can be seen in Table 4.1, host range correlates 
with the coat protein. a3–R1, which now synthesizes the ST-1 coat protein, only forms 
plaques on E. coli K12. ST-1–R26, which produces the a3 protein with the exception of 
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one amino acid, is an E. coli C specific phage. By contrast, chimeric coat proteins (a3–
R184 and ST-1–R184) expand host range to both cell types.  
 
Expanded host range mutations are recessive: In most genetic selections using 
microviruses, single gain of function mutations typically appear at frequencies between 
10-4 – 10-6. (43, 51-57) However, unsusceptible host plating efficiencies were less than 
10-10 (Table 4.1) when using standard phage stocks, which are incubated until total cell 
lysis.  Moreover, unsusceptible host cell growth was unaffected despite draconian 
multiplicity of infection (MOI) values between 100-1000. This tight restrictive phenotype 
may indicate that altering host range requires multiple mutational events. However, one 
a3 expanded host range mutant was isolated. Despite the 10-11 isolation frequency 
associated with the a3 PA (polyamorous) mutant, only a single GàA transition was 
found within the entire genome. It conferred a DàN substitution in the viral coat protein. 
The structural consequences of this substitution, as well as other PA mutations, are 
discussed below. The exceptionally low isolation frequency of a single transition 
suggested an additional level of genetic complexity was affecting the selections.  
 
Both hosts lack restriction modification systems. E. coli C is naturally restriction minus 
(41), whereas the K12 strain (IJ1133) has been genetically modified (40). However, the 
presence of an unknown or uncharacterized restriction modification system could explain 
the low mutant isolation frequency. To test this hypothesis, the a3 PA mutant was 
propagated in each host. Afterwards progeny titers were determined on both E. coli 
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strains. They did not significantly differ (data not shown); thus, the existence of an 
unknown restriction system seemed unlikely. 
 
Alternatively, the PA phenotype may be recessive. Unlike functions governing 
intracellular growth, host range can operate on the extracellular level. Consequently, the 
MOI of the previously infected cell can influence phenotype penetrance and mutant 
isolation frequency. In this model, a PA genome packaged within a capsid containing 
both WT and PA coat proteins may not infect the new host. Viral stock preparations are 
designed to produce the highest possible titers. To allow for multiple propagation cycles, 
the culture’s initial MOI is very low. However, cultures incubate until all cells have been 
infected and slaughtered. Consequently, the last growth cycles occur at MOIs favoring 
co-infections. To test this hypothesis, a dominance assay was performed. Lysis-resistant 
cells were co-infected with a PA and non-PA parent at varying ratios (Table 4.2). The 
non-PA parent contained an amber mutation in gene H, which was complemented by a 
cloned a3 H gene. The resulting progeny could be distinguished by three differential 
plating assays. 
1) Total progeny: titer on E. coli C expressing the cloned a3 H gene.  
2) Genetically PA progeny, regardless of PA phenotype: titer on E. coli C without 
the cloned a3 H gene. This selects against the non-PA am(H) parent.  
3) Genetically and phenotypically PA progeny: titer on E. coli K12.  
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PA phenotype penetrance is classically defined as the percentage of genetically PA 
individuals displaying the associated phenotype. It can be determined with the following 
formula:  
 
                    titer on E. coli K12  
 Phenotype Penetrance Value (PPV) =    –––––––––––––––––––––––––––––––––––––––                                                 
              titer on E. coli C without the cloned a3 H gene   
 
 
In these experiments, the MOI of the PA parent was kept constant at 0.5, whereas the 
non-PA parental MOI varied from 0.5 to 10. At the higher MOIs (>5), nearly all PA 
infected cells will be co-infected with the non-PA parent. Thus, PA genomes will likely 
be packaged into heterogeneous capsids as described above. If the PA phenotype is 
recessive, the Phenotype Penetrance Value (PPV) will decrease as the non-PA parent 
MOI increases. As can be seen in Table 4.2, the PPV dropped nearly three orders of 
magnitude.  
 
Population life-history influences mutant isolation frequencies: If the PA phenotype 
is recessive, as the data suggest, the population’s “life-history” could significantly 
influence mutant isolation. If the population was derived from co-infected cells, 
frequencies could be misleadingly low. To test this hypothesis, genetic selections were 
performed with populations generated without co-infections. Several techniques were 
employed: overlay plates, plating permissive host infectious centers with unsusceptible 
hosts, terminating stock preparation before culture lysis, and low MOI infections with 
lysis inhibition. Of all four techniques, the lysis inhibition protocol was the most 
efficient, least problematic, and easily incorporated into high school curriculums. The 
 162 
technical advantages and drawbacks of each method and how they can be integrated into 
high school curricula are detailed in the Material and Methods section.  
 
Regardless of protocol, a3 PA mutants were isolated at a frequency of ~10-5, which is 
consistent with the generation of single point mutations. Although these mutants form 
plaques on both hosts, plaque morphology was noticeably smaller on E. coil K12. By 
contrast, no altered host range ST-1 mutants were isolated by these techniques. In this 
instance, the low isolation frequency may truly indicate that multiple mutational events 
are required. 
 
The a3 PA substitutions localize to a protein-protein interface: The PA mutations 
identified by direct selections are listed in Table 4.3 (first five entries). Five genetically 
distinct substitutions altered three coat protein residues. The mutant genomes were 
sequenced and no other substitutions were found, suggesting the identified mutations 
were both necessary and sufficient to confer the PA phenotype. Although more than 10 
independent sources were used, it is unlikely that the selections went to saturation. Two 
mutations, D395N and Q401K, were independently isolated once, whereas the Q401 and 
Q402 àR mutations were isolated from almost every independently prepared population. 
The positions of these amino acids, as well as other substitutions conferring the PA 
phenotype (see below), are indicated with asterisks in Figure 4.3 and are marked within 
the a3 x-ray structure (Figure 4.4). Only the D395N mutation is located directly at a 
diverged residue between a3 and ST-1. The amino acid in the ST-1 sequence is 
asparagine.  
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To identify other mutations, the existing PA mutants were experimentally evolved on 
both hosts.  Wild-type a3 was similarly treated on E. coli C to identify mutations that 
may arise from the passaging technique (Material and Methods). 19 genomes were 
selected for whole genome sequence analysis. Numerous substitutions were identified in 
each genome. However, many of them may not directly affect host range. Therefore, only 
mutations exclusively found in E. coli K12-evolved genomes were selected for further 
analysis: coat protein substitutions K361R and Q384K. To determine whether these 
mutations affected host range, they were placed in a wild-type background and assayed 
for plaque formation on E. coli K12. As can be seen in Table 4.3, both mutations 
conferred the PA phenotype.  
 
All of the PA mutations substitute a more basic amino acid for the wild-type residue: 
KàR (361), QàR (401 and 402), QàK (384, 401 and 402) or DàN (395). Unlike the 
other mutations, the Q384K conferred a very weak PA phenotype (Table 4.3). Moreover, 
in the a3 crystal structure (58), it is not located near the other substitutions, which reside 
within the outer circumference of the coat-spike protein interface (Figure 4.4, panels A B, 
and C).  
 
Mutations conferring the PA phenotype can be predicted, albeit in a limited 
manner: The location of the four sites conferring the strongest PA phenotypes: D395, 
Q401, Q402, and K361; cluster with their side chains oriented toward a descending loop 
of the major spike protein G (Figure 4.4, panel C).  Chemically, the PA substitutions are 
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more basic than the wild-type residues. These observations suggest that PA phenotypes 
may be predictable, a hypothesis tested by site-directed mutagenesis.  
 
Mutations in both genes F and G were designed to replace the wild-type residues with 
more basic ones.  Based on location and side chain orientation, G protein substitutions at 
T75 and D76 were predicted to confer the PA phenotype, whereas substitutions at I177, 
H178, and Q181 were not expected to alter host range. With the exception of the D76 
mutagenesis, primers contained ARA at the target site, encoding either lysine (AAA) or 
arginine (AGA).  Codon D76 was changed to AAC (asparagine). Mutagenized DNA was 
transfected into both E. coli C and K12. The T75 and D76 reactions produced plaques on 
both hosts. Two mutants were recovered, T75R and D76N, and both displayed the PA 
phenotype (Table 4.3). The other G gene reactions: I177, H178, and H181; only produced 
plaques on E. coli C.  I177R, I177K, H178K, Q181K, and Q181R mutants were 
recovered on that host but did not alter host range: E. coli K12 plating efficiencies were 
four orders of magnitude lower than those obtained on E. coli C. 
 
In the capsid protein, PA phenotypes were predicted for substitutions at S400, but not at 
Q399 and L404. However, the results were more complex. Transfection plates were 
incubated at both 30° and 37°C. With one exception (see below), plaques only developed 
on E. coli C.  The coat F genes were sequenced (N>12) and all were wild-type. Typically, 
in our laboratory, viable mutants represent 25-50% of recovered progeny. Thus, these 
negative results may indicate lethal phenotypes. Alternatively, mutating these codons 
may be technically problematic. However, an unintended mutation was recovered. It 
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contained a methionine codon at Q399, likely arising from a spontaneous event after site-
directed mutagenesis: CAG (Q) àAAG (K) àATG (M); or a contaminating primer.   
 
While the recovery of the Q399M mutant argues against technically problematic site-
directed mutagenesis; it falls short of compelling. To more rigorously determine whether 
substitutions were lethal, recombination rescue experiments were performed with cloned 
genes containing the S400K, S400R, L404K, or L404R mutations. On the sup° host 
without a plasmid, the plating efficiency of am(F)Q399 was five orders of magnitude 
below the permissive titer. Thus, 10-5 represents the background am+ reversion 
frequency. Plating efficiency rose to ~10-3 in the presence of the uninduced, cloned wild-
type gene, reflecting a recombination frequency two logs above background.  By 
contrast, plating efficiency with the mutant plasmids was equal to the am+ reversion 
frequency. Thus, the inability to recover these mutant phages suggests that the 
substitutions confer a lethal phenotype. However, the underlying molecular basis of the 
lethal phenotype cannot be determined with this genetic assay.  
 
Exceptions to rules governing phenotype prediction: The unintended Q399M mutant 
was isolated on E. coli K12. Thus, it was subjected to selective pressure beyond viability, 
expanded host range. The mutation introduces a more hydrophobic amino acid that 
conferred a very weak PA phenotype (Table 4.3). Unlike the side chains at the 
neighboring PA sites, which are oriented toward the G protein spike, the Q399 side chain 
descends into the capsid. A more hydrophobic descending side chain, one oriented into 
the capsid, may affect the F-G interface like a more basic, ascending side chain. The 
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general rule also suggests that a D395àR substitution, like D395N, would similarly alter 
host range. However, it did not: the E. coli K12 plating frequency was less than 10-5. 
Lastly, residue Q384 is not in the F-G interface, yet Q384K conferred a weak PA 
phenotype. As visualized in the Cryo-EM structure of an infecting virion (30), this 
residue may affect a nearby lipid interacting ring.   
 
Reversion of the PA phenotype and structural data may identify another coat region 
governing host range:  As described above, PA mutants were experimentally evolved on 
both E. coli C and K12. Afterwards, approximately 50 plaques were assayed for host 
range phenotypes differing from their respective parents. All assayed plaques arising 
from passages through E. coli K12 retained the ability to form plaques on E. coli C. By 
contrast, Q402R and Q402K lineages evolved on E. coli C gave rise to strains that lost 
the PA phenotype. A common coat protein substitution was found in both lineages: 
I112V.  To determine whether this mutation was both necessary and sufficient to nullify 
the PA phenotype, it was placed directly into the Q401K, Q402R, Q402K, Q402R, and 
D395N genetic backgrounds. In all instances, the K12 plating efficiency fell more than 
five orders of magnitude. Thus, the I112V mutation nullified the PA phenotype. Residue 
I112V is not in the F-G interface. Instead, it resides within the aforementioned lipid 
interacting ring (30).  
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4.4 Discussion 
 
Host-mediated virus inactivation and its evolutionarily significance: Despite 
structural proteins displaying ~90% identity, bacteriophages a3 and ST-1 infect different 
E. coli strains.  Extracellular tropism can be divided into three stages: 1) attachment; 2) 
eclipse, defined as host-mediated inactivation; and 3) penetration, which involves 
breaching the cell wall and subsequent genome transport. Regardless of the 
permissive/unsusceptible nature of the host, attachment and eclipse did not appear to be 
affected. However, phages could breach only their permissive host’s cell wall.  In the 
unsusceptible host, eclipse leads to an off-pathway reaction that inactivates the infecting 
particle. Thus, sampling unsusceptible host surfaces can have negative consequences that 
could influence evolutionary trajectories in natural environments. While detrimental to 
the virus, at least in the laboratory setting, this could be evolutionarily advantageous to 
potential hosts, perhaps representing a prophylactic strategy in the virus-host arms race.  
The potential host culls the population from which an expanded host range mutant can 
emerge.  Alternatively, this may be a consequence of lab adaptation: a virus, removed 
from its natural multi-host environment, is continually propagated in one cell type. In a 
homogeneous host environment, selective pressure to avoid harmful non-host cell 
interactions, if they existed, would be greatly relaxed.  
 
The genetics of host range expansion and switching:   The host range of bacteriophage 
a3 and ST-1 were switched by interchanging their viral coat proteins. Thus, by strict 
definition, the viral coat protein is both necessary and sufficient to change host range.  
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However, genetic data suggest that there is a distinction between host switching and 
expansion, which is conferred by recessive, single point mutations.  
 
Unlike dominant and recessive phenotypes associated with intracellular processes, readily 
discerned by co-infection burst sizes, phenotypes governing extracellular phenomena 
affect the next generation. When genetically PA genomes were packaged into 
heterogeneous particles composed of wild-type and PA coat proteins, the phenotypic 
penetrance was greatly reduced (Table 4.2). Consequently, a3 PA mutants were only 
efficiently isolated from populations generated in low MOI environments.  Single 
mutants arose at a 10-4 – 10-5 frequency from those samples.  By contrast, when 
selections were conducted with standard, high-titer stocks, the frequency was ~10-11.  To 
generate the high titers favored by most researchers, cultures incubate until all cells 
produce progeny. Therefore, most cells will be co-infected in the final stages of stock 
growth.  If the proteins governing host-range operate within complexes; e. g. trimeric 
tailspikes, baseplates, multimeric spikes or an entire capsid; the population’s co-infection 
“life-history” will affect selections. Dominant alleles will be favored, whereas recessive 
ones will be under-isolated or undetected (8-10, 25). A similar phenomenon has been 
documented for antibody escape mutants (59), which are significantly underestimated in 
populations containing heterogeneous particles.   
 
The relative effect of the population’s life history may vary depending on whether the 
phage encodes a super-infection exclusion mechanism and/or has the ability to 
lysogenize. Two super-infection exclusion mechanisms have been documented in φX174 
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(60, 61), which is lytic phage.  However, there is a temporal aspect to super-infection 
exclusion: the excluding phage must first establish an infection. Indeed, super-infection 
exclusion was experimentally defined using delayed secondary infection protocols (60, 
61). Thus, simultaneous or near simultaneous coinfections could occur during  a standard 
stock preparation, especially if the rounds of infections are somewhat synchronized. The 
penultimate burst would rapidly change the culture from a low to a high MOI 
environment.  
 
ST-1 host range could be switched by interchanging its coat protein with a3. However, 
no PA mutants could be isolated regardless of the population’s “life-history.” When a3 
PA mutants were experimentally evolved in E. coli C, a second-site, PA-nullifying, 
mutation emerged. If the ST-1 coat protein naturally contains a “nullifying” amino acid, 
host range expansion may require two mutations: the acquisition of a PA mutation and 
the loss of the “nullifier.”  The “nullifying” moniker is entirely semantic, reflecting its 
isolation after the PA mutations. Nonetheless, its existence demonstrates that small, often 
ignored, conservative differences between independently lab adapted wild-type strains 
can have experimental consequences. Kumbaya, seemingly different yet rigorously 
generated and analyzed data sets may all be correct.  
 
The structural basis of host range, receptor interactions, and phenotype prediction: 
When visualized within the a3 virion structure, most of the coat protein PA mutations 
clustered to the outer circumference of the coat-spike interface. The substitutions were 
more positively charged than the wild-type amino acid residues. Moreover, side chains 
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were oriented toward a descending G protein insertion loop.  This suggested that PA 
phenotypes could be predicted, at least within the limited context of the hosts and phages 
used in this study. To test this simple hypothesis, charges were introduced into the 
descending G protein insertion loop (Figure 4.4), which resulted in the PA phenotype 
(Table 4.3).  By contrast, alterations in side chains oriented away from this region did not 
expand host range. However, two observations suggest that the initial hypothesis requires 
refinement: 1) Some substitutions conferred lethal phenotypes, which precluded host 
range examination, and 2) the introduction of a more hydrophobic amino acid (QàM) 
with a descending side chain also conferred a PA phenotype, albeit a weak one.  
 
The viral antireceptor may be an interface between protein complexes: Crill and 
colleagues examined evolutionary reversals when φX174 was adapted by repetitively 
switching between two permissive deep rough LPS hosts (62). Similar to our results, they 
identified three fitness-elevating, coat protein residues located on the outer circumference 
of the coat-spike interface (Figure 4.5).  Although the experimental approaches differed, 
the collective results are very consistent with the cryo-EM reconstruction of infecting 
particles, further indicating that G spike removal is critical to early infection (30). This 
may broaden the classical concept of viral antireceptors to structural interfaces between 
protein subassemblies. The contrasting phenotypes of G protein PA substitutions and the 
G protein chimeric virions further support the importance of the interface. The chimeras, 
generated by exchanging the entire G protein between a3 and ST-1, did not exhibit 
altered host ranges. However, the F-G interface would not be identical in these strains. 
The limited differences between the a3 and ST-1 G protein primary structure are 
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confined to the protein’s apical regions. By contrast, G protein PA substitutions affect the 
interface located on the basal surface.  
 
Multiple interactions with a single receptor most likely govern early infection:  
Many bacterial viruses require primary and secondary receptors. Primary receptors are 
usually located on the host’s exterior surface (e.g. LPS, teichoic acid, and pili), and 
typically mediate reversible attachment. The second receptor, which induces penetration, 
is often a membrane protein (17-19). Although LPS appears to be the only receptor used 
by φX174-like viruses (21), distinct LPS-virion interactions may mimic a multiple-
receptor system. Both structural and genetic data support this model.  
 
Figure 5 illustrates the amino acids genetically identified to affect φX174 and a3 host 
range. It also depicts residues identified in x-ray and cryo-EM studies that may play a 
role in early infection. A 6-carbon sugar binding site, located near the three-fold axis of 
symmetry (Figure 4.5, purple residues), may govern reversible attachment. Although its 
direct role has yet to be experimentally addressed, x-ray structures show bound sugar 
molecules (31, 32). Moreover, Ca++ ions, which facilitate attachment, change this site 
from a nonbinding to sugar binding conformation (33). This interaction is followed by at 
least two additional LPS-mediated reactions: 1) spike removal, and 2) capsid protein 
melding with the lipid bilayer. Although the exact residues merging with the cell 
membrane are not known, they all reside in the EF insertion loop that extends from the 
coat protein’s jelly roll fold. Some residues within this loop form a bulge surrounding the 
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five-fold axis of symmetry (Fig. 4.5 dark grey).  Like the nullifying mutation described in 
this study, other host range affecting-mutations map to this region (26, 62).  
 
Standard laboratory techniques: less can be more: During the course of this study, it 
became apparent that standard laboratory techniques and protocols, often deemed trivial, 
can greatly influence experimental results. The PA mutants isolated in this study had a 
recessive phenotype. If not for the first author’s tenacity or dumb luck isolating the initial 
mutant (frequency = 10-11), the study would have been terminated. Either no conclusion 
or incorrect ones would have been drawn. In this instance, standard virus stock 
preparation; a + 50-year practice, never questioned and falsely deemed adequate for any 
experiment; could have greatly influenced outcomes. During viral penetration and 
genome trafficking, proteins often operate in complexes, which were assembled in the 
previously infected cell.  As demonstrated here, the recovery of recessive gain of function 
mutants can be highly influenced by the “life history” of the population subjected to 
selective pressure.   
 
 
4.5 Materials, Methods, and Acknowledgements 
 
Phage plating, media, buffers, and stock preparation. Plating, media, buffers, and 
standard stock preparation have been previously described (37). 
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Bacterial strains. The wild-type Escherichia coli C strain C122 and derivatives BAF5 
(supE) and BAF8 (supF) have been previously described (37, 38). RY7211 contains a 
mutation in the mraY gene, conferring resistance to viral E protein-mediated lysis (39). 
The E. coli K12 strain IJ1133 was genetically modified to eliminate restriction 
modification systems (40).  E. coli C is naturally devoid of restriction modification 
systems (41). IJ1198 and IJ1220 are respective supF and supE derivatives of IJ1133 (40).     
 
Cloning of a3 and ST-1 genes. To clone the a3 and ST-1 coat F genes, nucleotides 
3067-4362 (42) were PCR-amplified with primers with introducing upstream NcoI and 
downstream HindIII sites. To clone the ST-1 spike G gene, nucleotides 4348-4985 were 
PCR amplified with primers introducing upstream NcoI and downstream EcoRI sites. To 
clone the α3 spike G gene nucleotides 4366 to 4961 were amplified primers introducing 
upstream NcoI and downstream AleI sites. To clone the ST-1 DNA pilot H gene 
nucleotides 5063-42 were amplified with primers introducing upstream SacII and 
downstream XhoI sites. And lastly, to clone the α3 pilot H gene nucleotides 5083-6089 
were amplified with primers introducing upstream BglII and downstream XhoI sites. The 
PCR products were digested with the specified enzymes and ligated into pSE420 DNA 
(Invitrogen) digested with the same enzymes.  
 
Mutations were introduced into the cloned a3 F gene by amplifying the entire plasmid 
with Q5 DNA polymerase (NEB) with abutting primers, one of which introduced the 
desired mutation. The PCR product’s 5’ hydroxyl termini were phosphorylated and ends 
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ligated together using T4 polynucleotide kinase and ligase (NEB), respectively. The 
nucleotide sequences of all clones were verified by a direct DNA sequencing analysis. 
 
Construction of a3 and ST-1 chimera via recombination. E. coli C cells harboring the 
cloned ST-1 F gene was infected with wild-type a3. For ST-1, K12 cells contained the 
cloned a3 F gene. 30 ml cell cultures were grown to a concentration of ~108 cells/ml, 
infected at an MOI of ~10-5 and incubated for 2 hr. Cultures did not incubate until lysis. 
After the addition of lysozyme, cultures were titered on both permissive and 
unsusceptible hosts. Putative recombinants were identified as described in the Results.  
 
Site directed phage mutants of a3.  Single-stranded (ss) viral DNA was isolated by the 
OLT (Our Little Trick) protocol, which has been previously described (43). Mutations 
were introduced by amplifying the entire genome with abutting primers, one of which 
introduced the desired mutation. The PCR products were treated as described above. The 
resulting ligation products were transfected into C122. If the ligation product contained 
an amber mutation, BAF5(supE) was transfected.  
 
Attachment, eclipse, and K+ assays. Attachment and eclipse assays have been 
previously described (44, 45). K+ efflux assays, modeled after a previously published 
protocol (46), were performed by first growing cells to an OD660 of 0.08 in TKY media 
(1.0 % tryptone, 0.5% KCl, 0.5% yeast extract) at 37°C. Cells were pelletized and 
washed in an equal volume of SM buffer (100 mM NaCl, 10 mM MgSO4, 50 mM Tris 
pH=7.5), washed again in 1/10th the volume of SM buffer, and resuspended in 1/100th the 
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volume of iced SM buffer containing 10 mM MgCl2 and 5.0 mM CaCl2. The cell culture 
was divided into 1.0 mL aliquots, kept on ice, and chilled phage was added at an MOI of 
75. Presumably, high MOIs are required to detect the efflux signal (46-48). Iced SM 
buffer containing MgCl2 and CaCl2 was added to equalize aliquot volumes. Cultures were 
incubated for 15 minutes on ice to allow phage pre-attachment. At 1.0-minute intervals, 
cultures were diluted 10-fold into SM buffer containing MgCl2 and CaCl2 preheated to 
37°C. Immediately after dilution, an Orion Ionplus potassium electrode (Thermo 
Scientific) connected to a Sartorius PB-11 pH meter was inserted into an infection and a 
reading was taken after 1.0 minute. This electrode was then rinsed with DI H2O, blotted 
dry, and placed into the dilution of the subsequent infection. The electrode was rotated 
between infections at one-minute intervals once all infections were diluted. 
 
Genetic selections with populations generated in low MOI environments. Four 
different techniques were used to obtain populations generated in low MOI environments. 
1) Overlay protocol: ~107 infectious particles and ~108 permissive host cells were mixed 
in 2.0 ml soft agar (37) and plated. After a 30 min incubation at 33°C, ~108 unsusceptible 
host cells in soft agar were poured atop the plates, which were then incubated at 37°C for 
5 hrs. 2) Pre-attachment protocol: approximately ~106 infectious particles and ~107 
permissive host cells were mixed and incubated at 37°C for five minutes. Afterwards, ~ 
5.0 X 108 unsusceptible host cells in 2.0 ml soft agar was added to the reaction mixtures, 
plated and incubated at 37°C. 3) Low titer stock protocol: This was identical to a standard 
stock preparation (37) but the culture was not allowed to incubate until lysis. 4) Lysis 
inhibition protocol: for a3, a single plaque (~106 – 107 phage) and 0.1 ml of lysis 
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resistant cells (~108 cells) were placed into 1.0 ml TKY media (1.0% tryptone, 0.5 KCl, 
0.5 yeast extract) supplemented with 10.0 mM MgCl2 and 5.0 mM CaCl2. Infections were 
incubated for 5 hr at 37°C and then placed on ice. Egg white lysozyme was added to a 
final concentration of 2.0 mg/ml and incubated overnight at 4°C. For mutant isolation, 
progeny were plated on the unsusceptible host. For ST-1, a phage with an amber mutation 
in the gene E, which encodes the viral lysis protein, was used. The protocol was identical 
to that used for a3 except E. coli K12 IJ1133 cells (sup°) were infected. The 
unsusceptible host for mutant isolation was E. coli C BAF8 (supF).  
 
Of all four techniques, the lysis inhibition protocol was the most efficient. Each single 
plaque infection represents an independent population source. Unlike generating low titer 
stocks, infections did not need to be continuously monitored for lysis. For the overlay and 
pre-attachment techniques, permissive rounds of infections occurred on the same plate 
from which host range mutants were picked. Consequently, mutant plaques often 
contained a high level of wild-type phage, which obscured sequencing results without 
prior plaque purification. The lysis inhibition protocol was also the easiest to integrate 
into off-campus, high school schedules as a “fully hands on” endeavor.  Infections were 
started before the school day began and incubated while the students attended their other 
classes. Lysozyme was added during their scheduled laboratory class and incubated 
overnight.  The next morning, selection plates were prepared before the start of classes 
and incubated during the day. Students picked plaques during their scheduled science 
hour. PCR reactions and product purification were also performed during scheduled 
science hours.   
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Experimental evolution: Starting with single plaques of each PA mutant, virions were 
stabbed into plates freshly seeded with bacteria and incubated for five hours at 37°C. 
Virions from the same starting plaque were initially stabbed into both E. coli C and K12 
containing plates. Afterwards, the subsequent populations were kept separate. A portion 
of the phage from each clearing were then transferred to a freshly prepared plate.  Wild-
type a3 was similarly passaged on E. coli C to identify mutations that may arise from the 
passaging technique. After the 10th passage, at which time clearings had become 
substantially larger, 24 individual plaques were isolated from each population and plated 
on both E. coli C and K12 to determine whether passaging on one host lead to any 
alterations in host range. For the reasons discussed above, this protocol was also easy to 
integrate into off-campus, high school schedules as a “fully hands on” endeavor.   
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4.7 Figures and Tables 
 
Table 4.1: Host range of coat protein chimeric virions  
––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
     Coat protein compositiona             Plating efficiencyb: 
     ––––––––––––––––––––––            –––––––––––––––– 
Phagea   a3     ST-1  C122  K12 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
Wild-type a3  100%      0%              1.0           <10-10 
a3–R1   0%           100%           <10-6  1.0 
a3–R184  43%         57%              0.9  1.0 
 
Wild-type ST-1 0%           100%                    <10-10  1.0 
ST-1–R26  6%           94%              1.0  <10-4 
ST-1–R184  43%         57%              0.4  1.0 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
a Coat protein composition and mutant phage nomenclature were derived from the coat 
protein sequence. They indicate the first amino acid that is identical to the foreign protein 
sequence within the recombinant strain. For example, the coat protein sequence found in 
strain a3–R184 becomes identical to the ST-1 sequence at residue 184. With the 
exception of the coat protein gene, or a portion thereof, the remaining genome is derived 
entirely from a3. Both coat proteins are 431 amino acids in length.  
b Plating efficiency is defined as assay titer/most permissive titer. Thus, if assay and most 
permissive titers were obtained on the same host, the plating efficiency was reported as 
1.0. 
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Table 4.2: Expanded host range is recessive 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
   Frequency of gene H complementation- PPV: PA phenotype 
             
Parental MOIs  independent progeny determined ona: penetrance  valueb  
–––––––––––– ––––––––––––––––––––––––––––––––––    –––––––––––––––––– 
am(H)     PA  A) E. coli K12  B) E. coli C   (A/B) 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
0.5     0     < 10-6       10-5c   NA 
0     0.5      0.7        1.0    0.7d 
0.5     0.5      0.08        0.5    0.16 
5.0     0.5      1.5 ´ 10-3       0.15                 1.0 ´ 10-2 
10     0.5      5.0 ´ 10-4       0.1            5.0 ´ 10-3 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
a The titer of gene H complementation-independent progeny was determined by plating 
on sup° strains of E. coli C and K12, which selects against the non-PA am(H) parent.  
b PPV conveys the percentage of genetically PA individuals, inferred by the absence of 
the am(H) mutation, that display the PA phenotype, determined by the ability to form 
plaques on E. coli K12.   
c This value established experimental background: the loss of the am(H) phenotype via 
either reversion of recombination with the cloned a3H gene.  The total titer was 
determined with E. coli C cells expressing the cloned a3 H gene.  
d This value established the background level arising from natural differences in plating 
efficiencies.   
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Table 4.3. Plating efficiencies of PA mutants 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
 Plating efficiency on 
    Identification or  Independent    –––––––––––––––––– 
Mutant    isolation methoda isolations E. coli C      E. coli K12 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
a3 PA(F)D395N  Direct selection       1  1.0  0.7 
a3 PA(F)Q401K  Direct selection       1  0.9  1.0 
a3 PA(F)Q401R  Direct selection       9  1.0  1.0 
a3 PA(F)Q402K  Direct selection       2  0.5  1.0 
a3 PA(F)Q402R  Direct selection       8  1.0  0.9 
a3 PA(F)K361R  Exp.b Evolution     NA  1.0  1.0 
a3 PA(F)Q384K  Exp.  Evolution     NA  1.0          ~10-1 – 10-2 c 
a3 PA(G)T75R  SDM   NA  1.0  0.5 
a3 PA(G)D76N  SDM   NA  1.0                    ~10-1 – 10-2 c 
a3 PA(F)Q399M  SDM & reversion  NA  1.0          ~10-1 – 10-2 c 
Non-PA mutants  SDM   NA  1.0               <10-5 
G protein: I177R, I177K,    
H178K, Q181K, Q181R 
Protein F: D395R 
 
Nullifier (F)I112V with SDM     NA  1.0               <10-5 
Q401K, Q401R, Q402K, 
Q401R, D395N 
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––– 
a Mutant nomenclature: mutant names reflect the protein, position, and substitutions conferring the PA 
phenotype. For example, PA(F)D395N reflects a DàN substitution at position 395 in the coat F protein.   
b Abbreviations: Exp. Evolution: experimental evolution. NA: not applicable. SDM: site-directed 
mutagenesis. SDM & reversion: site-directed mutagenesis followed by a reversion event, see text for 
details.  
c The PA phenotype was extremely weak, as reflected by low variable plating efficiencies and pathetic 
pinprick plaques. 
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FIGURE LEGENDS 
 
FIG. 4.1 Early microvirus infection. Reversible attachment, likely mediated by a 6-
carbon sugar binding site, is followed by the formation of a host-induced unique vertex. 
The infecting particle loses the G protein spike complex at the lipid-interacting vertex 
and the capsid protein merges with the membrane. Five coat proteins rearrange, forming 
a pore through which the H-tube, a DNA-translocating conduit, emerges from the 
particle.  
 
FIG. 4.2 Attachment, eclipse and penetration as a function of host range. The permissive 
host for a3 is E. coli C, whereas ST-1 is a K12 specific phage. A) Attachment and eclipse 
experiments were performed in triplicate. The host cells and phages used in each 
experiment are given in the figure. Error bars convey standard deviation.  B) a3-induced 
K+ efflux. Solid blue: E. coli C with a3; solid magenta: E. coli K12 with a3;  open blue: 
E. coli C alone; open magenta, E. coli K12; alone. C) ST-1-induced K+ efflux. Solid blue: 
E. coli C with ST-1; solid magenta: E. coli K12 with ST-1; open blue: E. coli C alone; 
open magenta, E. coli K12; alone.  
 
FIG. 4.3 Amino acids sequences of the a3 and ST-1 coat proteins. Identical amino acids 
are depicted in black text on the central line, whereas diverged amino acids are indicated 
with blue (a3) and magenta (ST-1) text, above and below the central line, respectively. 
The junctions found in recombinants are given by the position of the colored boxes. 
Colors and arrows indicate which viruses donated the sequence. For example, the coat 
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protein sequence of a3-R1 is 100% identical to ST-1. Thus, it is positioned at the 
beginning of the sequence and is shaded magenta. By contrast, the first 183 amino acids 
in the a3-R184 coat protein are derived from a3, as indicated by the blue leftward arrow. 
The remaining amino acids are derived from ST-1. Asterisks indicate sites at which point 
mutations conferred PA phenotypes in a3. 
 
FIG. 4.4 The location of PA substitutions within the a3 x-ray structure. A and B) Space 
filling renderings of the a3 x-ray structure. The coat F protein is depicted in white, the 
spike G protein in magenta. The PA substitutions are depicted in blue. One G protein 
spike has been removed (panel B) to illustrate the location of PA substitutions within the 
F–G protein interface. C) The F–G interface. The PA substitutions, coat and spike 
proteins are colored as described above.  Numbers depict the amino acid’s location within 
the primary structure. D) Phenotypes of site-directed mutations. Side chain colors: blue, 
substitutions conferring the PA phenotype; grey, substitutions that did not alter host 
range; black, substitutions likely conferring a lethal phenotype.  
 
FIG. 4.5 Structurally and genetically defined residues governing host range and 
extracellular virus-host interactions in φX174 and a3. The image depicts the a3 structure. 
The root-mean-square deviations between equivalent Cα atoms of the φX174 and a3 coat 
proteins, which share 72% sequence identity, is only 0.8 Å (58). Thus, equivalent φX174 
residues could be reasonably mapped onto the a3 virion. Mutations identified in this 
study are colored dark blue. Primarily residing within the coat F – spike G protein 
interface, they are more easily visualized when a spike complex is removed (right image). 
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Mutations identified in φX174 studies (26, 62) are depicted in cyan. The residues of the 
conserved 6-carbon sugar binding site are highlighted in purple (31-33). The bulge-
forming EF insertion loop, which contains the residues that merge with the lipid bilayer 
(30), is depicted in dark grey.  The images was generated using Chimera (63) and Protein 
Data Bank accession code 1M06. 
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FIG 4.1 Early microvirus infection 
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FIG 4.2 Attachment, eclipse and penetration as a function of host range 
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FIG 4.3 Amino acids sequences of the a3 and ST-1 coat proteins 
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FIG 4.4 The location of PA substitutions within the a3 x-ray structure 
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FIG 4.5 Structurally and genetically defined residues governing host range and 
extracellular virus-host interactions in φX174 and a3 
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CHAPTER 5 
FUTURE DIRECTIONS 
 
 
5.1 Is the unique vertex induced or preordained? 
Many viruses eject their genetic material through a unique vertex. The vertex contains 
specialized proteins that participate in the ejection process. In tailed phages, a 
dodecameric portal structure occupies their procapsid’s unique vertex (1, 2). The genome 
is packaged through the portal by the viral terminase, an enzymatic complex that couples 
ATP hydrolysis to genome packaging (3). The phage tail attaches to the portal once 
packaging is completed. Thus the genome is ejected through the portal structure to 
initiate an infection (4, 5).  
 
Portals are not limited to phage systems. Herpesviruses, for example, also utilize these 
structures (6, 7). Their portals are structurally similar to those of phage, and they also 
package and eject their genomes through them (8, 9). During infection, the enveloped 
herpes virion fuses with the cytoplasmic or endocytic membrane, releasing the capsid 
into host cell’s cytoplasm (10). The capsid is then trafficked to the nucleus. The portal 
docks with a nuclear pore and the viral genome is ejected into the nucleus (11–13). The 
unique vertex is preordained in all of the above systems. It is found in the procapsid and 
remains in place throughout the assembly process. However, some viruses appear to lack 
a preordained unique vertex.  
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Poliovirus, for example, appears to utilize a single vertex during genome delivery, yet all 
of the virion’s vertices are identical. To initiate an infection, poliovirus first binds to a 
host cell’s surface receptors, triggering its endocytic pathway (14, 15). The virus 
becomes internalized within an endosome where it undergoes structural changes, 
releasing its internal protein VP4 (16, 17). VP4, together with the VP1 capsid proteins at 
the open vertex, become membrane associated and form a channel, releasing the ssRNA 
genome into the host cell’s cytoplasm (18–20). It appears that poliovirus does not need a 
unique vertex, as the viral proteins are contained within an endosome and its capsid 
contains 60 copies of both VP4 and VP1 (21). The proteins are icosahedrally ordered. 
They are present at every 5-fold symmetry axis; therefore, any vertex is capable of pore 
formation.  
 
FX174, by contrast, carries twelve copies of its DNA piloting protein H.  During an 
infection event, ten H proteins exit the capsid and form a cell wall spanning conduit. The 
cryo-electron microscopy (Cryo-EM) reconstructions of eclipsing jX174 particles, both 
DNA-filled and empty, suggest that the H proteins appear to emerge from a single 5-fold 
axis of symmetry. (22). In the DNA-filled reconstruction, a single, unopened vertex is 
attached to the lipid bilayer (Figure 4.1A and D). There is a cylindrical region of lower 
density above the attached vertex. The region extends 110 Å into the virion and is 80 Å 
wide. This region likely contains the H protein oligomer as proteins are typically less 
dense than DNA. In the second structure, the contents of the virion have exited through a 
30 Å wide opening at the attached vertex (Figure 4.1B and E). Thus, jX174 also utilizes 
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a unique vertex. However, it is not known if the unique vertex is preordained during 
virion morphogenesis or induced at the infection site.  
 
An H protein oligomer would likely be found at a preordained vertex, if one exists. 
However, the jX174 procapsid is constructed from twelve identical, 12S*, assembly 
intermediates, each containing a monomeric H protein (Figure 4.2). The H proteins 
would need to congregate at a single vertex after procapsid assembly. Two procapsid 
structures were determined, a 26 Å resolution cryo-EM reconstruction and a 3.5 Å 
resolution X-ray crystal structure (23, 24). In both structures, under each 5-fold axis of 
symmetry, there is a region of protein-like density that has been attributed to H protein, 
but the density could not be confidently assigned. This region is surrounded by density 
belonging to the internal scaffolding protein. If this is correct, H appears to remain 
monomeric within the procapsid and the internal scaffolding protein may hold it in place. 
 
H oligomerization could occur during genome packaging or at the subsequent infection 
site. During packaging, the internal scaffolding proteins are displaced by the DNA 
binding protein. H protein may be freed and allowed to congregate at a single vertex 
during this process. The structure of the jX174 virion was determined to 3.5 Å 
resolution. Like the procapsid structures, electron density could not be unambiguously 
assigned to H proteins. Again, there is diffuse density under the 5-fold axes. It may be 
produced by H protein or the ssDNA genome, thus the status of a unique vertex is still 
ambiguous. Cryo-EM was also used to examine virions for any asymmetric features. 
Thousands of particles were examined and no asymmetry was detected. However, 
 198 
simulated micrographs were produced of an H-tube containing jX174 virion, i.e. the H-
tube X-ray structure was placed inside the virion X-ray structure (Figure 5.3, row a). 
Increasing amounts of noise were added to the simulated micrographs. Nearly all 
structural details were washed out when this level of noise reached that of actual jX174 
virion micrographs.  
 
A second approach was taken to detect asymmetry within jX174 virions: bubblegram 
imaging. During electron microscopy, samples are bombarded with an electron beam. 
Repeated bombardment of biological samples causes radiolytic damage to the sample’s 
proteins and nucleic acids, producing H2. Samples are embedded in vitreous ice in cryo-
EM preparations. This traps the H2, producing a bubble that is visible in the resulting 
micrographs. For reasons that are not understood, the different biological components 
undergo radiolysis at different rates. The rate is also influenced by the component’s local 
environment. For example, proteins embedded in DNA bubble faster than surface 
exposed proteins, while surface proteins bubble faster than DNA. Thus, this technique 
can be used to determine if a virion contains proteinaceous structures embedded within 
its packaged genome (25, 26). If the bubbles’ locations are consistent, they can be used to 
generate an asymmetric reconstruction of the virion based on its inner features. 
 
A bubblegram analysis was performed on the microvirus ST-1 to determine if an H 
protein core exists within the virion. Purified ST-1 virions were flash frozen on cryo-EM 
grids. The virions were repeatedly dosed with electrons and monitored for bubble 
formation. As can be seen in Figure 4, bubbles only formed within virions. Arrows 
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indicate unpackaged virus-like particles in panel 1 and 8. It appears that proteins, most 
likely protein H, are embedded within the ST-1 genome. However, the bubble locations 
were not consistent enough to guide image reconstruction. Thus, it is still unknown if the 
H proteins form a core within the virion and if so, where it is located. 
 
A third approach could be designed; however, it relies on an unproven assumption. Many 
results suggest, but do not rigorously demonstrate, that a portion of H protrudes from the 
virion. Two studies have shown that H protein may participate in host attachment. In the 
first, his-tagged H was purified and tested for LPS binding specificity (27, 28). The 
protein only bound LPS purified from jX174-susceptible host strains. This evidence falls 
short of compelling, as H protein evolved alongside its host’s LPS. The protein may bind 
poorly to foreign LPS because it has been optimized to the host’s LPS structure. In the 
second study, mutations conferring changes near H protein’s N-terminus inhibited 
attachment (29). Again, this is not entirely compelling; mutant DNA binding proteins, 
which are completely internalized, can affect attachment kinetics (30). Thus, anything 
could possibly affect virion structure could affect attachment. Lastly, it was reported that 
monoclonal antibodies that bind to denatured H protein can cross-react with virions and 
procapsids. However, this data was only mentioned as a personal communication within 
another manuscript (23).  
 
Each finding falls short of compelling when considered individually. Yet, the results tend 
to suggest that a portion of H protein may protrude from the virion. If this is true, then it 
may be possible to raise an antibody against or tag the exposed portion of H protein. 
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Once marked, cryo-EM could be used to visualize the location(s) of the exposed H-
protein segment. If a single vertex is marked, then this would be a strong indication that a 
preordained unique vertex exists. The tag or fab fragments could then be used to reveal 
unique vertex’s structure after building an asymmetric or 5-fold averaged reconstruction 
of the virion. Alternatively, if all vertices were marked, efforts could be focused on 
understanding how ten H proteins relocate and oligomerize at a single vertex during the 
infection.  
 
 
5.2 How does H stimulate synthesis of viral coat protein? 
In chapter 2, infected cell lysates were run on SDS-PAGE gels and the viral coat protein 
band intensity was compared to a host protein band. In null-H infections lacking H 
complementation, the viral coat/host protein ratio was reduced when compared to wild-
type or complemented null-H mutant infections (Figure 5.5A). This result suggests that 
de novo synthesis of H protein is required for efficient viral coat protein synthesis. It is 
not known if H protein affects synthesis of other viral proteins. Other viral protein bands 
cannot be sufficiently resolved when using SDS-PAGE. Western blotting with antibodies 
raised against viral proteins may answer this question.  
 
The mechanism by which H stimulates protein synthesis is unknown. It could act on the 
level of genome replication, transcription, or translation. Previous work has investigated 
the effect of de novo H synthesis on double-stranded (ds) genome replication (31). In the 
study, cells resistant to viral induced lysis harboring an empty, non-expressing plasmid 
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were infected with wild-type jX174 or a null-H mutant. The infections were chemically 
lysed after three hours and the plasmid and ds genome molecules purified. The purified 
molecules were run on an agarose gel and the genome/plasmid intensity ratio was 
determined. The null-H and wild-type infections had similar ratios, suggesting that de 
novo H synthesis has no effect on ds genome replication (Figure 5.5B). Thus, it appears 
that H is affecting a step downstream of DNA synthesis.  
 
FX174 utilizes a relatively simple gene expression system. Unlike other phages with 
early and late gene expression programs, all of its genes are transcribed simultaneously. 
Transcription is controlled by three promoters and four inefficient terminators. The 
promoters are located upstream of genes A, B, and D, while the terminators are 
downstream of genes J, F, G, and H (Figure 5.6). The terminators are inefficient, and the 
polymerase has a 40 to 60% chance of continuing through the J, F, and G terminators and 
a 10% chance of continuing through the final terminator (32). This system appears to 
govern viral protein stoichiometry. For example, each procapsid contains 240 copies of 
the external scaffolding protein D. The gene encoding protein D is sandwiched between 
the promoters and terminators. Thus, every viral transcript contains the D message. By 
contrast, each procapsid contains twelve copies of protein H. An RNA polymerase must 
pass three terminators to produce an H containing message, thereby making it one of the 
rarest messages.  
 
Viral transcription levels in the context of de novo H synthesis have not been thoroughly 
investigated. Protein H may be acting as a transcription factor or may be affecting 
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terminator efficiency. This hypothesis could be initially explored by determining 
transcript ratios. Lysis-resistant cells containing a plasmid encoding an inducible wild-
type H gene and a constitutively expressed chloramphenicol acetyltransferase (CAT) 
gene will be infected with a null-H mutant. The infected culture will be split, pelletized, 
and each half resuspended in media containing a repressor or inducer. At timepoints, the 
infected cells will be collected, lysed, and their mRNA purified. cDNA will be produced 
from the RNA and used in qPCR reactions. Primers targeting viral gene B, viral gene F, 
viral gene H, or the CAT transcript will be used to determine the relative transcript 
amounts.  
 
If protein H somehow modulates transcription, then there may be a difference in 
transcript ratios between the induced and repressed infections. For example, the ratio of 
viral B and F messages could be compared. Gene B is upstream of the terminators, while 
gene F lies downstream of a single terminator. If H is affecting terminator efficiency, 
then the F:B transcript ratio may be higher in induced infections. If a difference is found, 
the region of DNA interacting with protein H could possibly be identified with a bacterial 
one-hybrid system and/or an electrophoretic mobility shift assay. Alternatively, if H is 
acting as a transcriptional attenuator, the RNA target could be identified with RNA 
electrophoretic mobility shift assays or CLIP (crosslinking and immunoprecipitation of 
RNA–protein complexes). In the unlikely case that H has no effect on transcription and 
plays a role in translation, then a Co-IP analysis may identify its interaction partners. 
 
5.3 The genome ejection model needs further testing and refinement 
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Chapter 3 focused on the H-tube’s inner surface. The surface is lined primarily with 
glutamine side chains with the exception of one region near the tube’s C-terminal 
opening. This region is conserved in other microvirus clades, suggesting it may play a 
role during genome delivery. The non-glutamine residues in this region were replaced 
with glutamine to explore the region’s significance and the general role of glutamine 
residues. Three of the mutant H proteins conferred a cold-sensitive phenotype. The 
results of subsequent experiments suggested that the extra glutamine residues did not 
prevent channel formation, yet genome delivery was inhibited. The results were used to 
construct a model describing microvirus genome delivery mechanics. In this model, there 
are two primary forces acting on the genome while in transit: a force driving the genome 
into the cytoplasm and another opposing its movement.  
 
The energy source driving genome transit is not definitively known. There are two 
competing models. The continuum mechanics model proposes that the required energy 
could be stored within the packaged genome. Most dsDNA phage genomes are packaged 
with an ATP hydrolyzing motor. Although each motor has slightly different 
characteristics, most appear to package the dsDNA genomes very tightly, usually to a 
density of approximately 500 mg/mL. DNA strands, which repel each other, are forced 
into close proximity within the capsid. This repulsive force is thought to drive the 
ejection process. Thus, a portion of the chemical energy used to power packaging 
becomes stored within the compressed genome. Although data collected from in vitro 
genome ejection experiments supports this model, there is debate as to whether this 
energy powers genome delivery in vivo (33, 34).  
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In the hydrodynamic model, by contrast, the energy source may exist at the infection site 
(35). During growth, bacteria must maintain turgor pressure, resulting in an osmotic 
pressure imbalance between the cell and its environment. Water will be pulled into the 
cytoplasm if the cell wall is punctured. This osmotic imbalance could provide the energy 
required to complete genome delivery. Like the continuum mechanics model, the process 
begins during genome packaging. The packaging motor performs reverse osmosis: water 
is stripped off the DNA and driven out of the water permeable capsid. However, instead 
of interhelical repulsion forces driving genome transport, osmosis drives genome 
transport. When a phage forms a channel across its host’s cell wall, water will flow back 
into the capsid and through the channel, dragging the genome into the host.  
 
Either energy source can be incorporated into our microvirus genome delivery model. 
However, in our model, there is a force opposing the genome’s movement. This may 
counter the force driving the genome into the host, thereby slowing and regulating its 
transit. A regulated release may prevent genome tangling or tube failure. In our model, 
the opposing force is provided by the amide and guanidinium containing side chains 
lining the H-tube’s inner surface. They can form hydrogen bonds with nucleotides; thus, 
H-bond formation and separation may create friction on the genome as it passes.  
 
Multiple aspects of this model have not been fully tested. In the current work, additional 
glutamine side chains were added near the tube’s C-terminal opening. The data suggests 
that these mutant side chains trap genomes within the tube at low temperatures. If the 
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model is correct, then the additional glutamine residues are increasing the frictional force 
acting on the genome during its passage. If the force driving the genome into the cell is 
reduced at lower temperatures, then the increased frictional force may completely counter 
it, trapping the genome mid-transit. Two other approaches can be taken to further test and 
refine the model: the number of inward facing glutamines can be reduced and/or the size 
of the genome can be altered.  
 
The first approach is already underway. The glutamine residues near the tube’s narrowest 
point have been targeted in a preliminary genetic analysis. Site directed mutagenesis was 
used to separately randomize the glutamine codons at sites Q191 and Q195 and 
elsewhere. The resulting mutants were screened for temperature dependent phenotypes 
and their H genes sequenced. Several mutants have been isolated at sites Q191 and Q195.  
Although some mutants have cold-sensitive phenotypes, the majority appear to struggle 
at high temperatures. Mutation of the other inward-facing glutamine sites yielded only 
wild-type phenotypes. Preliminary results show that particles carrying the mutant H 
trigger K+ efflux at the restrictive temperature (Figure 5.9). Thus, it can be assumed that 
the virions are adsorbing to the host and forming channels. It is now a matter of 
determining if the mutant genomes reach the host’s inner membrane. 
 
The effects of genome size can be tested in the second approach. If the energy used 
during genome delivery is stored in the packaged genome, then changing the genome’s 
size will alter the amount of stored energy. In vitro experiments have shown that the 
amount of packaged DNA has an effect on capsid pressure in dsDNA phage systems 
 206 
(34). Bacteriophage l mutants with reduced genome sizes were tested in an in vitro 
ejection assay. The phage was mixed with its purified receptor in solutions of varying 
osmotic pressure. Ejection is inhibited if the solution’s osmotic pressure is high enough, 
allowing calculation of the ejection force. Wild-type l ejected its DNA with a force of 
13.8 pN, while reducing the genome size by 22% reduced the ejection force by 57%. An 
in vivo experiment could be designed using the jX174 system. Genome size can be 
reduced by 18-26% or increased by 2-6% without abolishing particle infectivity (36, 37). 
If capsid pressure is playing a role in the jX174 system then genome-length altered 
viruses may have more extreme temperature dependent phenotypes. Since pressure is 
dependent on temperature, virions carrying smaller genomes would be less pressurized at 
lower temperatures. This would reduce the force driving the genome into the cytoplasm, 
and if the microvirus genome ejection model is correct, the frictional force exerted by the 
glutamine resides may trap the genome while in transit. By contrast, increasing the 
genome size would increase the capsid pressure. This may overwhelm the frictional force 
at higher temperatures, which could disrupt the tube structure. 
 
5.4 Does our model apply to other viral systems? 
Perhaps the most striking feature of the jX174 genome delivery system are the H-tube’s 
inward facing amide and guanidinium containing side chains. These residues and their 
proposed function are the crux of the microvirus genome ejection model. Although the 
model needs further confirmation, refinement, and adjustment, there are two similar 
protein structures that suggest the findings may be applicable to other systems: the feline 
calicivirus and bacteriophage P22 portal proteins.  
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Feline calicivirus is a ssRNA virus. Cryo-EM was used to create a 3.5 Å reconstruction 
of a receptor bound feline calicivirus particle (38). Calicivirus enters host cells by 
hijacking their endocytic pathway. Once in an endosome, twelve copies of the minor 
capsid protein VP2 appear to emerge from a single 3-fold axis. The proteins form a 
dodecameric a-helical tube structure that presumably penetrates the endocytic membrane 
(Figure 5.10). Like the H-tube, the VP2-tube is also lined with D, E, K, N, Q, and R side 
chains and has a minimum internal diameter of 17 Å, wide enough for ssRNA passage. 
The structure is much shorter than the H-tube, however the tube must only penetrate an 
endocytic membrane and not a bacterial cell wall.  
 
The structure of the dsDNA phage P22 portal protein was recently refined to 7.0 Å 
resolution (2, 39, 40). The portal also features a dodecameric a-helical tube that is 
approximately 34 Å wide and 140 Å long (Figure 5.11B). This tube is found within the 
P22 capsid, and the genome must move through this structure during packaging and 
during penetration. The resolution of the structure is not high enough to resolve the tube’s 
inward facing side chains. However, the tube’s primary sequences are 30% identical to 
that of protein H. Moreover, a sequence alignment shows that the H tube’s inward facing 
K, N, Q, and R residues line up reasonably to those of the P22 portal tube (Figure 5.11A). 
If these residues are also inward facing, then they may be generating a frictional force on 
a dsDNA genome. 
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Although there are two similar structures, the characteristics of the H-tube do not appear 
to be universal. The dsDNA phage T4 uses a contractile tail to puncture the host cell wall. 
During contraction, a rigid, tube contained within the tail is driven through the host cell 
wall. The tube is composed of multiple copies of gp19, arranged into a stack of 
hexameric rings (Figure 5.12). A 3.4 Å cryo-EM reconstruction was generated (41). 
Unlike the tubes described above, the T4 tube is not a-helical. Gp19 is composed 
primarily of b-sheets. The tube’s inner diameter is 35 Å and its inner surface is lined 
primarily with D and E side chains, making the surface electronegative. This may repel 
the negatively charged phosphate groups in the genome’s backbone. If this mechanism is 
correct, then friction may not have a role in T4 genome delivery or it may be provided 
elsewhere. 
 
5.5: FX174 host range and attachment 
 
In chapter 4, the factors dictating microvirus host range were defined. Two viruses, a3 
and ST-1, respectively infect E. coli C and E. coli K12. Their structural proteins are 90% 
identical. Thus, it seemed possible to isolate mutants with altered host ranges, e.g. an a3 
mutant capable of infecting E. coli K12. After developing new viral stock preparation 
protocols, numerous a3 mutants were isolated that could form plaques on both E. coli C 
and K12. The mutants all had single point mutations conferring changes in the coat 
protein at the coat-spike interface, suggesting that this interface may determine the 
virus’s host range. ST-1 mutants capable of infecting K12 were also isolated, although 
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this only occurred after large portions of the ST-1 coat gene recombined with a cloned a3 
coat gene.  
 
FX174 was also included in the study. It infects E. coli C and its coat protein is 72% 
identical to a3’s coat protein. The extracellular steps of the jX174 infection cycle were 
also analyzed to determine if the virus adsorbs to K12. Unlike ST-1 and a3, jX174 
attached poorly to K12. Eclipse assays were also performed on the fraction that attached, 
but the results were highly variable. Unlike a3, no jX174 host range expansion mutants 
were isolated from populations generated in low MOI environments. This suggests that a 
number of mutational changes are likely required for jX174 to productively infect K12.  
 
In order to establish a productive infection, the virion must first adsorb to the host, move 
its genome into the cytoplasm, and interact with host replication machinery. It may be 
possible to generate a jX174 mutant capable of efficient attachment, however there is no 
guarantee the virus is compatible with K12’s DNA replication machinery. This question 
could be addressed by transfecting purified jX174 ssDNA into K12. Any produced 
progeny could be detected by lysing the transfected K12 culture and titering on C122.  
 
If progeny jX174 can be produced in K12, then it may only be a matter of isolating a 
mutant capable of adsorption. It appears that a number of mutational steps are required 
before jX174 can efficiently attach to and eclipse on K12. This makes isolation of a 
mutant capable of infecting K12 from a low M.O.I. environment highly unlikely; thus, it 
may be necessary to first select for mutants capable of efficient K12 attachment. Isolation 
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of a mutant that attaches may reduce the number of mutational steps required to infect 
K12, which may make subsequent selections more productive.  
 
If the temperature is below 16°C, jX174 can attach to cells, but cannot initiate the 
penetration process. This characteristic can be used to select for mutants capable of 
improved K12 attachment by incubating the virus with K12 cells at 15°C. The cells and 
any attached virions can be pelleted, leaving unattached particles in the supernatant. 
Since attachment is Ca2+ dependent, the pellet can be resuspended in an EDTA-
containing solution to release attached phage. The collected virions can be passaged 
through E. coli C to increase their numbers and allow more mutations to accumulate. This 
process can be repeated until a mutant capable of efficient K12 attachment is isolated. If 
this reduces the number of mutational steps required to infect K12, then selections for a 
mutant capable of plaque formation may be successful. 
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5.7 Figure Legends 
FIGURE LEGENDS 
 
FIG 5.1 Cryo-EM reconstructions of eclipsing φX174. A and D) Unopened particle. B 
and E) Opened, empty particle. C) Superposition of panels A and B. Panels A, B, and C 
are cross sections along the 2-fold symmetry axis. Panels D and E show the 
reconstructions from their attached 5-fold axis.  
 
FIG 5.2 ΦX174 Morphogenetic pathway. 
 
FIG 5.3 Simulation of cryo-electron micrographs of WX174 containing one H tube. (a-f) 
Each column (1–8) shows a different orientation of the virus. Each row shows 
progressively more noise. The top row has no noise and clearly shows the fivefold 
vertices of the virus and the buried H tube (sideways in column 1 and top view in column 
5). (g) Micrographs of the actual virus. All evidence of the five-fold spikes has been lost 
in row f. Similarly, there is no evidence of the spikes in the actual micrographs shown in 
row g. Thus, the micrographs give no hint of whether there is an H tube or partly 
assembled H tube in the virus. 
 
FIG 5.4 ST-1 Bubblegram analysis. Micrograph images are numbered with their 
exposure number. For example, the upper right micrograph depicts the sample’s 14th 
exposure to the electron beam, thus it is labeled “14.” Empty particles are marked with 
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white arrows in micrographs 1 and 22. A single particle has been circled to illustrate 
bubble development. 
 
FIG 5.5 A) Viral protein levels in am(H) mutant-infected cells with and without 𝚫H gene 
expression. SDS-PAGE analysis of viral coat protein levels in uninfected (UI), wild-type-
infected (WT), and null-H (am(H)) mutant-infected cells expressing the 𝚫H gene 
constructs. B) Agarose gel analysis showing relative recovery of plasmid and viral RF 
DNAs from cells. The white space between lanes indicates removal of irrelevant lanes 
from the image. 
 
FIG 5.6 Linear depiction of the φX174 genetic map. Promoters and terminators are 
depicted with “P’s” and “T’s,” respectively. The subscript letter demarks the location and 
name of the promoter or terminator. Grey lines represent transcripts. The width of the line 
reflects the gene transcript’s relative abundance in an infected cell. Transcripts from PA 
are unstable, which is indicated with a series of dots. 
 
FIG 5.7 SDS-PAGE analysis of particles produced in am(H) mutant-infected cells 
expressing cloned wild-type H (WT H), 𝚫7-3, 𝚫7-10, 𝚫14-2&3, 𝚫14-3&4, 𝚫14-9&10, 
and 𝚫14-10&1 genes or non-expressing cells (NE). 
 
FIG 5.8 Potassium efflux curves from cells infected with Q195X mutants at 42°C. Efflux 
values are reported as the increase in millivolts after the initial millivolt reading. More 
positive values indicate more extracellular K+ is present.  
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FIG 5.9 Ribbon depiction of the calicivirus VP2 structure. Four VP2 monomers have 
been colored for clarity, the remaining are gray. Inward facing residues are shown as 
sticks. A) View from the tube’s N-terminal opening, which is outside the virus particle. 
B) Cross-section of the tube. Six VP2 monomers have been removed to show the tube’s 
interior. PDB ID: 6GSI 
 
FIG 5.10 A) Alignment of the phiX174 H protein to the P22 portal protein (30% 
identical residues, 40% similar residues). Residues highlighted in green are both 
conserved and inward facing in the phiX174 structure. 
FIG 5.11 Ribbon depiction of the phage T4 gp19 structure. A single gp19 monomer has 
been colored for clarity, the remaining are gray. Inward facing residues are shown as 
sticks. A) Cross-section of the tube. B) View down the tube’s central axis. PDB ID: 
5W5F 
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FIG 5.1 Cryo-EM reconstructions of eclipsing φX174 
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FIG 5.2 ΦX174 Morphogenetic pathway 
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FIG 5.3 Simulation of cryo-electron micrographs 
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FIG 5.7 SDS-PAGE analysis of particles produced in am(H) mutant-infected cells 
expressing cloned H genes 
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FIG 5.8 Potassium efflux curves from cells infected with Q195X mutants 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 227 
 
 
 
 
FI
G
 5
.9
 R
ib
bo
n 
de
pi
ct
io
n 
of
 th
e 
ca
lic
iv
iru
s V
P2
 st
ru
ct
ur
e 
 
 228 
 
 
 
 
FIG 5.10 Comparison of the jX174 H-tube and the P22 portal structure 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 229 
 
FI
G
 5
.1
1 
Ri
bb
on
 d
ep
ic
tio
n 
of
 th
e 
ph
ag
e 
T4
 g
p1
9 
str
uc
tu
re
 
 
 230 
FULL DISSERTAION REFERENCES 
Chapter 1 
 
1.  Wommack KE, Colwell RR. 2000. Virioplankton: Viruses in Aquatic Ecosystems. 
Microbiol Mol Biol Rev 64:69–114. 
 
2.  Kimura M, Jia ZJ, Nakayama N, Asakawa S. 2008. Ecology of viruses in soils: 
Past, present and future perspectives. Soil Sci Plant Nutr 54:1–32. 
 
3.  Suttle CA. 2005. Viruses in the sea. Nature 437:356–361. 
 
4.  Breitbart M, Rohwer F. 2005. Here a virus, there a virus, everywhere the same 
virus? Trends Microbiol 13:278–284. 
 
5.  Breitbart M, Hewson I, Felts B, Mahaffy JM, Nulton J, Salamon P, Rohwer F. 
2003. Metagenomic Analyses of an Uncultured Viral Community from Human 
Feces. J Bacteriol 185:6220–6223. 
 
6.  Georgopoulos CP, Hendrix RW, Kaiser AD, Wood WB. 1972. Role of the Host 
Cell in Bacteriophage Morphogenesis: Effects of a Bacterial Mutation on T4 Head 
Assembly. Nat New Biol 239:38–41. 
 
7.  Georgopoulos CP, Hendrix RW, Casjens SR, Kaiser AD. 1973. Host participation 
in bacteriophage lambda head assembly. J Mol Biol 76:45–60. 
 
8.  Jazwinski SM, Lindberg AA, Kornberg A. 1975. The lipopolysaccharide receptor 
for bacteriophages jX174 and S13. Virology 66:268–282. 
 
9.  Parent KN, Erb ML, Cardone G, Nguyen K, Gilcrease EB, Porcek NB, Pogliano J, 
Baker TS, Casjens SR. 2014. OmpA and OmpC are critical host factors for 
bacteriophage Sf6 entry in Shigella. Mol Microbiol 92:47–60. 
 
10.  Valentine RC, Strand M. 1965. Complexes of F-Pili and RNA Bacteriophage. 
Science 148:511–513. 
 
11.  Lovett PS. 1972. PBP1: A flagella specific bacteriophage mediating transduction 
in Bacillus pumilus. Virology 47:743–752. 
 
12.  Nicola A V., Aguilar HC, Mercer J, Ryckman B, Wiethoff CM. 2013. Virus Entry 
by Endocytosis. Adv Virol 2013:1–2. 
 
13.  Dáder B, Then C, Berthelot E, Ducousso M, Ng JCK, Drucker M. 2017. Insect 
transmission of plant viruses: Multilayered interactions optimize viral propagation. 
Insect Sci 24:929–946. 
 231 
 
14.  Bamford DH, Palva ET, Lounatmaa K. 1976. Ultrastructure and Life Cycle of the 
Lipid-containing Bacteriophage Φ6. J Gen Virol 32:249–259. 
 
15.  Hoogstraten D, Qiao X, Sun Y, Hu A, Onodera S, Mindich L. 2000. 
Characterization of Φ8, a Bacteriophage Containing Three Double-Stranded RNA 
Genomic Segments and Distantly Related to Φ6. Virology 272:218–224. 
 
16.  Vidaver AK, Koski RK, Van Etten JL. 1973. Bacteriophage Φ6: a Lipid-
Containing Virus of Pseudomonas phaseolicola. J Virol 11:799–805. 
 
17.  Jäälinoja HT, Huiskonen JT, Butcher SJ. 2007. Electron Cryomicroscopy 
Comparison of the Architectures of the Enveloped Bacteriophages Φ6 and Φ8. 
Structure 15:157–167. 
 
18.  Huiskonen JT, de Haas F, Bubeck D, Bamford DH, Fuller SD, Butcher SJ. 2006. 
Structure of the Bacteriophage Φ6 Nucleocapsid Suggests a Mechanism for 
Sequential RNA Packaging. Structure 14:1039–1048. 
 
19.  de Haas F, Paatero AO, Mindich L, Bamford DH, Fuller SD. 1999. A symmetry 
mismatch at the site of RNA packaging in the polymerase complex of dsRNA 
bacteriophage φ6. J Mol Biol 294:357–372. 
 
20.  Mäntynen S, Laanto E, Kohvakka A, Poranen MM, Bamford JKH, Ravantti JJ. 
2015. New enveloped dsRNA phage from freshwater habitat. J Gen Virol 
96:1180–1189. 
 
21.  Romantschuk M, Bamford DH. 1985. Function of Pili in Bacteriophage Φ6 
Penetration. J Gen Virol 66:2461–2469. 
 
22.  Bamford DH, Romantschuk M, Somerharju PJ. 1987. Membrane fusion in 
prokaryotes: bacteriophage phi6 membrane fuses with the Pseudomonas syringae 
outer membrane. EMBO J 6:1467–1473. 
 
23.  Hantula J, Bamford DH. 1988. Chemical crosslinking of bacteriophage φ6 
nucleocapsid proteins. Virology 165:482–488. 
 
24.  Caldentey J, Bamford DH. 1992. The lytic enzyme of the Pseudomonas phage φ6. 
Purification and biochemical characterization. Biochim Biophys Acta - Protein 
Struct Mol Enzymol 1159:44–50. 
 
25.  Mindich L, Lehman J. 1979. Cell Wall Lysin as a Component of the Bacteriophage 
Φ6 Virion. J Virol 30:489–496. 
 
26.  Cvirkaite-Krupovic V, Poranen MM, Bamford DH. 2010. Phospholipids act as 
secondary receptor during the entry of the enveloped, double-stranded RNA 
 232 
bacteriophage Φ6. J Gen Virol 91:2116–2120. 
 
27.  Romantschuk M, Olkkonen VM, Bamford DH. 1988. The nucleocapsid of 
bacteriophage Φ6 penetrates the host cytoplasmic membrane. EMBO J 7:1821–
1829. 
 
28.  Krupovič M, Bamford DH. 2007. Putative prophages related to lytic tailless 
marine dsDNA phage PM2 are widespread in the genomes of aquatic bacteria. 
BMC Genomics 8:236. 
 
29.  Leigh BA, Breitbart M, Oksanen HM, Bamford DH, Dishaw LJ. 2018. Genome 
Sequence of PM2-Like Phage Cr39582, Induced from a Pseudoalteromonas sp. 
Isolated from the Gut of Ciona robusta. Genome Announc 6. 
 
30.  Abrescia NGA, Grimes JM, Kivelä HM, Assenberg R, Sutton GC, Butcher SJ, 
Bamford JKH, Bamford DH, Stuart DI. 2008. Insights into Virus Evolution and 
Membrane Biogenesis from the Structure of the Marine Lipid-Containing 
Bacteriophage PM2. Mol Cell 31:749–761. 
 
31.  Camerini-Otero R., Franklin R. 1972. Structure and synthesis of a lipid-containing 
bacteriophage. Virology 49:385–393. 
 
32.  Espejo RT, Canelo ES. 1968. Origin of Phospholipid in Bacteriophage PM2. J 
Virol 2:1235–1240. 
 
33.  Kivelä HM, Männistö RH, Kalkkinen N, Bamford DH. 1999. Purification and 
Protein Composition of PM2, the First Lipid-Containing Bacterial Virus To Be 
Isolated. Virology 262:364–374. 
 
34.  Cvirkaitė-Krupovič V, Krupovič M, Daugelavičius R, Bamford DH. 2010. 
Calcium ion-dependent entry of the membrane-containing bacteriophage PM2 into 
its Pseudoalteromonas host. Virology 405:120–128. 
 
35.  Kivela HM, Daugelavicius R, Hankkio RH, Bamford JKH, Bamford DH. 2004. 
Penetration of Membrane-Containing Double-Stranded-DNA Bacteriophage PM2 
into Pseudoalteromonas Hosts. J Bacteriol 186:5342–5354. 
 
36.  Kivela HM, Madonna S, Krupovic M, Tutino ML, Bamford JKH. 2008. Genetics 
for Pseudoalteromonas Provides Tools To Manipulate Marine Bacterial Virus 
PM2. J Bacteriol 190:1298–1307. 
 
37.  Berrier C, Bonhivers M, Letellier L, Ghazi A. 2000. High-conductance channel 
induced by the interaction of phage lambda with its receptor maltoporin. FEBS 
Lett 476:129–133. 
 
38.  Shapira A, Giberman E, Kohn A. 1974. Recoverable potassium fluxes variations 
 233 
following adsorption of T4 phage and their ghosts on Escherichia coli B. J Gen 
Virol 23:159–171. 
 
39.  Boulanger P, Letellier L. 1992. Ion channels are likely to be involved in the two 
steps of phage T5 DNA penetration into Escherichia coli cells. J Biol Chem 
267:3168–72. 
 
40.  Koning RI, Gomez-Blanco J, Akopjana I, Vargas J, Kazaks A, Tars K, Carazo JM, 
Koster AJ. 2016. Asymmetric cryo-EM reconstruction of phage MS2 reveals 
genome structure in situ. Nat Commun 7:12524. 
 
41.  Dent KC, Thompson R, Barker AM, Hiscox JA, Barr JN, Stockley PG, Ranson 
NA. 2013. The Asymmetric Structure of an Icosahedral Virus Bound to Its 
Receptor Suggests a Mechanism for Genome Release. Structure 21:1225–1234. 
 
42.  Toropova K, Stockley PG, Ranson NA. 2011. Visualising a Viral RNA Genome 
Poised for Release from Its Receptor Complex. J Mol Biol 408:408–419. 
 
43.  Rolfsson Ó, Middleton S, Manfield IW, White SJ, Fan B, Vaughan R, Ranson NA, 
Dykeman E, Twarock R, Ford J, Cheng Kao C, Stockley PG. 2016. Direct 
Evidence for Packaging Signal-Mediated Assembly of Bacteriophage MS2. J Mol 
Biol 428:431–448. 
 
44.  Stockley PG, White SJ, Dykeman E, Manfield I, Rolfsson O, Patel N, Bingham R, 
Barker A, Wroblewski E, Chandler-Bostock R, Weiß EU, Ranson NA, Tuma R, 
Twarock R. 2016. Bacteriophage MS2 genomic RNA encodes an assembly 
instruction manual for its capsid. Bacteriophage 6:e1157666. 
 
45.  Hung PP, Ling CM, Overby LR. 1969. Self-Assembly of Qbeta and MS2 Phage 
Particles: Possible Function of Initiation Complexes. Science (80- ) 166:1638–
1640. 
 
46.  Date T. 1979. Kinetic Studies of the Interaction between MS2 Phage and F Pilus of 
Escherichia coli. Eur J Biochem 96:167–175. 
 
47.  Krahn PM, O’Callaghan RJ, Paranchych W. 1972. Stages in phage R17 infection 
VI. Injection of A Protein and RNA into the Host Cell. Virology 47:628–637. 
 
48.  Shiba T, Suzuki Y. 1981. Localization of A protein in the RNA-A protein complex 
of RNA phage MS2. Biochim Biophys Acta - Nucleic Acids Protein Synth 
654:249–255. 
 
49.  Leipold B, Hofschneider PH. 1975. Isolation of an infectious RNA-A-protein 
complex from the bacteriophage M12. FEBS Lett 55:50–52. 
 
50.  Paranchych W, Krahn PM, Bradley RD. 1970. Stages in phage R17 infection V. 
 234 
Phage Eclipse and the Role of F Pili. Virology 41:465–473. 
 
51.  Silverman PM, Valentine RC. 1969. The RNA Injection Step of Bacteriophage f2 
Infection. J Gen Virol 4:111–124. 
 
52.  Danziger RE, Paranchych W. 1970. Stages in phage R17 infection III. Energy 
Requirements for the F-pili Mediated Eclipse of Viral Infectivity. Virology 
40:554–564. 
 
53.  Shiba T, Miyake T. 1975. New type of infectious complex of E. coli RNA phage. 
Nature 254:157–158. 
 
54.  Rumnieks J, Tars K. 2017. Crystal Structure of the Maturation Protein from 
Bacteriophage Qβ. J Mol Biol 429:688–696. 
 
55.  Wang YA, Yu X, Silverman PM, Harris RL, Egelman EH. 2009. The Structure of 
F-Pili. J Mol Biol 385:22–29. 
 
56.  Harrington LC, Rogerson AC. 1990. The F pilus of Escherichia coli appears to 
support stable DNA transfer in the absence of wall-to-wall contact between cells. J 
Bacteriol 172:7263–7264. 
 
57.  Ou JT, Anderson TF. 1970. Role of Pili in Bacterial Conjugation. J Bacteriol 
102:648–654. 
 
58.  Babic A, Lindner AB, Vulic M, Stewart EJ, Radman M. 2008. Direct Visualization 
of Horizontal Gene Transfer. Science (80- ) 319:1533–1536. 
 
59.  Goldbourt A, Gross BJ, Day LA, McDermott AE. 2007. Filamentous Phage 
Studied by Magic-Angle Spinning NMR: Resonance Assignment and Secondary 
Structure of the Coat Protein in Pf1. J Am Chem Soc 129:2338–2344. 
 
60.  Marvin DA, Welsh LC, Symmons MF, Scott WRP, Straus SK. 2006. Molecular 
Structure of fd (f1, M13) Filamentous Bacteriophage Refined with Respect to X-
ray Fibre Diffraction and Solid-state NMR Data Supports Specific Models of 
Phage Assembly at the Bacterial Membrane. J Mol Biol 355:294–309. 
 
61.  Marvin DA, Symmons MF, Straus SK. 2014. Structure and assembly of 
filamentous bacteriophages. Prog Biophys Mol Biol 114:80–122. 
 
62.  Bradley DE, Whelan J. 1989. Escherichia coli tolQ Mutants Are Resistant to 
Filamentous Bacteriophages That Adsorb to the Tips, not the Shafts, of 
Conjugative Pili. Microbiology 135:1857–1863. 
 
63.  Webster RE. 1996. Biology of the Filamentous Bacteriophage, p. 1–20. In Phage 
Display of Peptides and Proteins: A Laboratory Manual. Elsevier. 
 235 
 
64.  Lorenz SH, Jakob RP, Weininger U, Balbach J, Dobbek H, Schmid FX. 2011. The 
Filamentous Phages fd and IF1 Use Different Mechanisms to Infect Escherichia 
coli. J Mol Biol 405:989–1003. 
 
65.  Heilpern AJ, Waldor MK. 2003. PIII CTX, a Predicted CTXphi; Minor Coat 
Protein, Can Expand the Host Range of Coliphage fd To Include Vibrio cholerae. J 
Bacteriol 185:1037. 
 
66.  Endemann H, Bross P, Rasched I. 1992. The adsorption protein of phage IKe. 
Localization by deletion mutagenesis of domains involved in infectivity. Mol 
Microbiol 6:471–478. 
 
67.  Novotny CP, Fives Taylor P. 1974. Retraction of F pili. J Bacteriol 117:1306–
1311. 
 
68.  Sun TP, Webster RE. 1986. fii, a bacterial locus required for filamentous phage 
infection and its relation to colicin-tolerant tolA and tolB. J Bacteriol 165:107–
115. 
 
69.  Sun TP, Webster RE. 1987. Nucleotide sequence of a gene cluster involved in 
entry of E colicins and single-stranded DNA of infecting filamentous 
bacteriophages into Escherichia coli. J Bacteriol 169:2667–2674. 
 
70.  Heilpern AJ, Waldor MK. 2000. CTXphi Infection of Vibrio cholerae Requires the 
tolQRA Gene Products. J Bacteriol 182:1739–1747. 
 
71.  Cascales E, Buchanan SK, Duche D, Kleanthous C, Lloubes R, Postle K, Riley M, 
Slatin S, Cavard D. 2007. Colicin Biology. Microbiol Mol Biol Rev 71:158–229. 
 
72.  Clarke M, Maddera L, Harris RL, Silverman PM. 2008. F-pili dynamics by live-
cell imaging. Proc Natl Acad Sci 105:17978–17981. 
 
73.  Lee S-W, Mao C, Flynn CE, Belcher AM. 2002. Ordering of Quantum Dots Using 
Genetically Engineered Viruses. Science (80- ) 296:892–895. 
 
74.  Holliger P, Riechmann L, Williams RL. 1999. Crystal structure of the two N-
terminal domains of g3p from filamentous phage fd at 1.9 Å: evidence for 
conformational lability 1 1Edited by J. M. Thornton. J Mol Biol 288:649–657. 
 
75.  Eckert B, Martin A, Balbach J, Schmid FX. 2005. Prolyl isomerization as a 
molecular timer in phage infection. Nat Struct Mol Biol 12:619–623. 
 
76.  Rakonjac J, Feng J, Model P. 1999. Filamentous phage are released from the 
bacterial membrane by a two-step mechanism involving a short C-terminal 
fragment of pIII 1 1Edited by M. Gottesman. J Mol Biol 289:1253–1265. 
 236 
 
77.  Bennett NJ, Rakonjac J. 2006. Unlocking of the Filamentous Bacteriophage Virion 
During Infection is Mediated by the C Domain of pIII. J Mol Biol 356:266–273. 
 
78.  Bennett NJ, Gagic D, Sutherland-Smith AJ, Rakonjac J. 2011. Characterization of 
a Dual-Function Domain That Mediates Membrane Insertion and Excision of Ff 
Filamentous Bacteriophage. J Mol Biol 411:972–985. 
 
79.  Smilowitz H. 1974. Bacteriophage f1 infection: fate of the parental major coat 
protein. J Virol 13:94. 
 
80.  Trenkner E, Bonhoeffer F, Gierer A. 1967. The fate of the protein component of 
bacteriophage fd during infection. Biochem Biophys Res Commun 28:932–939. 
 
81.  Abrescia NGA, Cockburn JJB, Grimes JM, Sutton GC, Diprose JM, Butcher SJ, 
Fuller SD, San Martín C, Burnett RM, Stuart DI, Bamford DH, Bamford JKH. 
2004. Insights into assembly from structural analysis of bacteriophage PRD1. 
Nature 432:68–74. 
 
82.  Bamford D, McGraw T, MacKenzie G, Mindich L. 1983. Identification of a 
protein bound to the termini of bacteriophage PRD1 DNA. J Virol 47:311–6. 
 
83.  Bamford DH, Caldentey J, Bamford JKH. 1995. Bacteriophage Prd1: A Broad 
Host Range Dsdna Tectivirus With an Internal Membrane, p. 281–319. In 
Advances in Virus Research. 
 
84.  Cockburn JJB, Abrescia NGA, Grimes JM, Sutton GC, Diprose JM, Benevides 
JM, Thomas GJ, Bamford JKH, Bamford DH, Stuart DI. 2004. Membrane 
structure and interactions with protein and DNA in bacteriophage PRD1. Nature 
432:122–125. 
 
85.  Rydman PS, Caldentey J, Butcher SJ, Fuller SD, Rutten T, Bamford DH. 1999. 
Bacteriophage PRD1 contains a labile receptor-binding structure at each vertex. J 
Mol Biol 291:575–587. 
 
86.  Davis TN, Muller ED, Cronan JE. 1982. The virion of the lipid-containing 
bacteriophage PR4. Virology 120:287–306. 
 
87.  Tuma R, Bamford JHK, Bamford DH, Thomas GJ. 1996. Structure, interactions 
and dynamics of PRD1 virus II. Organization of the viral membrane and DNA. J 
Mol Biol 257:102–115. 
 
88.  Santos-Pérez I, Oksanen HM, Bamford DH, Goñi FM, Reguera D, Abrescia NGA. 
2017. Membrane-assisted viral DNA ejection. Biochim Biophys Acta - Gen Subj 
1861:664–672. 
 
 237 
89.  Mindich L, Bamford D, McGraw T, Mackenzie G. 1982. Assembly of 
bacteriophage PRD1: particle formation with wild-type and mutant viruses. J Virol 
44:1021–30. 
 
90.  Kotilainen MM, Grahn AM, Bamford JK, Bamford DH. 1993. Binding of an 
Escherichia coli double-stranded DNA virus PRD1 to a receptor coded by an IncP-
type plasmid. J Bacteriol 175:3089–3095. 
 
91.  Grahn AM, Daugelavičius R, Bamford DH. 2002. Sequential model of phage 
PRD1 DNA delivery: Active involvement of the viral membrane. Mol Microbiol 
46:1199–1209. 
 
92.  Rydman PS, Bamford DH. 2000. Bacteriophage PRD1 DNA entry uses a viral 
membrane-associated transglycosylase activity. Mol Microbiol 37:356–363. 
 
93.  Peralta B, Gil-Carton D, Castaño-Díez D, Bertin A, Boulogne C, Oksanen HM, 
Bamford DH, Abrescia NGA. 2013. Mechanism of Membranous Tunnelling 
Nanotube Formation in Viral Genome Delivery. PLoS Biol 11:e1001667. 
 
94.  Daugelavicius R, Bamford JK, Bamford DH. 1997. Changes in host cell energetics 
in response to bacteriophage PRD1 DNA entry. J Bacteriol 179:5203–5210. 
 
95.  Molineux IJ, Panja D. 2013. Popping the cork: mechanisms of phage genome 
ejection. Nat Rev Microbiol 11:194–204. 
 
96.  Casjens SR, Molineux IJ. 2012. Short Noncontractile Tail Machines: Adsorption 
and DNA Delivery by Podoviruses, p. 143–179. In Rossmann, MG, Rao, VB 
(eds.), Viral Molecular Machines. Springer US, Boston, MA. 
 
97.  Davidson AR, Cardarelli L, Pell LG, Radford DR, Maxwell KL. 2012. Long 
Noncontractile Tail Machines of Bacteriophages, p. 115–142. In Rossmann, MG, 
Rao, VB (eds.), Viral Molecular Machines. Springer US, Boston, MA. 
 
98.  Leiman PG, Schneider MM. 2012. Contractile Tail Machines of Bacteriophages, p. 
93–114. In Rossmann, MG, Rao, VB (eds.), Viral Molecular Machines. Springer 
US, Boston, MA. 
 
99.  Taylor NMI, Prokhorov NS, Guerrero-Ferreira RC, Shneider MM, Browning C, 
Goldie KN, Stahlberg H, Leiman PG. 2016. Structure of the T4 baseplate and its 
function in triggering sheath contraction. Nature 533:346–352. 
 
100.  Hu B, Margolin W, Molineux IJ, Liu J. 2015. Structural remodeling of 
bacteriophage T4 and host membranes during infection initiation. Proc Natl Acad 
Sci 112:E4919–E4928. 
 
101.  Aksyuk AA, Leiman PG, Kurochkina LP, Shneider MM, Kostyuchenko VA, 
 238 
Mesyanzhinov V V., Rossmann MG. 2009. The tail sheath structure of 
bacteriophage T4: A molecular machine for infecting bacteria. EMBO J 28:821–
829. 
 
102.  Leiman PG, Chipman PR, Kostyuchenko VA, Mesyanzhinov V V., Rossmann 
MG. 2004. Three-Dimensional Rearrangement of Proteins in the Tail of 
Bacteriophage T4 on Infection of Its Host. Cell 118:419–429. 
 
103.  Guerrero‐Ferreira RC, Hupfeld M, Nazarov S, Taylor NM, Shneider MM, 
Obbineni JM, Loessner MJ, Ishikawa T, Klumpp J, Leiman PG. 2019. Structure 
and transformation of bacteriophage A511 baseplate and tail upon infection of 
Listeria cells. EMBO J e99455. 
 
104.  Browning C, Shneider MM, Bowman VD, Schwarzer D, Leiman PG. 2012. Phage 
Pierces the Host Cell Membrane with the Iron-Loaded Spike. Structure 20:326–
339. 
 
105.  Moak M, Molineux IJ. 2004. Peptidoglycan hydrolytic activities associated with 
bacteriophage virions. Mol Microbiol 51:1169–1183. 
 
106.  Katsura I. 1976. Morphogenesis of bacteriophage lambda tail. Polymorphism in 
the assembly of the major tail protein. J Mol Biol 107:307–326. 
 
107.  Vegge CS, Brondsted L, Neve H, Mc Grath S, van Sinderen D, Vogensen FK. 
2005. Structural Characterization and Assembly of the Distal Tail Structure of the 
Temperate Lactococcal Bacteriophage TP901-1. J Bacteriol 187:4187–4197. 
 
108.  Katsura I, Hendrix RW. 1984. Length determination in bacteriophage lambda tails. 
Cell 39:691–698. 
 
109.  Katsura I. 1987. Determination of bacteriophage λ tail length by a protein ruler. 
Nature 327:73–75. 
 
110.  Casjens SR, Hendrix RW. 1974. Locations and amounts of the major structural 
proteins in bacteriophage lambda. J Mol Biol 88:535–545. 
 
111.  Schwartz M. 1975. Reversible interaction between coliphage lambda and its 
receptor protein. J Mol Biol 99:185–201. 
 
112.  Heller K, Braun V. 1982. Polymannose O-antigens of Escherichia coli, the binding 
sites for the reversible adsorption of bacteriophage T5+ via the L-shaped tail 
fibers. J Virol 41:222–7. 
 
113.  Baptista C, Santos MA, Sao-Jose C. 2008. Phage SPP1 Reversible Adsorption to 
Bacillus subtilis Cell Wall Teichoic Acids Accelerates Virus Recognition of 
Membrane Receptor YueB. J Bacteriol 190:4989–4996. 
 239 
 
114.  Boulanger P, Jacquot P, Plançon L, Chami M, Engel A, Parquet C, Herbeuval C, 
Letellier L. 2008. Phage T5 Straight Tail Fiber Is a Multifunctional Protein Acting 
as a Tape Measure and Carrying Fusogenic and Muralytic Activities. J Biol Chem 
283:13556–13564. 
 
115.  Feucht A, Schmid A, Benz R, Schwarz H, Heller KJ. 1990. Pore formation 
associated with the tail-tip protein pb2 of bacteriophage T5. J Biol Chem 
265:18561–18567. 
 
116.  Cumby N, Reimer K, Mengin-Lecreulx D, Davidson AR, Maxwell KL. 2015. The 
phage tail tape measure protein, an inner membrane protein and a periplasmic 
chaperone play connected roles in the genome injection process of E . coli phage 
HK97. Mol Microbiol 96:437–447. 
 
117.  Scandella D, Arber W. 1974. An Escherichia coli mutant which inhibits the 
injection of phage λ DNA. Virology 58:504–513. 
 
118.  Scandella D, Arber W. 1976. Phage λ DNA injection into Escherichia coli pel− 
mutants is restored by mutations in phage genes V or H. Virology 69:206–215. 
 
119.  Hu B, Margolin W, Molineux IJ, Liu J. 2013. The bacteriophage T7 virion 
undergoes extensive structural remodeling during infection. Science (80- ) 
339:576–579. 
 
120.  Lindberg AA, Sarvas M, Makela PH. 1970. The Tail Sheath of Bacteriophage N4 
Interacts with the Escherichia coli Receptor. Infect Immun 1:88–97. 
 
121.  McPartland J, Rothman-Denes LB. 2009. The Tail Sheath of Bacteriophage N4 
Interacts with the Escherichia coli Receptor. J Bacteriol 191:525–532. 
 
122.  Leiman PG, Battisti AJ, Bowman VD, Stummeyer K, Mühlenhoff M, Gerardy-
Schahn R, Scholl D, Molineux IJ. 2007. The Structures of Bacteriophages K1E 
and K1-5 Explain Processive Degradation of Polysaccharide Capsules and 
Evolution of New Host Specificities. J Mol Biol 371:836–849. 
 
123.  Bayer ME, Takeda K, Uetake H. 1980. Effects of receptor destruction by 
Salmonella bacteriophages ϵ15 and c341. Virology 105:328–337. 
 
124.  Schulz EC, Schwarzer D, Frank M, Stummeyer K, Mühlenhoff M, Dickmanns A, 
Gerardy-Schahn R, Ficner R. 2010. Structural Basis for the Recognition and 
Cleavage of Polysialic Acid by the Bacteriophage K1F Tailspike Protein EndoNF. 
J Mol Biol 397:341–351. 
 
125.  Porcek NB, Parent KN. 2015. Key residues of S. flexneri OmpA mediate infection 
by bacteriophage Sf6. J Mol Biol 427:1964–1976. 
 240 
 
126.  Xu J, Gui M, Wang D, Xiang Y. 2016. The bacteriophage φ29 tail possesses a 
pore-forming loop for cell membrane penetration. Nature 534:544–547. 
 
127.  Hoffman B, Levine M. 1975. Bacteriophage P22 virion protein which performs an 
essential early function. II. Characterization of the Gene 16 Function. J Virol 
16:1547–1559. 
 
128.  Hoffman B, Levine M. 1975. Bacteriophage P22 virion protein which performs an 
essential early function. I. Analysis of 16-ts mutants. J Virol 16:1536–46. 
 
129.  Jin Y, Sdao SM, Dover JA, Porcek NB, Knobler CM, Gelbart WM, Parent KN. 
2015. Bacteriophage P22 ejects all of its internal proteins before its genome. 
Virology 485:128–134. 
 
130.  Perez GL, Huynh B, Slater M, Maloy S. 2009. Transport of phage P22 DNA 
across the cytoplasmic membrane. J Bacteriol 91:135–140. 
 
131.  Israel V. 1977. E Proteins of Bacteriophage P22. I. Identification and Ejection 
from Wild-Type and Defective Particles. J Virol 23:91–97. 
 
132.  Zhao H, Speir JA, Matsui T, Lin Z, Liang L, Lynn AY, Varnado B, Weiss TM, 
Tang L. 2016. Structure of a bacterial virus DNA-injection protein complex 
reveals a decameric assembly with a constricted molecular channel. PLoS One 
11:1–16. 
 
133.  Inagaki M, Kawaura T, Wakashima H, Kato M, Nishikawa S, Kashimura N. 2003. 
Different contributions of the outer and inner R-core residues of 
lipopolysaccharide to the recognition by spike H and G proteins of bacteriophage 
φX174. FEMS Microbiol Lett 226:221–227. 
 
134.  McKenna R, Xia D, Willingmann P, Ilag LL, Krishnaswamy S, Rossmann MG, 
Olson NH, Baker TS, Incardona NL. 1992. Atomic structure of single-stranded 
DNA bacteriophage phi X174 and its functional implications. Nature 355:137–43. 
 
135.  McKenna R, Ilag L, Rossmann M. 1994. Analysis of the Single-stranded DNA 
Bacteriophage PhiX174 Refined at a Resolution of 3.0A. J Mol Biol. 
 
136.  Bernal RA, Hafenstein S, Esmeralda R, Fane BA, Rossmann MG. 2004. The 
φX174 protein J mediates DNA packaging and viral attachment to host cells. J 
Mol Biol 337:1109–1122. 
 
137.  Ilag LL, Olson NH, Dokland T, Music CL, Cheng RH, Bowen Z, McKenna R, 
Rossmann MG, Baker TS, Incardona NL. 1995. DNA packaging intermediates of 
bacteriophage φX174. Structure 3:353–363. 
 
 241 
138.  Ilag LL, McKenna R, Yadav MP, BeMiller JN, Incardona NL, Rossmann MG. 
1994. Calcium Ion-induced Structural Changes in Bacteriophage φX174. J Mol 
Biol 244:291–300. 
 
139.  Roznowski AP, Young RJ, Love SD, Andromita AA, Guzman VA, Wilch MH, 
Block A, McGill A, Lavelle M, Romanova A, Sekiguchi A, Wang M, Burch AD, 
Fane BA. 2018. Recessive Host Range Mutants and Unsusceptible Cells That 
Inactivate Virions without Genome Penetration: Ecological and Technical 
Implications. J Virol 93:1–16. 
 
140.  Sun Y, Roznowski AP, Tokuda JM, Klose T, Mauney A, Pollack L, Fane BA, 
Rossmann MG. 2017. Structural changes of tailless bacteriophage ΦX174 during 
penetration of bacterial cell walls. Proc Natl Acad Sci 114:13708–13713. 
 
141.  Jazwinski SM, Lindberg AA, Kornberg A. 1975. The gene H spike protein of 
bacteriophages ∅X174 and S13. I. Functions in phage-receptor recognition and in 
transfection. Virology 66:283–293. 
 
142.  Jazwinski SM, Marco R, Kornberg A. 1975. The gene H spike protein of 
bacteriophages ∅X174 and S13. II. Relation to synthesis of the parental replicative 
form. Virology 66:294–305. 
 
143.  Sun L, Young LN, Zhang X, Boudko SP, Fokine A, Zbornik E, Roznowski AP, 
Molineux IJ, Rossmann MG, Fane BA. 2014. Icosahedral bacteriophage ΦX174 
forms a tail for DNA transport during infection. Nature 505:432–435. 
 
144.  Shepard W, Cruse WBT, Fourme R, De La Fortelle E, Prangé T. 1998. A zipper-
like duplex in DNA: The crystal structure of d(GCGAAAGCT) at 2.1 Å 
resolution. Structure 6:849–861. 
 
145.  Mandel-Gutfreund Y, Schueler O, Margalit H. 1995. Comprehensive Analysis of 
Hydrogen Bonds in Regulatory Protein DNA-Complexes: In Search of Common 
Principles. J Mol Biol 253:370–382. 
 
146.  Luscombe NM. 2001. Amino acid-base interactions: a three-dimensional analysis 
of protein-DNA interactions at an atomic level. Nucleic Acids Res 29:2860–2874. 
 
147.  Luscombe NM, Thornton JM. 2002. Protein–DNA Interactions: Amino Acid 
Conservation and the Effects of Mutations on Binding Specificity. J Mol Biol 
320:991–1009. 
 
148.  Suzuki M. 1994. A framework for the DNA–protein recognition code of the probe 
helix in transcription factors: the chemical and stereochemical rules. Structure 
2:317–326. 
 
 242 
149.  Conley MJ, McElwee M, Azmi L, Gabrielsen M, Byron O, Goodfellow IG, Bhella 
D. 2019. Calicivirus VP2 forms a portal-like assembly following receptor 
engagement. Nature 565:377–381. 
 
 
Chapter 2 
 
1.  Leiman PG, Schneider MM. 2012. Contractile Tail Machines of Bacteriophages, p. 
93–114. In Rossmann, MG, Rao, VB (eds.), Viral Molecular Machines. Springer 
US, Boston, MA. 
 
2.  Hu B, Margolin W, Molineux IJ, Liu J. 2013. The bacteriophage T7 virion 
undergoes extensive structural remodeling during infection. Science (80- ) 
339:576–579. 
 
3.  Esquinas-rychen M, Erni B. 2001. Facilitation of Bacteriophage Lambda DNA 
Injection by Inner Membrane Proteins of the Bacterial Phosphoenol-
pyruvate:Carbohydrate Phosphotransferase System (PTS). J Mol Microbiol 
Biotechnol 3:361–370. 
 
4.  Russel M, Model P. 2006. Filamentous phage, p 146–160. In Calendar R (ed), The 
bacteriophages, 2nd ed. Oxford Press, London, United Kingdom. 
 
5.  Van Duin J, Tsareva N. 2006. Single-stranded RNA phages, p 175–196. In 
Calendar R (ed), The bacteriophages, 2nd ed. Oxford Press, London, United 
Kingdom 
 
6.  Jazwinski SM, Lindberg AA, Kornberg A. 1975. The gene H spike protein of 
bacteriophages ∅X174 and S13. I. Functions in phage-receptor recognition and in 
transfection. Virology 66:283–293. 
 
7.  Jazwinski SM, Marco R, Kornberg A. 1975. The gene H spike protein of 
bacteriophages ∅X174 and S13. II. Relation to synthesis of the parental replicative 
form. Virology 66:294–305. 
 
8.  Sun L, Young LN, Zhang X, Boudko SP, Fokine A, Zbornik E, Roznowski AP, 
Molineux IJ, Rossmann MG, Fane BA. 2014. Icosahedral bacteriophage ΦX174 
forms a tail for DNA transport during infection. Nature 505:432–435. 
 
9.  Sun L, Rossmann MG, Fane BA. 2014. High-Resolution Structure of a Virally 
Encoded DNA-Translocating Conduit and the Mechanism of DNA Penetration. J 
Virol 88:10276–10279. 
 
10.  Tang J, Lander GC, Olia A, Li R, Casjens S, Prevelige P, Cingolani G, Baker TS, 
Johnson JE. 2011. Article Peering Down the Barrel of a Bacteriophage Portal : The 
 243 
Genome Packaging and Release Valve in P22. Struct Des 19:496–502. 
 
11.  Olia AS, Prevelige PE, Johnson JE, Cingolani G. 2011. Three-dimensional 
structure of a viral genome-delivery portal vertex. Nat Struct Mol Biol 18:597–
603. 
 
12.  Egelman EH, Xu C, DiMaio F, Magnotti E, Modlin C, Yu X, Wright E, Baker D, 
Conticello VP. 2015. Structural Plasticity of Helical Nanotubes Based on Coiled-
Coil Assemblies. Structure 23:280–289. 
 
13.  Pieters BJGE, van Eldijk MB, Nolte RJM, Mecinović J. 2016. Natural 
supramolecular protein assemblies. Chem Soc Rev 45:24–39. 
 
14.  Cherwa JE, Organtini LJ, Ashley RE, Hafenstein SL, Fane BA. 2011. In vitro 
assembly of the øx174 procapsid from external scaffolding protein oligomers and 
early pentameric assembly intermediates. J Mol Biol 412:387–396. 
 
15.  Cherwa JE, Uchiyama A, Fane BA. 2008. Scaffolding Proteins Altered in the 
Ability To Perform a Conformational Switch Confer Dominant Lethal Assembly 
Defects. J Virol 82:5774–5780. 
 
16.  Ruboyianes M V, Chen M, Dubrava MS, Cherwa JE, Fane BA. 2009. The 
Expression of N-Terminal Deletion DNA Pilot Proteins Inhibits the Early Stages 
of ΦX174 Replication. J Virol 83:9952–9956. 
 
17.  Fane BA, Hayashi M. 1991. Second-site suppressors of a cold-sensitive prohead 
accessory protein of bacteriophage φX174. Genetics 128:663–71. 
 
18.  Fane BA, Head S, Hayashi M. 1992. Functional relationship between the J proteins 
of bacteriophages φX174 and G4 during phage morphogenesis. J Bacteriol 
174:2717–2719. 
 
19.  Bernhardt TG, Struck DK, Young R. 2001. The Lysis Protein E of φX174 Is a 
Specific Inhibitor of the MraY-catalyzed Step in Peptidoglycan Synthesis. J Biol 
Chem 276:6093–6097. 
 
20.  Sanger F, Coulson AR, Friedmann T, Air GM, Barrell BG, Brown NL, Fiddes JC, 
Hutchison CA, Slocombe PM, Smith M. 1978. The nucleotide sequence of 
bacteriophage φX174. J Mol Biol 125:225–246. 
 
21.  Fane BA, Shien S, Hayashi M. 1993. Second-site suppressors of a cold-sensitive 
external scaffolding protein of bacteriophage φX174. Genetics 134:1003–11. 
 
22.  Burch AD, Ta J, Fane BA. 1999. Cross-functional analysis of the Microviridae 
internal scaffolding protein. J Mol Biol 286:95–104. 
 
 244 
23.  Uchiyama A, Fane BA. 2005. Identification of an Interacting Coat-External 
Scaffolding Protein Domain Required for both the Initiation of ΦX174 Procapsid 
Morphogenesis and the Completion of DNA Packaging. J Virol 79:6751–6756. 
 
24.  Cherwa JE, Sanchez-Soria P, Wichman HA, Fane BA. 2009. Viral Adaptation to 
an Antiviral Protein Enhances the Fitness Level to Above That of the Uninhibited 
Wild Type. J Virol 83:11746–11750. 
 
25.  Hafenstein SL, Chen M, Fane BA. 2004. Genetic and functional analyses of the 
φX174 DNA binding protein: the effects of substitutions for amino acid residues 
that spatially organize the two DNA binding domains. Virology 318:204–213. 
 
26.  McKenna R, Bowman BR, Ilag LL, Rossmann MG, Fane BA. 1996. Atomic 
structure of the degraded procapsid particle of the bacteriophage G4: Induced 
structural changes in the presence of calcium ions and functional implications. J 
Mol Biol 256:736–750. 
 
27.  Cherwa JE, Young LN, Fane BA. 2011. Uncoupling the functions of a 
multifunctional protein: The isolation of a DNA pilot protein mutant that affects 
particle morphogenesis. Virology 411:9–14. 
 
28.  Young LN, Hockenberry AM, Fane BA. 2014. Mutations in the N Terminus of the 
ΦX174 DNA Pilot Protein H Confer Defects in both Assembly and Host Cell 
Attachment. J Virol 88:1787–1794. 
 
29.  Mano Y, Sakai H, Komano T. 1979. Growth and DNA synthesis of bacteriophage 
φX174 in a dnaP mutant of Escherichia coli. J Virol 30:650–6. 
 
30.  Harbury P, Zhang T, Kim P, Alber T. 1993. A switch between two-, three-, and 
four-stranded coiled coils in GCN4 leucine zipper mutants. Science (80- ) 
262:1401–1407. 
 
32.  Bayer ME, Starkey TW. 1972. The adsorption of bacteriophage ΦX174 and its 
interaction with Escherichia coli; a kinetic and morphological study. Virology 
49:236–256. 
 
33.  Spindler KR, Hayashi M. 1979. DNA synthesis in Escherichia coli cells infected 
with gene H mutants of bacteriophage φX174. J Virol 29:973–82. 
 
34.  Dokland T, McKenna R, Llag LL, Bowman BR, Incardona NL, Fane BA, 
Rossmann MG. 1997. Structure of a viral procapsid with molecular scaffolding. 
Nature 389:308–313. 
 
35.  McKenna R, Xia D, Willingmann P, Ilag LL, Krishnaswamy S, Rossmann MG, 
Olson NH, Baker TS, Incardona NL. 1992. Atomic structure of single-stranded 
DNA bacteriophage phi X174 and its functional implications. Nature 355:137–43. 
 245 
Chapter 3 
 
1.  Bauer DW, Huffman JB, Homa FL, Evilevitch A. 2013. Herpes Virus Genome, 
The Pressure Is On. J Am Chem Soc 135:11216–11221. 
 
2.  Molineux IJ, Panja D. 2013. Popping the cork: mechanisms of phage genome 
ejection. Nat Rev Microbiol 11:194–204. 
 
3.  Aksyuk AA, Leiman PG, Kurochkina LP, Shneider MM, Kostyuchenko VA, 
Mesyanzhinov V V., Rossmann MG. 2009. The tail sheath structure of 
bacteriophage T4: A molecular machine for infecting bacteria. EMBO J 28:821–
829. 
 
4.  Fokine A, Rossmann MG. 2014. Molecular architecture of tailed double-stranded 
DNA phages. Bacteriophage 4:e28281. 
 
5.  Hu B, Margolin W, Molineux IJ, Liu J. 2013. The bacteriophage T7 virion 
undergoes extensive structural remodeling during infection. Science (80- ) 
339:576–579. 
 
6.  Cumby N, Reimer K, Mengin-Lecreulx D, Davidson AR, Maxwell KL. 2015. The 
phage tail tape measure protein, an inner membrane protein and a periplasmic 
chaperone play connected roles in the genome injection process of E . coli phage 
HK97. Mol Microbiol 96:437–447. 
 
7.  Jin Y, Sdao SM, Dover JA, Porcek NB, Knobler CM, Gelbart WM, Parent KN. 
2015. Bacteriophage P22 ejects all of its internal proteins before its genome. 
Virology 485:128–134. 
 
8.  Dent KC, Thompson R, Barker AM, Hiscox JA, Barr JN, Stockley PG, Ranson 
NA. 2013. The Asymmetric Structure of an Icosahedral Virus Bound to Its 
Receptor Suggests a Mechanism for Genome Release. Structure 21:1225–1234. 
 
9.  Krahn PM, O’Callaghan RJ, Paranchych W. 1972. Stages in phage R17 infection 
VI. Injection of A Protein and RNA into the Host Cell. Virology 47:628–637. 
 
10.  Toropova K, Stockley PG, Ranson NA. 2011. Visualising a Viral RNA Genome 
Poised for Release from Its Receptor Complex. J Mol Biol 408:408–419. 
 
11.  Webster RE. 1996. Biology of the Filamentous Bacteriophage, p. 1–20. In Phage 
Display of Peptides and Proteins: A Laboratory Manual. Elsevier. 
 
12.  Bennett NJ, Rakonjac J. 2006. Unlocking of the Filamentous Bacteriophage Virion 
During Infection is Mediated by the C Domain of pIII. J Mol Biol 356:266–273. 
 
13.  Bennett NJ, Gagic D, Sutherland-Smith AJ, Rakonjac J. 2011. Characterization of 
 246 
a Dual-Function Domain That Mediates Membrane Insertion and Excision of Ff 
Filamentous Bacteriophage. J Mol Biol 411:972–985. 
 
14.  Sun Y, Roznowski AP, Tokuda JM, Klose T, Mauney A, Pollack L, Fane BA, 
Rossmann MG. 2017. Structural changes of tailless bacteriophage ΦX174 during 
penetration of bacterial cell walls. Proc Natl Acad Sci 114:13708–13713. 
 
15.  Sun L, Young LN, Zhang X, Boudko SP, Fokine A, Zbornik E, Roznowski AP, 
Molineux IJ, Rossmann MG, Fane BA. 2014. Icosahedral bacteriophage ΦX174 
forms a tail for DNA transport during infection. Nature 505:432–435. 
 
16.  Cherwa JE, Young LN, Fane BA. 2011. Uncoupling the functions of a 
multifunctional protein: The isolation of a DNA pilot protein mutant that affects 
particle morphogenesis. Virology 411:9–14. 
 
17.  Dokland T, Bernal RA, Burch A, Pletnev S, Fane BA, Rossmann MG. 1999. The 
role of scaffolding proteins in the assembly of the small, single-stranded DNA 
virus φX174. J Mol Biol 288:595–608. 
 
18.  Dokland T, McKenna R, Llag LL, Bowman BR, Incardona NL, Fane BA, 
Rossmann MG. 1997. Structure of a viral procapsid with molecular scaffolding. 
Nature 389:308–313. 
 
19.  Ilag LL, Olson NH, Dokland T, Music CL, Cheng RH, Bowen Z, McKenna R, 
Rossmann MG, Baker TS, Incardona NL. 1995. DNA packaging intermediates of 
bacteriophage φX174. Structure 3:353–363. 
 
20.  Novak CR, Fane BA. 2004. The functions of the N terminus of the φX174 internal 
scaffolding protein, a protein encoded in an overlapping reading frame in a two 
scaffolding protein system. J Mol Biol 335:383–390. 
 
21.  Azuma J, Morita J, Komano T. 1980. Process of Attachment of ΦX174 Parental 
DNA to the Host Cell Membrane. J Biochem 88:525–532. 
 
22.  Mano Y, Sakai H, Komano T. 1979. Growth and DNA synthesis of bacteriophage 
φX174 in a dnaP mutant of Escherichia coli. J Virol 30:650–6. 
 
23.  Murakami Y, Nagata T, Schwarz W, Wada C, Yura T. 1985. Novel dnaG mutation 
in a dnaP mutant of Escherichia coli. J Bacteriol 162:830–2. 
 
24.  Conley MJ, McElwee M, Azmi L, Gabrielsen M, Byron O, Goodfellow IG, Bhella 
D. 2019. Calicivirus VP2 forms a portal-like assembly following receptor 
engagement. Nature 565:377–381. 
 
25.  Shepard W, Cruse WBT, Fourme R, De La Fortelle E, Prangé T. 1998. A zipper-
like duplex in DNA: The crystal structure of d(GCGAAAGCT) at 2.1 Å 
 247 
resolution. Structure 6:849–861. 
 
26.  Luscombe NM. 2001. Amino acid-base interactions: a three-dimensional analysis 
of protein-DNA interactions at an atomic level. Nucleic Acids Res 29:2860–2874. 
 
27.  Luscombe NM, Thornton JM. 2002. Protein–DNA Interactions: Amino Acid 
Conservation and the Effects of Mutations on Binding Specificity. J Mol Biol 
320:991–1009. 
 
28.  Mandel-Gutfreund Y, Schueler O, Margalit H. 1995. Comprehensive Analysis of 
Hydrogen Bonds in Regulatory Protein DNA-Complexes: In Search of Common 
Principles. J Mol Biol 253:370–382. 
 
29.  Suzuki M. 1994. A framework for the DNA–protein recognition code of the probe 
helix in transcription factors: the chemical and stereochemical rules. Structure 
2:317–326. 
 
30.  Rokyta DR, Burch CL, Caudle SB, Wichman H a. 2006. Horizontal Gene Transfer 
and the Evolution of Microvirid Coliphage Genomes. J Bacteriol 188:1134–1142. 
 
31.  Simossis VA, Heringa J. 2005. PRALINE: a multiple sequence alignment toolbox 
that integrates homology-extended and secondary structure information. Nucleic 
Acids Res 33:W289–W294. 
 
32.  Simossis VA. 2005. Homology-extended sequence alignment. Nucleic Acids Res 
33:816–824. 
 
33.  Roznowski AP, Fane BA. 2016. Structure-Function Analysis of the ΦX174 DNA-
Piloting Protein Using Length-Altering Mutations. J Virol 90:7956–7966. 
 
34.  Young LN, Hockenberry AM, Fane BA. 2014. Mutations in the N Terminus of the 
ΦX174 DNA Pilot Protein H Confer Defects in both Assembly and Host Cell 
Attachment. J Virol 88:1787–1794. 
 
35.  Ilag LL, McKenna R, Yadav MP, BeMiller JN, Incardona NL, Rossmann MG. 
1994. Calcium Ion-induced Structural Changes in Bacteriophage φX174. J Mol 
Biol 244:291–300. 
 
36.  Ruboyianes M V, Chen M, Dubrava MS, Cherwa JE, Fane BA. 2009. The 
Expression of N-Terminal Deletion DNA Pilot Proteins Inhibits the Early Stages 
of ΦX174 Replication. J Virol 83:9952–9956. 
 
37.  Boulanger P, Letellier L. 1992. Ion channels are likely to be involved in the two 
steps of phage T5 DNA penetration into Escherichia coli cells. J Biol Chem 
267:3168–72. 
 
 248 
38.  Keweloh H, Bakker EP. 1984. Permeability changes in the cytoplasmic membrane 
of Escherichia coli K-12 early after infection with bacteriophage T1. J Bacteriol 
160:347–353. 
 
39.  Roznowski AP, Young RJ, Love SD, Andromita AA, Guzman VA, Wilch MH, 
Block A, McGill A, Lavelle M, Romanova A, Sekiguchi A, Wang M, Burch AD, 
Fane BA. 2018. Recessive Host Range Mutants and Unsusceptible Cells That 
Inactivate Virions without Genome Penetration: Ecological and Technical 
Implications. J Virol 93:1–16. 
 
40.  Jazwinski SM, Marco R, Kornberg A. 1975. The gene H spike protein of 
bacteriophages ∅X174 and S13. II. Relation to synthesis of the parental replicative 
form. Virology 66:294–305. 
 
41.  Morein S, Henricson D, Rilfors L. 1994. Separation of Inner and Outer Membrane 
Vesicles from Escherichia coli in Self-Generating Percoll Gradients. Anal 
Biochem 216:47–51. 
 
42.  Luria S, Delbrück M. 1943. Mutations of Bacteria from Virus Sensitivity to Virus 
Resistance. Genetics 28:491–511. 
 
43.  Fane BA, Hayashi M. 1991. Second-site suppressors of a cold-sensitive prohead 
accessory protein of bacteriophage φX174. Genetics 128:663–71. 
 
44.  Fane BA, Shien S, Hayashi M. 1993. Second-site suppressors of a cold-sensitive 
external scaffolding protein of bacteriophage φX174. Genetics 134:1003–11. 
 
45.  Gordon EB, Fane BA. 2013. Effects of an Early Conformational Switch Defect 
during ΦX174 Morphogenesis Are Belatedly Manifested Late in the Assembly 
Pathway. J Virol 87:2518–2525. 
 
46.  Gordon EB, Knuff CJ, Fane BA. 2012. Conformational Switch-Defective ϕX174 
Internal Scaffolding Proteins Kinetically Trap Assembly Intermediates before 
Procapsid Formation. J Virol 86:9911–9918. 
 
47.  Floor E. 1970. Interaction of morphogenetic genes of bacteriophage T4. J Mol Biol 
47:293–306. 
 
48.  Sternberg N. 1976. A genetic analysis of bacteriophage λ head assembly. Virology 
71:568–582. 
 
49.  Van Valen D, Wu D, Chen Y-J, Tuson H, Wiggins P, Phillips R. 2012. A Single-
Molecule Hershey-Chase Experiment. Curr Biol 22:1339–1343. 
 
50.  García LR, Molineux IJ. 1995. Incomplete entry of bacteriophage T7 DNA into F 
plasmid-containing Escherichia coli. J Bacteriol 177:4077–4083. 
 249 
 
51.  Lanni YT. 1968. First-step-transfer deoxyribonucleic acid of bacteriophage T5. 
Bacteriol Rev 32:227–42. 
 
52.  Lanni YT. 1965. DNA transfer from phage T5 to host cells: dependence on 
intercurrent protein synthesis. Proc Natl Acad Sci 53:969–973. 
 
53.  Moffatt BA, Studier FW. 1988. Entry of bacteriophage T7 DNA into the cell and 
escape from host restriction. J Bacteriol 170:2095–2105. 
 
54.  Fane BA, Head S, Hayashi M. 1992. Functional relationship between the J proteins 
of bacteriophages φX174 and G4 during phage morphogenesis. J Bacteriol 
174:2717–2719. 
 
55.  Bernhardt TG, Struck DK, Young R. 2001. The Lysis Protein E of φX174 Is a 
Specific Inhibitor of the MraY-catalyzed Step in Peptidoglycan Synthesis. J Biol 
Chem 276:6093–6097. 
 
56.  Burch AD, Ta J, Fane BA. 1999. Cross-functional analysis of the Microviridae 
internal scaffolding protein. J Mol Biol 286:95–104. 
 
57.  Uchiyama A, Fane BA. 2005. Identification of an Interacting Coat-External 
Scaffolding Protein Domain Required for both the Initiation of ΦX174 Procapsid 
Morphogenesis and the Completion of DNA Packaging. J Virol 79:6751–6756. 
 
58.  Cherwa JE, Sanchez-Soria P, Wichman HA, Fane BA. 2009. Viral Adaptation to 
an Antiviral Protein Enhances the Fitness Level to Above That of the Uninhibited 
Wild Type. J Virol 83:11746–11750. 
 
59.  Hafenstein SL, Chen M, Fane BA. 2004. Genetic and functional analyses of the 
φX174 DNA binding protein: the effects of substitutions for amino acid residues 
that spatially organize the two DNA binding domains. Virology 318:204–213. 
 
60.  Karkhanis YD, Zeltner JY, Jackson JJ, Carlo DJ. 1978. A new and improved 
microassay to determine 2-keto-3-deoxyoctonate in lipopolysaccharide of gram-
negative bacteria. Anal Biochem 85:595–601. 
 
Chapter 4 
 
1. Leiman PG, Chipman PR, Kostyuchenko VA, Mesyanzhinov VV, Rossmann 
MG. 2004. Three-dimensional rearrangement of proteins in the tail of 
bacteriophage T4 on infection of its host. Cell 118:419-29. 
 
2. Belnap DM, Filman DJ, Trus BL, Cheng N, Booy FP, Conway JF, Curry S, 
Hiremath CN, Tsang SK, Steven AC, Hogle JM. 2000. Molecular tectonic model 
 250 
of virus structural transitions: the putative cell entry states of poliovirus. J Virol 
74:1342-54. 
 
3. Bubeck D, Filman DJ, Cheng N, Steven AC, Hogle JM, Belnap DM. 2005. The 
structure of the poliovirus 135S cell entry intermediate at 10-angstrom resolution 
reveals the location of an externalized polypeptide that binds to membranes. J 
Virol 79:7745-55. 
 
4. Hu B, Margolin W, Molineux IJ, Liu J. 2013. The bacteriophage t7 virion 
undergoes extensive structural remodeling during infection. Science 339:576-9. 
5. Cotmore SF, Tattersall P. 2007. Parvoviral host range and cell entry mechanisms. 
Adv Virus Res 70:183-232. 
 
 
6. Lee H, Shingler KL, Organtini LJ, Ashley RE, Makhov AM, Conway JF, 
Hafenstein S. 2016. The novel asymmetric entry intermediate of a picornavirus 
captured with nanodiscs. Sci Adv 2:e1501929. 
 
7. Hueffer K, Parker JS, Weichert WS, Geisel RE, Sgro JY, Parrish CR. 2003. The 
natural host range shift and subsequent evolution of canine parvovirus resulted 
from virus-specific binding to the canine transferrin receptor. J Virol 77:1718-26. 
 
8. Duffy S, Turner PE, Burch CL. 2006. Pleiotropic costs of niche expansion in the 
RNA bacteriophage phi 6. Genetics 172:751-7. 
 
9. Ford BE, Sun B, Carpino J, Chapler ES, Ching J, Choi Y, Jhun K, Kim JD, Lallos 
GG, Morgenstern R, Singh S, Theja S, Dennehy JJ. 2014. Frequency and fitness 
consequences of bacteriophage phi6 host range mutations. PLoS One 9:e113078. 
 
10. Tetart F, Repoila F, Monod C, Krisch HM. 1996. Bacteriophage T4 host range is 
expanded by duplications of a small domain of the tail fiber adhesin. J Mol Biol 
258:726-31. 
 
11. Yosef I, Goren MG, Globus R, Molshanski-Mor S, Qimron U. 2017. Extending 
the Host Range of Bacteriophage Particles for DNA Transduction. Mol Cell 
66:721-728 e3. 
 
12. Bertozzi Silva J, Storms Z, Sauvageau D. 2016. Host receptors for bacteriophage 
adsorption. FEMS Microbiol Lett 363. 
 
13. Mindich L, Bamford D, McGraw T, Mackenzie G. 1982. Assembly of 
bacteriophage PRD1: particle formation with wild-type and mutant viruses. J 
Virol 44:1021-30. 
 
14. Mindich L, Sinclair JF, Cohen J. 1976. The morphogenesis of bacteriophage phi6: 
particles formed by nonsense mutants. Virology 75:224-31. 
 251 
 
15. Mindich L, Sinclair JF, Levine D, Cohen J. 1976. Genetic studies of temperature-
sensitive and nonsense mutants of bacteriophage phi6. Virology 75:218-23. 
 
16. Stengele I, Bross P, Garces X, Giray J, Rasched I. 1990. Dissection of functional 
domains in phage fd adsorption protein. Discrimination between attachment and 
penetration sites. J Mol Biol 212:143-9. 
 
17. Baptista C, Santos MA, Sao-Jose C. 2008. Phage SPP1 reversible adsorption to 
Bacillus subtilis cell wall teichoic acids accelerates virus recognition of 
membrane receptor YueB. J Bacteriol 190:4989-96. 
 
18. McPartland J, Rothman-Denes LB. 2009. The tail sheath of bacteriophage N4 
interacts with the Escherichia coli receptor. J Bacteriol 191:525-32. 
 
19. Parent KN, Erb ML, Cardone G, Nguyen K, Gilcrease EB, Porcek NB, Pogliano 
J, Baker TS, Casjens SR. 2014. OmpA and OmpC are critical host factors for 
bacteriophage Sf6 entry in Shigella. Mol Microbiol 92:47-60. 
 
20. Meyer JR, Dobias DT, Weitz JS, Barrick JE, Quick RT, Lenski RE. 2012. 
Repeatability and contingency in the evolution of a key innovation in phage 
lambda. Science 335:428-32. 
 
21. Michel A, Clermont O, Denamur E, Tenaillon O. 2010. Bacteriophage PhiX174's 
ecological niche and the flexibility of its Escherichia coli lipopolysaccharide 
receptor. Appl Environ Microbiol 76:7310-3. 
 
22. Weisbeek PJ, van de Pol JH, van Arkel GA. 1973. Mapping of host range mutants 
of bacteriophage phiX174. Virology 52:408-16. 
 
23. Sinsheimer RL. 1968. Bacteriophage phi-X174 and related viruses. Prog Nucleic 
Acid Res Mol Biol 8:115-69. 
 
24. Tessman ES. 1965. Complementation Groups in Phage S13. Virology 25:303-21. 
 
25. Bone DR, Dowell CE. 1973. A mutant of bacteriophage phiX174 which infects E. 
coli K12 strains. I. Isolation and partial characterization of phiXtB. Virology 
52:319-29. 
 
26. Cox J, Putonti C. 2010. Mechanisms responsible for a PhiX174 mutant's ability to 
infect Escherichia coli by phosphorylation. J Virol 84:4860-3. 
 
27. Newbold JE, Sinsheimer RL. 1970. The process of infection with bacteriophage 
phiX174. XXXII. Early steps in the infection process: attachment, eclipse and 
DNA penetration. J Mol Biol 49:49-66. 
 
 252 
28. Sun L, Rossmann MG, Fane BA. 2014. High-resolution structure of a virally 
encoded DNA-translocating conduit and the mechanism of DNA penetration. J 
Virol 88:10276-9. 
 
29. Sun L, Young LN, Zhang X, Boudko SP, Fokine A, Zbornik E, Roznowski AP, 
Moulineux I, Rossmann MG, Fane BA. 2014. Icosahedral ΦX174 forms a tail for 
DNA transport. Nature 505:432-5. 
 
30. Sun Y, Roznowski AP, Tokuda JM, Klose T, Mauney A, Pollack L, Fane BA, 
Rossmann MG. 2017. Structural changes of tailless bacteriophage PhiX174 
during penetration of bacterial cell walls. Proc Natl Acad Sci U S A 114:13708-
13713. 
 
31. McKenna R, Ilag LL, Rossmann MG. 1994. Analysis of the single-stranded DNA 
bacteriophage phi X174, refined at a resolution of 3.0 A. J Mol Biol 237:517-43. 
 
32. McKenna R, Xia D, Willingmann P, Ilag LL, Krishnaswamy S, Rossmann MG, 
Olson NH, Baker TS, Incardona NL. 1992. Atomic structure of single-stranded 
DNA bacteriophage phi X174 and its functional implications. Nature 355:137-43. 
 
33. Ilag LL, McKenna R, Yadav MP, BeMiller JN, Incardona NL, Rossmann MG. 
1994. Calcium ion-induced structural changes in bacteriophage phi X174. J Mol 
Biol 244:291-300. 
 
34. Rokyta DR, Burch CL, Caudle SB, Wichman HA. 2006. Horizontal gene transfer 
and the evolution of microvirid coliphage genomes. J Bacteriol 188:1134-42. 
35. Sandulache R, Prehm P, Kamp D. 1984. Cell wall receptor for bacteriophage Mu 
G(+). J Bacteriol 160:299-303. 
 
36. Bowes JM, Dowell CE. 1974. Purification and some properties of bacteriophage 
ST-1. J Virol 13:53-61. 
 
37. Fane BA, Hayashi M. 1991. Second-site suppressors of a cold-sensitive prohead 
accessory protein of bacteriophage phi X174. Genetics 128:663-71. 
 
38. Fane BA, Head S, Hayashi M. 1992. Functional relationship between the J 
proteins of bacteriophages phi X174 and G4 during phage morphogenesis. J 
Bacteriol 174:2717-9. 
 
39. Bernhardt TG, Struck DK, Young R. 2001. The lysis protein E of phi X174 is a 
specific inhibitor of the MraY-catalyzed step in peptidoglycan synthesis. J Biol 
Chem 276:6093-7. 
 
40. Moak M, Molineux IJ. 2000. Role of the Gp16 lytic transglycosylase motif in 
bacteriophage T7 virions at the initiation of infection. Mol Microbiol 37:345-55. 
 
 253 
41. Daniel AS, Fuller-Pace FV, Legge DM, Murray NE. 1988. Distribution and 
diversity of hsd genes in Escherichia coli and other enteric bacteria. J Bacteriol 
170:1775-82. 
 
42. Kodaira K, Nakano K, Okada S, Taketo A. 1992. Nucleotide sequence of the 
genome of the bacteriophage alpha 3: interrelationship of the genome structure 
and the gene products with those of the phages, phi X174, G4 and phi K. Biochim 
Biophys Acta 1130:277-88. 
 
43. Blackburn BJ, Li S, Roznowski AP, Perez AR, Villarreal RH, Johnson CJ, Hardy 
M, Tuckerman EC, Burch AD, Fane BA. 2017. Coat protein mutations that alter 
the flux of morphogenetic intermediates through the phiX174 early assembly 
pathway. J Virol doi:JVI.01384-17 [pii] 
 
44. Cherwa JE, Jr., Sanchez-Soria P, Wichman HA, Fane BA. 2009. Viral adaptation 
to an antiviral protein enhances the fitness level to above that of the uninhibited 
wild type. J Virol 83:11746-50. 
 
45. Hafenstein SL, Chen M, Fane BA. 2004. Genetic and functional analyses of the 
oX174 DNA binding protein: the effects of substitutions for amino acid residues 
that spatially organize the two DNA binding domains. Virology 318:204-13. 
 
46. Cumby N, Reimer K, Mengin-Lecreulx D, Davidson AR, Maxwell KL. 2015. The 
phage tail tape measure protein, an inner membrane protein and a periplasmic 
chaperone play connected roles in the genome injection process of E. coli phage 
HK97. Mol Microbiol 96:437-47. 
 
47. Boulanger P, Letellier L. 1992. Ion Channels Are Likely to Be Involved in the 2 
Steps of Phage-T5 DNA Penetration into Escherichia-Coli-Cells. Journal of 
Biological Chemistry 267:3168-3172. 
 
48. Letellier L, Plancon L, Bonhivers M, Boulanger P. 1999. Phage DNA transport 
across membranes. Res Microbiol 150:499-505. 
 
49. Newbold JE, Sinsheimer RL. 1970. Process of infection with bacteriophage phi-
X174. XXXIV. Kinetic of the attachment and eclipse steps of the infection. J 
Virol 5:427-31. 
 
50. Boulanger P, Letellier L. 1992. Ion channels are likely to be involved in the two 
steps of phage T5 DNA penetration into Escherichia coli cells. J Biol Chem 
267:3168-72. 
 
51. A. ZA. 1972. Protein volume in solution. Prog Biophys Mol Biol 24:107-123. 
 
 254 
52. Cherwa JE, Jr., Fane BA. 2009. Complete virion assembly with scaffolding 
proteins altered in the ability to perform a critical conformational switch. J Virol 
83:7391-6. 
 
53. Cherwa JE, Jr., Uchiyama A, Fane BA. 2008. Scaffolding proteins altered in the 
ability to perform a conformational switch confer dominant lethal assembly 
defects. J Virol 82:5774-80. 
 
54. Doore SM, Baird CD, Roznowski AP, Fane BA. 2014. The evolution of genes 
within genes and the control of DNA replication in microviruses. Mol Biol Evol 
31:1421-31. 
 
55. Gordon EB, Knuff CJ, Fane BA. 2012. Conformational Switch-Defective øX174 
Internal Scaffolding Proteins Kinetically Trap Assembly Intermediates before 
Procapsid Formation. J Virol 86:9911-8. 
 
56. Roznowski AP, Fane BA. 2016. Structure-Function Analysis of the varphiX174 
DNA-Piloting Protein Using Length-Altering Mutations. J Virol 90:7956-66. 
 
57. Uchiyama A, Chen M, Fane BA. 2007. Characterization and function of putative 
substrate specificity domain in microvirus external scaffolding proteins. J Virol 
81:8587-92. 
 
58. Bernal RA, Hafenstein S, Olson NH, Bowman VD, Chipman PR, Baker TS, Fane 
BA, Rossmann MG. 2003. Structural studies of bacteriophage alpha3 assembly. J 
Mol Biol 325:11-24. 
 
59. Holland JJ, de la Torre JC, Steinhauer DA, Clarke D, Duarte E, Domingo E. 
1989. Virus mutation frequencies can be greatly underestimated by monoclonal 
antibody neutralization of virions. J Virol 63:5030-6. 
 
60. Hutchison CA, 3rd, Sinsheimer RL. 1971. Requirement of protein synthesis for 
bacteriophage phi X174 superinfection exclusion. J Virol 8:121-4. 
 
61. van der Avoort HG, van Arkel GA, Weisbeek PJ. 1982. Cloned bacteriophage phi 
X174 DNA sequence interferes with synthesis of the complementary strand of 
infecting bacteriophage phi X174. J Virol 42:1-11. 
 
62. Crill WD, Wichman HA, Bull JJ. 2000. Evolutionary reversals during viral 
adaptation to alternating hosts. Genetics 154:27-37. 
 
63. Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, 
Ferrin TE. 2004. UCSF Chimera--a visualization system for exploratory research 
and analysis. J Comput Chem 25:1605-12. 
 
 
 255 
Chapter 5 
 
1.  Sun L, Zhang X, Gao S, Rao PA, Padilla-Sanchez V, Chen Z, Sun S, Xiang Y, 
Subramaniam S, Rao VB, Rossmann MG. 2015. Cryo-EM structure of the 
bacteriophage T4 portal protein assembly at near-atomic resolution. Nat Commun 
6:1–11. 
 
2.  Olia AS, Prevelige PE, Johnson JE, Cingolani G. 2011. Three-dimensional 
structure of a viral genome-delivery portal vertex. Nat Struct Mol Biol 18:597–
603. 
 
3.  Casjens SR. 2011. The DNA-packaging nanomotor of tailed bacteriophages. Nat 
Rev Microbiol 9:647–657. 
 
4.  Rajagopala S V, Casjens S, Uetz P. 2011. The protein interaction map of 
bacteriophage lambda. BMC Microbiol 11:213. 
 
5.  Kikuchi Y, King J. 1975. Assembly of the tail of bacteriophage T4. J Supramol 
Struct 3:24–38. 
 
6.  Rochat RH, Liu X, Murata K, Nagayama K, Rixon FJ, Chiu W. 2011. Seeing the 
Portal in Herpes Simplex Virus Type 1 B Capsids. J Virol 85:1871–1874. 
 
7.  Bauer DW, Li D, Huffman J, Homa FL, Wilson K, Leavitt JC, Casjens SR, Baines 
J, Evilevitch A. 2015. Exploring the Balance between DNA Pressure and Capsid 
Stability in Herpesviruses and Phages. J Virol 89:9288–9298. 
 
8.  Newcomb WW, Juhas RM, Thomsen DR, Homa FL, Burch AD, Weller SK, 
Brown JC. 2001. The UL6 Gene Product Forms the Portal for Entry of DNA into 
the Herpes Simplex Virus Capsid. J Virol 75:10923–10932. 
 
9.  Chang JT, Schmid MF, Rixon FJ, Chiu W. 2007. Electron Cryotomography 
Reveals the Portal in the Herpesvirus Capsid. J Virol 81:2065–2068. 
 
10.  Connolly SA, Jackson JO, Jardetzky TS, Longnecker R. 2011. Fusing structure 
and function: a structural view of the herpesvirus entry machinery. Nat Rev 
Microbiol 9:369–381. 
 
11.  Ojala PM, Sodeik B, Ebersold MW, Kutay U, Helenius A. 2000. Herpes Simplex 
Virus Type 1 Entry into Host Cells: Reconstitution of Capsid Binding and 
Uncoating at the Nuclear Pore Complex In Vitro. Mol Cell Biol 20:4922–4931. 
 
12.  Pasdeloup D, Blondel D, Isidro AL, Rixon FJ. 2009. Herpesvirus Capsid 
Association with the Nuclear Pore Complex and Viral DNA Release Involve the 
Nucleoporin CAN/Nup214 and the Capsid Protein pUL25. J Virol 83:6610–6623. 
 
 256 
13.  Shahin V, Hafezi W, Oberleithner H, Ludwig Y, Windoffer B, Schillers H, Kuhn 
JE. 2006. The genome of HSV-1 translocates through the nuclear pore as a 
condensed rod-like structure. J Cell Sci 119:23–30. 
 
14.  Belnap DM, McDermott BM, Filman DJ, Cheng N, Trus BL, Zuccola HJ, 
Racaniello VR, Hogle JM, Steven  a C. 2000. Three-dimensional structure of 
poliovirus receptor bound to poliovirus. Proc Natl Acad Sci 97:73–78. 
 
15.  Brandenburg B, Lee LY, Lakadamyali M, Rust MJ, Zhuang X, Hogle JM. 2007. 
Imaging Poliovirus Entry in Live Cells. PLoS Biol 5:e183. 
 
16.  Belnap DM, Filman DJ, Trus BL, Cheng N, Booy FP, Conway JF, Curry S, 
Hiremath CN, Tsang SK, Steven AC, Hogle JM. 2000. Molecular Tectonic Model 
of Virus Structural Transitions: the Putative Cell Entry States of Poliovirus. J Virol 
74:1342–1354. 
 
17.  Strauss M, Schotte L, Karunatilaka KS, Filman DJ, Hogle JM. 2017. Cryo-electron 
Microscopy Structures of Expanded Poliovirus with VHHs Sample the 
Conformational Repertoire of the Expanded State. J Virol 91:1–22. 
 
18.  Groppelli E, Levy HC, Sun E, Strauss M, Nicol C, Gold S, Zhuang X, Tuthill TJ, 
Hogle JM, Rowlands DJ. 2017. Picornavirus RNA is protected from cleavage by 
ribonuclease during virion uncoating and transfer across cellular and model 
membranes. PLOS Pathog 13:e1006197. 
 
19.  Danthi P, Tosteson M, Li Q -h., Chow M. 2003. Genome Delivery and Ion 
Channel Properties Are Altered in VP4 Mutants of Poliovirus. J Virol 77:5266–
5274. 
 
20.  Fricks CE, Hogle JM. 1990. Cell-induced conformational change in poliovirus: 
externalization of the amino terminus of VP1 is responsible for liposome binding. 
J Virol 64:1934–45. 
 
21.  Hogle J, Chow M, Filman D. 1985. Three-dimensional structure of poliovirus at 
2.9 A resolution. Science (80- ) 229:1358–1365. 
 
22.  Sun Y, Roznowski AP, Tokuda JM, Klose T, Mauney A, Pollack L, Fane BA, 
Rossmann MG. 2017. Structural changes of tailless bacteriophage ΦX174 during 
penetration of bacterial cell walls. Proc Natl Acad Sci 114:13708–13713. 
 
23.  Ilag LL, Olson NH, Dokland T, Music CL, Cheng RH, Bowen Z, McKenna R, 
Rossmann MG, Baker TS, Incardona NL. 1995. DNA packaging intermediates of 
bacteriophage φX174. Structure 3:353–363. 
 
 
 
 257 
24.  Dokland T, Bernal RA, Burch A, Pletnev S, Fane BA, Rossmann MG. 1999. The 
role of scaffolding proteins in the assembly of the small, single-stranded DNA 
virus φX174. J Mol Biol 288:595–608. 
 
25.  Cheng N, Wu W, Watts NR, Steven AC. 2014. Exploiting radiation damage to 
map proteins in nucleoprotein complexes: The internal structure of bacteriophage 
T7. J Struct Biol 185:250–256. 
 
26.  Cheng N, Wu W, Steven AC, Thomas J, Black L. 2012. Bubblegrams reveal the 
inner body of bacteriophage phiKZ. Microsc Microanal 18:112–113. 
 
27.  Suzuki R, Inagaki M, Karita S, Kawaura T, Kato M, Nishikawa S, Kashimura N, 
Morita J. 1999. Specific interaction of fused H protein of bacteriophage φX174 
with receptor lipopolysaccharides. Virus Res 60:95–99. 
 
28.  Nishikawa S. 2000. Characterization of the Binding of spike H Protein of 
Bacteriophage phiX174 with Receptor Lipopolysaccharides 127:577–583. 
 
29.  Young LN, Hockenberry AM, Fane BA. 2014. Mutations in the N Terminus of the 
ΦX174 DNA Pilot Protein H Confer Defects in both Assembly and Host Cell 
Attachment. J Virol 88:1787–1794. 
 
30.  Bernal RA, Hafenstein S, Esmeralda R, Fane BA, Rossmann MG. 2004. The 
φX174 protein J mediates DNA packaging and viral attachment to host cells. J 
Mol Biol 337:1109–1122. 
 
31.  Ruboyianes M V, Chen M, Dubrava MS, Cherwa JE, Fane BA. 2009. The 
Expression of N-Terminal Deletion DNA Pilot Proteins Inhibits the Early Stages 
of ΦX174 Replication. J Virol 83:9952–9956. 
 
32.  Hayashi M, Aoyama A, Richardson DL, Hayashi MN. 1988. Biology of the 
Bacteriophage φX174, p. 1–71. In Calendar, R (ed.), The Bacteriophages Volume 
2. Plenum Publishing Corporation, New York. 
 
33.  Molineux IJ, Panja D. 2013. Popping the cork: mechanisms of phage genome 
ejection. Nat Rev Microbiol 11:194–204. 
 
34.  Grayson P, Evilevitch A, Inamdar MM, Purohit PK, Gelbart WM, Knobler CM, 
Phillips R. 2006. The effect of genome length on ejection forces in bacteriophage 
lambda. Virology 348:430–436. 
 
35.  Lemay SG, Panja D, Molineux IJ. 2013. Role of osmotic and hydrostatic pressures 
in bacteriophage genome ejection. Phys Rev E 87:022714. 
 
36.  Aoyama A, Hayashi M. 1985. Effects of genome size on bacteriophage ΦX174 
DNA packaging in vitro. J Biol Chem 260:11033–11038. 
 258 
 
 
37.  Russell PW, Muller UR. 1984. Construction of Bacteriophage phiX174 Mutants 
with Maximum Genome Sizes. J Virol 52:822–827. 
 
38.  Conley MJ, McElwee M, Azmi L, Gabrielsen M, Byron O, Goodfellow IG, Bhella 
D. 2019. Calicivirus VP2 forms a portal-like assembly following receptor 
engagement. Nature 565:377–381. 
 
39.  Sun L, Young LN, Zhang X, Boudko SP, Fokine A, Zbornik E, Roznowski AP, 
Molineux IJ, Rossmann MG, Fane BA. 2014. Icosahedral bacteriophage ΦX174 
forms a tail for DNA transport during infection. Nature 505:432–435. 
 
40.  Lokareddy RK, Sankhala RS, Roy A, Afonine P V., Motwani T, Teschke CM, 
Parent KN, Cingolani G. 2017. Portal protein functions akin to a DNA-sensor that 
couples genome-packaging to icosahedral capsid maturation. Nat Commun 
8:14310. 
 
41.  Zheng W, Wang F, Taylor NMI, Guerrero-Ferreira RC, Leiman PG, Egelman EH. 
2017. Refined Cryo-EM Structure of the T4 Tail Tube: Exploring the Lowest Dose 
Limit. Structure 25:1436–1441.e2. 
 
